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 The microtubule [MT] cytoskeleton of S. pombe is a highly dynamic network 
of filaments that facilitates intracellular transport, determines cell polarity and plays 
an essential role in chromosome separation during mtosis. In fission yeast, MTs are 
nucleated in a temporally and spatially regulated manner from sites called 
Microtubule Organising Centres [MTOCs], through theactivity of both the γ-tubulin 
complex [γ-TuC] and the Mto1/2 complex. The Mto1/2 complex determines the 
localisation of the γ-TuC at MTOCs, which change throughout the cell cyce. As 
cells enter mitosis the cytoplasmic array of MT bundles depolymerise. They are 
replaced by the intranuclear mitotic spindle and cytoplasmic spindle pole body-
derived astral MTs that in turn give way to the formation of the post-anaphase array. 
Although much is known about the properties of each type of MT array, the 
mechanism by which the timing of MT nucleation at different MTOCs is regulated 
over the cell cycle remains unclear.   
 In the Mto1/2 complex, Mto1 is thought to provide th  primary interaction 
with the γ-TuC, and Mto2 functions by reinforcing this interaction. Due to the lack of 
structural information for the Mto1/2 complex, the molecular mechanism of Mto1/2-
mediated assembly of the γ-TuC at MTOCs is unknown. The aim of my study is to 
investigate the possibility that the Mto1/2 complex is able to promote γ-TuC 
assembly by forming a direct template. In addition, I will attempt to determine the 
molecular role of Mto2 within the Mto1/2 complex and examine ways in which 
regulation of Mto2 may influence the function the Mto1/2 complex at specific 
MTOCs.  
   x  
 As part of the investigation into the mechanism of Mto2 function, an in vitro 
analysis of recombinant protein demonstrated that in the absence of Mto1, purified 
Mto2 is able to self-interact as a tetramer. I have confirmed this interaction in vivo 
and have also shown that Mto2 forms a dimer as cellenter mitosis. However, in the 
context of an Mto1/2 complex the significance of the change in Mto2 oligomeric 
state remains unknown. Hydrodynamic analysis of a truncated form of the Mto1/2 
complex suggests that it may form a heterotetramer, a hypothesis which is consistent 
with the equimolar levels of Mto2 and Mto1 protein within the cell. This information 
provides some structural insight as to how the Mto1/2 complex may interact with the 
γ-TuC at MTOCs. Further analysis of the Mto1/2 complex revealed that in vivo, the 
Mto1-Mto2 interaction is disrupted during mitosis. This was found to correlate with 
the hyperphosphorylation of Mto2, which occurs as cells enter mitosis. Subsequently, 
an in vitro kinase assay demonstrated that phosphorylation of the Mto1/2 complex 
reduces the stability of the complex.  Mass spectrometry techniques and sequence 
conservation were used to identify several phosphorylated residues within Mto2 and 
the ability of these mutants to bind to Mto1 was analysed in vivo and in vitro. In 
summary, in this study I have uncovered a mechanism which allows fission yeast 
cells to regulate the nucleation of cytoplasmic MT nucleation in a cell-cycle 
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1.1 Microtubule function 
 
 Microtubules [MTs] are found in all eukaryotic cells and form a filamentous 
network between central peri-nuclear regions and the outer domains of the cell 
interior. MTs have important functions in regulating cell shape, growth and cell 
polarity. This is achieved by delivery of numerous polarity factors to sites of cell 
growth (Drubin et al. 1996; Ahringer 2003; Small et al. 2003; Snaith et al. 2005b). In 
addition, MTs also support processes such as endocytosis and exocytosis through the 
formation of an efficient transport and communication network that allows motor-
driven movement of membrane vesicles around the cell [reviewed in (Caviston et al. 
2006; Soldati et al. 2006). MTs also provide information that helps to regulate the 
positioning of several types of intracellular organelles such as the nucleus, Golgi 
apparatus and mitochondria (Ayscough et al. 1993; Yaffe et al. 1996; Hagan et al. 
1997; Tran et al. 2000). In specialised motile cells such as epithelial or neuronal cells, 
MTs co-ordinate with the actin cytoskeleton to promote cell protrusion and migration 
(Ballestrem et al. 2000; Gibney et al. 2003). MTs are essential during mitosis and 
meiosis, as they form the spindle, which connects the chromosomal DNA to 
centrosomes and facilitates separation of the genoms into two daughter cells. For 
the purpose of this report, the mitotic spindle will not be discussed, however, for 
reviews of the regulation and behaviour of MTs of the mitotic spindle see (Mishima 
et al. 2004; Glotzer 2009).  
 Microtubules were first observed by electron micros opy studies on epithelial 
cilia and spermatozoid flagella. Later studies confirmed the existence of similar 
tubular-like structures within the cytoplasm of many cell types. These structures 
were given the term ‘microtubules’ (Gibbons 1961; Ledbetter et al. 1963; 
Slautterback 1963). 
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 In the proliferating cells of higher eukaryotes, MTs are arranged into radial 
arrays that emanate from a peri-nuclear structure call d the centrosome. The 
centrosome is composed of a pair of centrioles that are encased in amorphous peri-
centriolar material [PCM]. The protein complexes found within the PCM nucleate 
MTs that form the cytoplasmic radial array (Gould, R. R. et al. 1977; Dictenberg et 
al. 1998). Centrioles are short barrel-like structures that are approximately 0.5 µm 
long and 0.23 µm wide and usually contain nine triplet MT seeds composed of 
glutamylated αβ-tubulin. These structures are essential for cell division in most but 
not all cell types [e.g. female gametes]. However, c ntrioles are not present in higher 
plants or fungi (Marshall 2009). During non-proliferative growth, centrioles can 
migrate to the cell cortex where they form basal bodies and nucleate axonemal MTs 
that are required to generate cilia and flagella. These structures have multiple 
functions depending on cell type. Non-motile primary cilia are found in the majority 
of cells and function as a hub for chemical sensation and signal transduction 
[reviewed in (Singla et al. 2006)]. Motile cilia exist on the apical surface of epithelial 
cells of the respiratory and reproductive tracts where a harmonious beating of cilia 
generates flow to move extracellular particles and/or clear debris. A specialised 
version of motile cilia called flagella have been developed in certain eukaryotic cells 
e.g. spermatozoa. The movement of the flagella is powered by MT motors, which 
unlike the beating movement of cilia, causes a screw-like or wave-like motion that 
allows the cells to efficiently propel themselves through the surrounding media (Berg 
et al. 1973). 
 The cytoskeletal structure of prokaryotes is less well defined. However, it has 
been shown that they have cytoskeletal structures that are constructed from polymers 
of the FtsZ protein which is an evolutionary ancestor of the MT constituent protein, 
tubulin (Lutkenhaus, J. F. et al. 1980). The structure of the FtsZ protein prevents it 
from forming the same MT structure as observed in higher eukaryotes and instead 
FtsZ is thought to form single protofilaments, sheets and tubule-like conformations 
(Erickson et al. 1996b). Unlike eukaryotes, where MTs have important roles 
throughout the cell cycle, FtsZ polymers appear to function primarily during 
cytokinesis, where FtsZ forms Z-rings at the cell division site (Addinall et al. 1996). 
Many of the proteins that are required for cell division are targeted to the Z-ring 
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during cytokinesis; consequently deletion of FtsZ protein leads to long aseptated 
cells (Lutkenhaus, J. et al. 1997). 
  
 In addition to centrosomal and basal body-derived radial MT arrays there are 
a number of non-centrosomal linear MT arrays. Comparatively, our current 
understanding of the function and regulation of non-ce trosomal MTs is significantly 
less clear than what has been established for centrosomal arrays. It appears that there 
is a certain level of redundancy between the two, as cells which have had their 
centrosome removed can re-establish a relatively normal interphase cellular array 
from centrosome independent sites (Karsenti t al. 1984). Cells that have had their 
centrosomes removed can also nucleate a bipolar spindle. The majority of these MTs 
are nucleated from sites on the chromosomes themselves; however, these cells often 
fail to complete cytokinesis due to spindle alignmet defects (Khodjakov et al. 2000; 
Khodjakov et al. 2001).  
 Non-centrosomal linear MT arrays run parallel to the cell axis and are 
primarily found in differentiated cells such as in neurons, epithelial and muscle cells 
(Keating et al. 1999; Bartolini et al. 2006). These MTs are thought to be generated 
from a mixture of sources including release from the centrosome, MT breakage 
events and nucleation from non-centrosomal sites at the nuclear envelope or from 
pre-existing MTs (Bugnard et al. 2005). 
 Cells of higher plants do not have centrosomes. Therefore all MT arrays are 
non-centrosomal and, depending on the cell type and stage of the cell cycle, adopt a 
variety of different architectures. In epidermal cel s, a cortical array is formed in G1 
and S phase where MTs are nucleated at the cell cortex from pre-existing MTs or at 
de novo sites, and then are quickly arranged to form an organised array (Ehrhardt 
2008). During interphase and G1, MTs are nucleated from the nuclear envelope to 
form the peri-nuclear array which is believed to regulate the shape of the nucleus 
(Stoppin et al. 1994). The pre-prophase band is formed at the cell division site in late 
G2 and is required for proper organisation of the mitotic spindle (Ambrose t al. 
2008). The phragmoplast MTs are formed in telophase and align perpendicular to the 
cell division plate. These MTs are required to guide vesicles and cell wall material to 
the growing plate [reviewed in (Jurgens 2005)].   
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 In Saccharomyces cerevisiae, all MTs are nucleated from the centrosome 
equivalent, the spindle pole body [SPB]. However, like higher eukaryotes, MT 
nucleation in the closely related fission yeast Schizosaccharomyces pombe occurs 
from a mixture of both centrosomal and non-centrosomal sources. In addition to 
centrosomal MTs that are nucleated from the SPB, non-SPB MT arrays such as the 
post-anaphase array and a number of interphase MTs are nucleated from a several 
different sites throughout the cell cycle (Hagan 1998). These arrays are important for 
maintenance of cell shape and positioning of the organelles such as the nucleus 
which in turn determines the site of cell division. These linear arrays also insure that 
polarity factors such as Tea1 are delivered to the cell tips, so that a bipolar growth 
pattern is preserved (Radcliffe et al. 1998; Sawin et al. 1998; Snaith et al. 2005a). 
  
1.2 Structure of the Microtubule 
 
 MTs are protein polymers composed of dimers of α- and β-tubulin. A MT 
filament is composed from several polymers or protofilaments to form a hollow 
cylinder that is approximately 25 nm in diameter. The first in depth structural 
analysis of tubulin came in 1998 where electron crystallography was used to 
determine the structure of tubulin α/β dimers isolated from bovine brain tissue 
(Nogales et al. 1998). This analysis described the same basic struture for both α and 
β variants of tubulin. These proteins can be divided into two functional domains, the 
amino-terminal domain containing the nucleotide binding region and the carboxyl 
terminal domain which is thought to be the target of MT associated proteins [MAPs] 
and motor proteins. The tubulin dimers are arranged so that the nucleotide binding 
pocket of α-tubulin is hidden between the dimer interface. As a result, only β-tubulin 
bound GTP is able to hydrolyse, and α-tubulin remains GTP-associated.   
 MTs are held together by both longitudinal and later l associations between 
α- and β- tubulin monomers. The lateral line of like subunits is orientated with a 10° 
pitch from the horizontal, resulting in a 3-start helix, where upon full rotation the last 
monomer is three units above the first [8 nm apart]. Consequently at the seam of the 
MT there are lateral associations between α and β tubulin monomers (Mitchison, T. J. 
1993; Fan et al. 1996). Longitudinal associations of the α/β dimer give the 
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protofilament an intrinsic polarity, where the β-subunit is exposed at the plus end of 
the MT and α-tubulin is exposed at the minus end. 
 There was much debate over the exact structure of MTs, with early work 
proposing protofilament numbers ranging from 8-15 (Burton 1966; Bertolini et al. 
1970). Some of the first evidence for the compositin of MTs based on a 13-
protofilament structure came from the laboratory of Daniel Snyder (Tilney et al. 
1973). They used electron microscopy to show clear im ges of 13 subunit rings of 
equally spaced tubulin monomers from both cytoplasmic and cilia derived 
centrosomes. Subsequent work has shown that this number is subject to particular 
polymerisation conditions. For example, when polymerisation is induced in vitro, a 
mixture of 13,14, and 15 protofilaments have been observed (Langford 1980; 
McEwen et al. 1980; Evans et al. 1985). This number may also be species specific, 
for example in Caenorhabditis elegans the majority of MTs are 11-protofilament 
structures, however specific neuronal cells have been found to contain 15-
protofilament fibres, both of which respond differently to MT depolymerising drugs 
(Chalfie et al. 1982). 
 
1.3 Microtubule nucleation and polymerisation 
 
 Following purification of tubulin, the presence of molecules of GTP 
nucleotide within the MT was discovered (Weisenberg et al. 1968; Lee et al. 1975; 
Weisenberg et al. 1975). Some of the first efforts to analyse the prope ties of GTP 
hydrolysis derived kinetic data from turbidity experiments that measured polymer 
concentration and the release of radiolabelled inorganic phosphate [32Pi]. In these 
experiments it was demonstrated that one GTP was hydrolysed per tubulin dimer 
incorporated. First order kinetic equations showed that there was a delay between 
incorporation and GTP hydrolysis, indicating that these two events were not strictly 
linked. At the same time, experiments using non-hydrol sable analogs of GTP 
[GMPPNP and GMPPCP] demonstrated that GTP hydrolysis is not required for 
tubulin polymerisation (Penningroth et al. 1978). This suggested that there may be a 
small region of newly polymerised MT that contains GTP tubulin, called the GTP 
cap. The GTP cap has never been directly observed, but experimental data has 
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predicted that the minimum number of molecules of GTP-tubulin required to support 
MT polymerisation is 22 ± 11, but some estimates have shown that the cap can be up 
to 100 subunits deep [reviewed in (Desai et al. 1997)].  
 Margolis and Wilson used the presence of the GTP cap to design experiments 
to measure MT dynamics (Margolis et al. 1978). They used pulse chase of 3H-GTP 
to measure incorporation rates and loss rates at ste dy state tubulin concentration. 
This showed that incorporation of the label is linear with time, but when performed 
under steady-state where there is no net growth, there was no net increase in label 
incorporation, suggesting that label must be incorporated and released at equal rates. 
From this data they proposed a mechanism of ‘MT treadmilling’. This describes the 
process by which addition of tubulin dimers occurs from one end and removal of 
tubulin occurs from the opposite end. These early experiments were misleading 
because the MTs were contaminated with other MAPs which altered the MT 
polymerisation dynamics that would otherwise have be n observed for purified 
tubulin. 
 Subsequent experiments by Mitchison and Kirscher who, instead of 
considering the behaviour of the population as a whole, used electron microscopy to 
study the length of individual MTs over time and came to very different conclusion 
(Mitchison, T. et al. 1984a; Mitchison, T. et al. 1984b). They developed a technique 
which allowed them to isolate centrosomes and analyse their polymerisation 
properties in vitro. They found that the critical concentration for MT polymerisation 
was 14 µM in the absence of centrosome derived MT seeds and 3-4 µM in the 
presence of centrosomes. Using a population of pre-ormed MTs, on dilution of 
tubulin they showed that there was a proportional depolymerisation of MTs. 
However, the remaining MTs are capable of polymerisation. At a ‘steady-state’ 
tubulin concentration there are two phases of MTs, the majority are growing at a 
steady rate and the minority are rapidly shrinking to counteract the difference in 
tubulin concentration. The net increase in MT length suggests that transitions 
between phases are relatively rare events. This behaviour was described by 
Mitchison as ‘dynamic instability’ and is now widely accepted in current literature.  
By comparing the mean MT length over time as a functio  of tubulin concentration 
they then used this data to calculate rates of polymerisation. These experiments 
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demonstrated that during polymerisation, the on-rate of tubulin dimers is higher and 
the off-rate is lower at the plus end than at the minus end, indicating that the plus end 
is more stable. However, during depolymerisation the off-rate is a lot higher for the 
plus end, indicating that monomers are lost quicker from this end.  As Margolis and 
Wilson performed their experiments at steady state wh re there is no net growth, the 
polymerisation on-rate at the plus end dominated th resulting kinetic data, and the 
off-rates at plus ends were never observed.  
 The off-rate during depolymerisation was found to be three orders of 
magnitude higher that the off-rate during polymerisation. Mitchison and Kirschner 
believed that this represented the off-rates of GDP-tubulin and GTP-tubulin 
respectively. They also showed that shearing of MTs at steady state induced 
depolymerisation events, which supported the idea that the GTP cap stabilises the 
MT ends and that GDP-tubulin is more likely to depolymerise. This information 
provided one of the first experimental based theories to explain the function of GTP 
hydrolysis. Advances in technology have allowed analysis of MT structure at a 
molecular level, and it was subsequently shown that GTP bound β-tubulin forms a 
more stable lattice than GDP bound β-tubulin, confirming Mitchison’s results 
(Nogales et al. 1998). Non-hydrolysable nucleotide analogue-bound MTs are more 
structurally stable than the filaments containing the hydrolysed nucleotide, which 
have more weakly associated lateral contacts (Mejillano et al. 1990). Docking of the 
refined structure of purified αβ-tubulin dimers onto the protofilament lattice 
demonstrated that the αβ-tubulin dimers have a straight conformation when present 
in the MT lattice (Nogales et al. 1999; Lowe et al. 2001). This straight conformation 
is thought to be promoted by lateral association of tubulin dimers, as the structure of 
αβ-tubulin dimers isolated from preformed protofilaments that do not have lateral 
contacts followed a curved conformation (Ravelli t al. 2004). This difference in 
conformation was subsequently shown to correlate wih the hydrolysis of β-tubulin 
bound GTP into GDP (Wang et al. 2005). This observation provided the rationale for 
MT depolymerisation. When the straight GTP-bound tubulin dimers that stabilise the 
protofilament are lost from the plus end of the MT, this exposes the GDP-bound 
tubulin. The weakened lateral association of the curved GDP-bound tubulin causes 
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the individual protofilaments to peel away from thelattice. This phenomena was 
observed using electron microscopy of shortening MTs (Tran et al. 1997). 
 
1.4 The gamma-tubulin complex 
 
 The MT nucleating activity of the centrosome depends on a tubulin variant 
called gamma tubulin [γ-tubulin]. γ-tubulin was first identified the product of the 
mipA gene, a suppressor of a β-tubulin mutation in Aspergillus nidulans. γ-tubulin 
was found to be an essential gene, in which mutations inhibit nuclear division as well 
as a reduction in the length and number of cytoplasmic MTs (Oakley, C. E. et al. 
1989; Oakley, B. R. et al. 1990). Cloning of the homologous genes in higher 
eukaryotes showed that γ-tubulin localised to the PCM (Stearns et al. 1991; Zheng et 
al. 1991). Microinjection of an antibody raised against a γ-tubulin peptide into 
mammalian tissue culture cells prevented MT re-growth following depolymerisation 
induced by nocodazole or cold shock (Joshi et al. 1992). This suggested that γ-
tubulin was a critical component of the MT nucleation machinery. The first 
biochemical experiments on γ-tubulin revealed that unlike α/β-tubulin, it is present as 
a monomer, and the protein was localised to the minus ends of MTs (Melki et al. 
1993).  
 Initially there were two models to describe MT nucleation [reviewed in 
(Moritz et al. 2001)]. These are schematically represented in Figure 1.1. The 
Protofilament Model was proposed by Harold Erickson (Erickson et al. 1996a). It 
describes the polymerisation of α/β-tubulin dimers through lateral association with a 
γ-tubulin seed protofilament up to 14 subunits long, which extends into the α/β-
tubulin protofilament. Recent evidence to support this model includes the discovery 
that γ-tubulin interacts more strongly with β-tubulin than α-tubulin despite the fact 
that α-tubulin is found at the minus ends of MTs (Leguy et al. 2000). It is known that 
lateral interactions between α/β dimers are very weak. It was proposed that lateral 
binding of γ-tubulin with β-tubulin may act to support the α/β-tubulin lateral 
interactions. It has also been shown that single γ-tubulin monomers are sufficient to 
nucleate and cap MTs, indicating that complex structures are not required for MT 
nucleation in vitro (Leguy et al. 2000).  
































Figure 1.1 Models of γ-tubulin induced MT nucleation. In the Template model 
[left] the γ-tubulin interacts laterally to form a ring like structure which associates 
longitudinally with α-tubulin. The Protofilament model [right] describes the 
unwinding of the γ-tubulin ring into a short protofilament, which laterally 
associates with αβ-tubulin dimers. Figure modified from (Moritz et al. 2001).   
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 A second model, the Template model, was proposed by Yixian Zheng (Zheng 
et al. 1995). The Template Model describes the polymerisation of α/β dimers through 
longitudinal associations with a ring-like template of γ-tubulin. The proposed γ-
tubulin structure is a 3-start helix which can extend up to 12 nm into the 
protofilament to assimilate the pitch of the α/β-tubulin MT. This model was 
supported by negative stain electron-microscopy of MTs extracted from Xenopus 
laevis egg extracts, where incubation with gold particle-conjugated secondary 
antibody showed that γ-tubulin is not found more that 15 nm away from the minus 
end of the MT. This contradicted the Protofilament model which predicted that when 
fully extended the 14-subunit γ-tubulin protofilament would extend up to 50 nm into  
the fibre (Keating et al. 2000). The position of γ-tubulin was confirmed when 
measurements taken from reconstituted nucleation eve ts showed that 90% of gold-
labelled γ-tubulin was within 40 nm of the end of the MT (Wiese et al. 2000).  
 Purification of γ-tubulin revealed that it is part of a large complex with 
several other proteins and has a nucleation efficiency similar to that of the 
Drosophila melanogaster centrosome (Kellogg et al. 1992; Raff et al. 1993; Stearns 
et al. 1994; Zheng et al. 1995). Some of the most elegant experiments were 
performed by Zheng and colleagues, who used electron microscopy of γ-tubulin 
complexes purified from X. laevis to show that the complexes adopted a ring-like 
structure, 25-28 nm in diameter that was found to associate with the minus ends of 
MTs (Zheng et al. 1995). This was confirmed through additional imaging of both 
isolated centrosomes and purified γ-tubulin complexes from D. melanogaster (Moritz 
et al. 1995a; Moritz et al. 1995b; Moritz et al. 2000). Supporters of the Protofilament 
model would argue that MT-free helix structures represent arched protofilaments of 
γ-tubulin, similar to the structures formed from single α/β-tubulin protofilaments at 
depolymerising ends of MTs. It has also been predict  that single γ-tubulin 
molecules would be sufficient to cap minus ends of MTs, as they would form a 3-
turn helix that would prevent closing of the filament sheet (Erickson 2000; Leguy et 
al. 2000). However, evidence of a domed structure at the ends of MTs and the 
absence of γ-TuC spirals that extend out from the main protofilament, means the 
Template Model of MT nucleation is now widely accepted in the microtubule 
community.  
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 Subsequent research went on to characterise the purified γ-tubulin containing 
complexes. Extracts from D. melanogaster were analysed by sucrose gradient 
centrifugation and it was shown that γ-tubulin exists in two complexes of different 
size. Hydrodynamic analysis of the large complex demonstrated that it had an S-
value of 35.5 S, Stokes’ radius of 15 nm and a molecular mass of approximately 2.2 
MDa. Analysis of the small complex demonstrated that it had an S-value of 9.8 S,  
Stokes’ radius of 7 nm and a molecular mass of 280 KDa (Oegema et al. 1999). 
Upon treatment with 0.5 M salt the large complex is converted to small complex 
suggesting that the former is made up of subunits of the latter. Both of these 
complexes when isolated from sucrose gradient or gel-filtration can complement the 
salt stripped centrosome, which suggests that the interaction between the γ-tubulin 
containing complex and the centrosome scaffold is direct (Moritz et al. 1998; 
Oegema et al. 1999).  
 Purification of the γ-tubulin containing complex in several organisms allowed 
identification of the protein components. Many of these proteins contained so-called 
‘grip motifs’, however, the function of these domains remain unknown 
(Gunawardane t al. 2000a). γ-tubulin complex components include: 
Dgrip84/Xgrip110/SpAlp4/GCP2 and Dgrip91/Xgrip109/SpAlp6/GCP3, 
Dgrip128/Xgrip133/SpMod21/GCP5, Dgrip75/Xgrip75/SpGfth1/GCP4, 
Dgrip163/Xgrip210/SpAlp16/GCP6 and more recently Dgrip71WD/GCP-
WD/NEDD1. The entire complex was named the γ-tubulin ring complex [γ-TuRC] 
(Martin et al. 1998; Murphy et al. 1998; Zheng et al. 1998; Oegema et al. 1999; 
Gunawardane t al. 2000b; Murphy et al. 2001; Fujita et al. 2002; Gunawardane et al. 
2003; Anders et al. 2006; Haren et al. 2006; Luders et al. 2006; Verollet et al. 2006). 
The smaller complex isolated from salt-stripped centrosomes was found to consist of 
two copies of γ-tubulin and one copy of Dgrip84/Xgrip110/SpAlp4/GCP2 and 
Dgrip91/Xgrip109/SpAlp6/GCP3, and was designated th gamma tubulin small 
complex [γ-TuSC] (Oegema et al. 1999; Gunawardane et al. 2000b). A coverslip 
nucleation assay was developed to measure the nucleation activity of both complexes. 
It was found that the γ-TuRC has a 150 fold higher nucleation activity permole of 
complex than the γ-TuSC (Oegema et al. 1999). However, RNAi knockdown of 
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GCP-4/5/6 in D. melanogaster has shown that the γ-TuSC is sufficient to nucleate a 
basic centrosomal array (Verollet et al. 2006). 
 S. cerevisiae do not have homologs of GCP4-6, suggesting that the primary 
source of MT nucleation is via the γ-TuSC [known in budding yeast as the Tub4 
complex]. This indicates that other regulatory mechanisms may exist in budding 
yeast that promote the activity of this complex eith r though post-translational 
modifications or structural rearrangements. Research performed in the laboratory of 
David Agard attempted to address this problem by using electron microscopy to 
study the structure of the Tub4 complex (Kollman et al. 2008). They found that Tub4 
[γ-tubulin], Spc97p [GCP2] and Spc98p [GCP3] assemble to form a ‘Y-shaped’ 
complex, where immuno-gold-labelling was used to determine the position of Tub4 
at the arms and FRET was used to demonstrate that the N- erminal tails of both 
Spc98 and Spc97 form the body of the ‘Y’.  Interestingly, several classes of Tub4 
complex structure were observed, where the distance between the Tub4 subunits on 
the arms varied between 85 Å and 70 Å, suggesting a degree of flexibility in that part 
of the molecule. This supports the idea that Tub4/γ-TuSC undergoes a structural 
change that favours MT nucleation. However, as the authors argue, it is unlikely that 
the level of variation seen in purified complex is sufficient to facilitate the formation 
of lateral interactions between α/β-tubulin monomers, suggesting additional factors 
exist that enhance any structural rearrangement. 
  
 GCP1-6 are conserved in S. pombe. As in higher eukaryotes, the S. pombe    
γ-TuSC homologues, Gtb1, Alp4 and Alp6 are all essential for viability (Horio et al. 
1991; Stearns et al. 1991; Vardy et al. 2000). Strains containing temperature- 
sensitive alleles show large cytoplasmic MT bundles which curve around the cell tips 
(Paluh et al. 2000; Vardy et al. 2000). Nucleation assays in alp4-ts mutants show that 
the nucleation of cytoplasmic MTs is reduced (Zimmer an, S. et al. 2005). 
Additional members of the γ-TuRC, Gfh1, Alp16, and Mod21 [designated non-core 
γ-TuRC components] are not essential for viability, but the deletion mutants display 
moderate interphase MT defects. The number of interphase MTs is reduced to 1-3 in 
non-core mutants, compared with 3-5 for wild-type cells, and nucleation from non-
SPB sites is reduced by 30%. As the γ-TuSCs localise and nucleate from non-SPB 
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sites in non-core deletion mutants, this suggests that these proteins are able to 
compensate for the loss of γ-TuRC formation (Fujita et al. 2002; Venkatram et al. 
2004; Anders et al. 2006).  
 The relative contribution of both the γ-TuRC and the γ-TuSC, collectively 
known as the γ-tubulin complex [γ-TuC], to nucleation of the different MT arrays in 
fission yeast is unclear. When γ-TuC components are analysed by sucrose gradient 
sedimentation, γ-tubulin is mostly present in a low S-value complex [~8-9S], unlike 
γ-tubulin from both Xenopus and Drosophila extracts, which are mostly present in a 
large S-value complex [30-35 S] (Oegema et l. 1999). However, recent data suggest 
that members of the γ-TuRC co-localise with γ-TuSC at the minus ends of MTs, 
indicating that the large complex may be assembled.   
 
1.5 γ-tubulin associated proteins 
 
 There are a number of additional γ-TuC associated proteins that are required 
for the γ-TuC to function as an efficient MT nucleator. Several proteins have been 
shown to play a role in the recruitment and/or anchoring of the γ-TuRC within the 
PCM, many of which are influenced by levels of cell ycle-dependant regulation. 
Pericentrin is a large scaffold protein that exists in a number of different isoforms. 
Zimmerman and colleagues (Zimmerman, W. C. et al. 2004b) showed that 
Pericentrin A is required for anchoring of the γ-TuC at the PCM specifically during 
mitosis, through an interaction with GCP2/3 via its C-terminal domain, and this 
recruitment is required for proper spindle formation.     
Ninein is another protein that is required to localise the γ-TuRC to the PCM 
(Mogensen et al. 2000; Ou et al. 2002). However, Ninein has also been found at non-
centrosomal nucleation sites in specialised epithelial cells (Mogensen 1999). The 
similar Ninein-like protein [Nlp] plays a structural role in centrosome organisation 
where it is required to localise the γ-TuC to the centrosome during interphase. Nlp is 
phosphorylated by Plk-1 early in mitosis, causing it to dissociate from the 
centrosome. This is thought to allow the association of mitotic specific scaffold 
proteins the PCM (Casenghi et al. 2003).    
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 GCP-WD/NEDD1 is another protein that is required for γ-TuRC localisation 
to the centrosome. GCP-WD interacts with many of the γ-TuC components, and 
functions as a targeting factor (Gunawardane et al. 2003; Luders et al. 2006). During 
mitosis, GCP-WD also becomes phosphorylated by bothPlk1 and Cdk1, which is 
required to localise the γ-TuRC to the spindle poles (Zhang, X. et al. 2009). 
 Although homologs of many of these proteins have yet to be identified fission 
yeast, there are a number of proteins that are able to carry out the same recruitment 
and anchoring functions. For example S. pombe Mto1 has been shown to have 
structural resemblance to Ninein, and is also requid to localise the γ-TuC to the 
SPB (Sawin et al. 2004; Venkatram et al. 2004). 
 
1.6 Microtubule Organisation in S. pombe 
 
 Fission yeast is a unicellular haploid organism that is popular among 
scientists due to its short generation time, high recombination rates and genetic 
tractability. S. pombe are rod-like cells that are between 12 – 15 nm long a d 3 – 4 
nm wide. They grow in a bipolar manner until they rach the required length at 
which point they divide by medial fission. Fission yeast is a preferred organism to 
study MTs as the low number and size of MT bundles a lows tracking and 
measurement of MT dynamics. Fluorescent markers can easily be introduced into the 
cell and used to label the plus and minus ends of the MTs, as well as follow the 
behaviour of many other MT associated proteins. Additionally, as fission yeast is 
more closely related to higher eukaryotes than budding yeast, many of the factors 
involved in MT regulation are conserved and so give a better comparison than other 
unicellular species. 
 MTs are nucleated at specific sites within the cell al ed Microtubule 
Organising Centres [MTOCs]. Different MTOCs are schematically depicted in 
Figure 1.2. In fission yeast, in addition to the centrosome equivalent, an extensive 
non-centrosomal array is nucleated from other sites within the cell. For example, 
MTs are nucleated from the equatorial MTOC [eMTOC], and from interphase 
MTOCs [iMTOCs] (Hagan 1998). MTs nucleated from these different sites have a 
number of different functions within the cell and are required at different points 
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during the cell cycle. These properties make fission yeast a good model for studying 
the nature of MT nucleation from non-centrosomal MTOCs. 
 Unlike the centrosome, the structure of the SPB is relatively undefined. 
Electron microscopy has shown that it is composed of a cytoplasmic layer and 
nucleoplasmic layer that are connected by striations through the nuclear envelope 
(Ding et al. 1997). As S. pombe undergoes a closed mitosis, the SPB embeds itself 
into the nuclear envelope at the start of mitosis (Uzawa et al. 2004). Once in the 
membrane, in addition to nucleating MTs, the SPB is known to act as a signalling 
hub for many regulatory proteins including those involved in cell cycle progression 
e.g. the Plo1/PLK1 kinase (Doxsey t al. 2005; Hagan 2008).  
 In anaphase, astral MTs are nucleated from the both the nucleoplasmic and 
cytoplasmic face of the duplicated SPBs. The proposed function of S. pombe 
cytoplasmic astral MTs are to assist in the alignmet of the spindle along the cell axis 
so that equal segregation of genetic material between both daughter cells is ensured 
(Tolic-Norrelykke et al. 2004). However, cells which lack these structures do not 
display any major spindle elongation or alignment defects (Zimmerman, S. et al. 
2005). Astral MTs are essential for spindle orientation in budding yeast, as they 
guide the spindle MTs into the bud neck between mother and daughter cells 
[reviewed in (Bloom 2003)]. A similar process occurs in tissue cells of higher 
eukaryotes, where astral MTs are directed by extracellular cues, such as the substrate 
plane, to establish spindle polarity (Toyoshima et l. 2007). Additionally, unlike 
yeast, which determine their cell division plane prior to mitosis, it is thought that 
astral MTs of higher eukaryotes also contribute to localisation of the cleavage furrow 
by distributing proteins involved in actin polymerisation at the central cortex (Inoue 
et al. 2004; Bringmann et al. 2005).  
  
 Following completion of anaphase and initiation of spindle disassembly, a 
post-anaphase array [PAA] is nucleated in the division plane between the separated 
nuclei. Nucleation of the PAA is dependent on the formation of the cortical actin ring 
[CAR] (Pardo et al. 2003). This is an actin structure that is formed early in mitosis. It 
is assembled following release of Mid1 from the nucle s, which is required to 
establish the CAR at the cell cortex proximal to the nucleus (Chang et al. 1996; 
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Sohrmann et al. 1996). Mid1 functions by recruiting myosin II heavy and light chain 
proteins and several regulators of actin dynamics, in luding Rng2, the Cdc12 formin, 
and Cdc15 (Fankhauser t al. 1995; Chang et al. 1997; Kitayama et al. 1997; Eng et 
al. 1998). Together these proteins induce actin polymerisation, which is further 
organised by the recruitment of tropomyosin, α-actinin and Myp2 (Balasubramanian 
et al. 1992; Bezanilla et al. 1997; Wu et al. 2001).   
 Regulation of the PAA is influenced by two major signalling pathways. The 
Septation Initiation Network [SIN] is activated in late anaphase and causes the ring 
to constrict and induces formation of the septum [reviewed in (Krapp et al. 2004; 
Krapp et al. 2008)]. However, activation of the SIN alone is not sufficient to induce 
PAA formation, as the PAA does not form when SIN is induced during interphase 
using cdc16.116ts allele (Heitz et al. 2001).  
 The Anaphase Promoting Complex [APC] is a ubiquitin l gase which among 
other things is required to activate separase, an enzyme that proteolytically degrades 
cohesin, and allows sister-chromatid separation as cell  enter anaphase (Ciosk et al. 
1998; Uhlmann et al. 1999). The activity of the APC is also required for the 
formation of the PAA as temperature sensitive alleles of Cut4 and Cut9 [APC 
components] and Cut8 [required to localise the APC to the nuclear periphery] do not 
form a PAA at restrictive temperature. However, these mutants all form an actin ring, 
and progress through cytokinesis as normal, indicating that the SIN occurs 
independently of the APC (Heitz et al. 2001).  
 The mitotic Polo kinase has regulatory roles in both the APC and the SIN, 
and is therefore considered to be the missing link between the two pathways that 
connects them to the formation of the PAA [reviewed in (Archambault et al. 2009)].  
When Polo kinase Plo1 was expressed in G2 arrested fission yeast cells, PAA and 
primary septum formation was induced (Heitz et al. 2001). So far the intricate 
complexity of both the APC and the SIN pathways mean th t the mechanism that 
directly link them to the PAA through the Plk1 kinase remains unclear. 
 The exact function of the PAA is uncertain, as cells that lack the PAA are 
viable (Sawin et al. 2004; Venkatram et al. 2005).  Evidence suggests that the PAA 
may act to stabilise the position of the CAR during anaphase, as cells that are 
arrested in late anaphase with a stable actin ring, show a displaced non-centralised 
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ring position when treated with MT-depolymerising drug carbendazim [MBC] 
(Pardo et al. 2003). Other research has suggested that the PAA may also help to 
separate dividing nuclei (Hagan et al. 1988; Hagan et al. 1997). Homologous 
structures have been observed in higher plants, for example, the pre-prophase band 
that is required to organise the MT spindle (Ambrose et al. 2008), however, PAA-
like structures have yet to be confirmed in other yeasts. 
  
 Interphase MT organising centre [iMTOCs] is a descriptive term that 
encompasses any MTOC that nucleates MTs during interphase. During interphase, S. 
pombe contain 3-5 MT bundles, each containing 2-5 MTs that extend across the 
longitudinal axis of the cell (Hagan 1998; Drummond et al. 2000; Carazo-Salas et al. 
2007). The majority of these MTs are oriented with their minus ends anchored at the 
centre of the cell and their plus end facing towards the cell tip. There is also a region 
of overlap proximal to the nucleus where the MTs are bundled in an anti-parallel 
fashion (Drummond et al. 2000; Tran et al. 2001; Sagolla et al. 2003).  
 Traditionally, iMTOCs were defined as locations of MT nucleation following 
cold-shock or treatment with MT depolymerising drugs [e.g. MBC]. This description 
was later shown to be misleading, as upon cold-shock the majority of MTs were 
nucleated from sites on the nuclear surface as a reult from a redistribution of the MT 
nucleation machinery (Sawin et al. 2004). In addition, following MBC treatment, 
there can be ambiguity to whether MT growth occurs from true de novo nucleation 
sites or from MT ‘stubs’ found at regions of MT overlap that are resistant to MBC 
(Busch et al. 2004). Defined more broadly from in vivo imaging of GFP-tubulin, 
iMTOCs are found in a number of locations. These include the iSPB, the surface of 
the nuclear envelope, sites along the length of pre-existing MTs and very rarely from 
sites in the cytoplasm free from other MT polymers (Mata et al. 1997; Janson et al. 
2005).  
 It is difficult to say how much each iMTOC contributes to the total 
cytoplasmic array. Observation of MT nucleation along pre-existing MTs is 
particularly difficult as polymerised seeds are quickly bundled into parent MTs. 
However, the high concentration of γ-TuC proteins along the length of the MT 
indicates that this may occur with a relatively high frequency. MT nucleation 
































Figure 1.2 Microtubule organising centres of S. pombe. mSPB [mitotic 
spindle pole body]; iSPB [interphase spindle pole body]; eMTOC [equatorial 
MT organising complex]; iMTOC [interphase MT organisi g complex]. MT 
bundles are represented here as uniform structures, however, in vivo bundles 
are composed of several MTs which are distributed unevenly along the 
length of the bundle with multiple regions of overlap. 
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from the nuclear envelope is thought to facilitate  large number of de novo 
nucleation events. However, the mechanism by which t e γ-TuC proteins are 
localised and anchored to the surface is unclear. 
 
1.7 Mto1 and Mto2 
 
 Regulation of γ-TuC localisation and function in S. pombe has been shown to 
be dependent on a number of auxiliary proteins, the most prominent of which are 
microtubule organiser 1 and 2 [Mto1/Mto2]. Both proteins localise to all cytoplasmic  
MTOCs and are essential for nucleation of all non-SPB derived MTs (Sawin et al. 
2004; Venkatram et al. 2004; Samejima et al. 2005; Venkatram et al. 2005). Mto1 
and Mto2 were initially identified in the Sawin lab due to the curved cell phenotypes 
observed in the mutants isolated from a mutagenesis screen (Sawin et al. 2004; 
Samejima et al. 2005). Distant homologues for Mto1 have been identfi d in other 
metazoa e.g. S. cerevisiae Spc72, D. melanogaster centrosomin [Cnn], and human 
proteins CDK5RAP2 and myomegalin (Sawin et al. 2004). Recent release of the 
genomic sequence of closely related fission yeast Schizosaccharomyces japonicus 
has lead to the identification of the only known Mto2 homologue, SJAG_03264.2.  
 Deletion of Mto1 results in a complete loss of MT nucleation from 
cytoplasmic iMTOCs and both astral MTs and the PAA are absent. Interphase MTs 
are fewer and form large bundles (Sawin et al. 2004; Venkatram et al. 2004). It was 
shown that the cytoplasmic MTs present in the mto1∆ background are derived from 
nucleation events that occur on the nucleoplasmic face of the SPB, initiated by a 
functional homolog of Mto1 called Pcp1 (Flory et al. 2002; Zimmerman, S. et al. 
2004a). Once nucleated inside the nucleus, these MTs break through the nuclear 
envelope and escape into the cytoplasm. As a result there is a negligible MT 
regeneration following MT depolymerisation in mto1∆ cells (Sawin et al. 2004; 
Zimmerman, S. et al. 2005).  
 In mto2∆ cells, MT nucleation from the cytoplasmic face of the SPB is 
preserved, therefore the mto2∆ phenotype is overall less severe. Astral MTs are 
present, and there are more cytoplasmic MTs than in mto1∆. However, there are 
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fewer MTs than wild-type, and they are present in large bundles. Nucleation from the 
eMTOCs is also occasionally observed in mto2∆ cells, but at a highly reduced level.  
 Staining for tubulin in mto1∆ and mto2∆ cells revealed that the regulation of 
MT growth at the cell tip appears to be defective, resulting in the extension of MTs 
around the tip which gives the curved cell phenotype (Venkatram et al. 2004; 
Samejima et al. 2005). Some evidence has suggested that this mis-regulation may 
occur as a result of defective loading of plus-tip proteins e.g. EB1, in the early stages 
of MT polymerisation (Cuschieri et al. 2006; Fong, K. W. et al. 2009b).  
 Mto2 is a smaller protein of 397 aa. It does not have any distinctive structural 
domains except for a small region of coiled-coil in the N-terminus. Unlike Mto2, 
Mto1 is a large protein of 1115 aa and is composed f several structurally significant 
domains. It has extensive regions of coiled-coil in ts C-terminus in addition to a 
large globular domain at its N-terminus. Mutagenesis of Mto1 has revealed a stretch 
of conserved sequence within the globular region called the Centrosomin Motif 1 
[CM1] domain, which has been shown to be essential for the interaction with the γ-
TuC (Samejima et al. 2008). The function of the CM1 domain is conserved in Mto1 
homologs, Cnn and CDK5RAP2 (Zhang, J. et al. 2007; Fong, K. W. et al. 2008).  
 Co-immunoprecipitation experiments show that Mto1 and Mto2 strongly 
interact to form a complex [the Mto1/2 complex] (Samejima et al. 2005; Venkatram 
et al. 2005). The Mto2 interaction domain has been localised to a central region 
within the coiled-coil of Mto1. Both the Mto2 interaction domain and the CM1 
domain are required for the interaction of Mto1 with the γ-TuSC (Samejima et al. 
2005; Samejima et al. 2008). Further mutagenesis of the Mto1 C-terminal tail has 
identified regions of sequence that act as a localisation modules which target Mto1 to 
specific sites within the cell. For example, region 1049-1095 is required to localise 
Mto1 to the SPB during mitosis, 1049-1075 is required for SPB localisation during 
interphase, and 1028-1065 is required to localise Mto1 to the eMTOC. A separate 
region between 500-1065 is required for the localisation of Mto1 to pre-existing MTs.  
 Mto1 is required for Mto2 localisation to MTOCs, however, Mto1 is able to 
localise normally in mto2∆ cells, indicating that Mto2 does not function as a 
localisation or targeting factor for Mto1. As both proteins are required to efficiently 
interact with and localise the γ-TuC at cytoplasmic MTOCs, this suggests that Mto2 
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may have a structural role in the assembly of the Mto1/2 complex (Sawin et al. 2004; 
Samejima et al. 2008). However, exactly how Mto2 is able to influenc  the structure 
of Mto1 is currently unknown. 
 The targeting modules of Mto1 allow it to specify the location of the Mto1/2 
complex within the cell and therefore spatially regulate the nucleation of MTs. How 
the timing of this localisation is regulated is less clear. As described above, MT 
nucleation occurs from different MTOCs at different stages of the cell cycle. It is 
predicted that regulation of assembly and/or disassembly of the γ-TuC by the Mto1/2 
complex may be one way in which the cell is able to achieve this.  
 
1.8 Protein phosphorylation 
 
 From the first description of protein phosphorylation by Eugene Kennedy in 
1954 (Burnett et al. 1954), phosphorylation continues to function at the heart of 
molecular biology, contributing to the regulation of a multitude of cellular processes, 
from signal transduction, differentiation, and development to cell cycle and 
metabolism. Protein phosphorylation involves the transfer of the gamma phosphate 
group PO4
2-, from a nucleoside tri-phosphate to a hydroxyl group f an amino acid, 
i.e. serine, threonine, or tyrosine. This reaction is performed by protein kinases, and 
the reverse dephosphorylation reaction is carried out by protein phosphatases.  
 The primary functions of protein phosphorylation can be to turn ‘off’ or ‘on’ 
protein activity, change cellular localisation, or association with other proteins in a 
reversibly acute manner (Hunter 1995). The most comm n method by which 
phosphorylation acts to regulate protein activity is via a change in surface charge 
and/or protein conformation. Recent sequencing of various key genomes has 
highlighted the importance of phosphorylation, where it has been demonstrated that 
proteins directly involved in phosphorylation make up 2% of the human genome 
(Lander et al. 2001; Venter et al. 2001). It is estimated that one in three proteins are 
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1.9 Phosphorylation over the cell cycle 
 
 Phosphorylation is a key regulatory component of the cell-cycle control 
system. Transition between cell-cycle stages is regulated by several kinases including 
CDK1, PLK1 and the Aurora kinases, and all of which have been shown to 
phosphorylate targets related to MT nucleation. 
 In fission yeast, there is one CDK1 [Cdc2] which controls entry into different 
stages of the cell cycle through an association with different cyclins. Cyclin binding 
induces a conformational change which partially activ tes the CDK. However, Cdc2 
must also be phosphorylated in its active site to be fully active [reviewed in 
(Pavletich 1999)]. Phosphorylation also plays a role in CDK inhibition. During the 
G2-M transition, if various checkpoints have not been satisfied, Cdc2 is inhibited by 
the Wee1 kinase (Russell t al. 1987). When the requirements for mitosis have been 
fulfilled, this inhibitory phosphorylation is reliev d by Cdc25 phosphatase (Russell et 
al. 1986). CDK1-Cyclin phosphorylates many proteins throughout the cell cycle, 
many of which contain a S/T-P-X-R consensus sequence (Endicott et al. 1999).  
 As has already been mentioned, PLK-1/Polo/Plo1 kinase plays a major role in 
many of the processes linked to MT nucleation. It is a conserved S/T kinase that also 
plays a key regulatory role in mitosis (Carmena t l. 1998; Barr et al. 2004). In 
human cells, PLK1 is required for centrosome maturation and bipolar spindle 
formation in early mitosis as well exit from mitosis and cytokinesis (Sumara et al. 
2004; Brennan et al. 2007; Santamaria et al. 2007). The yeast homologue of Polo 
kinase, ScCdc5/SpPlo1 has a less important role in early mitosis, but is essential for 
mitotic exit pathway and cytokinesis (Yoshida et al. 2006). Polo kinase localisation 
changes during mitosis, reflecting its function at different subcellular structures 
[reviewed in (Petronczki et al. 2008)]. In prophase, Polo kinase is found at the 
centrosome where it is involved in the recruitment of γ-tubulin that is required for 
nucleation of the mitotic spindle (Casenghi et al. 2003; Zhang, X. et al. 2009). 
During metaphase, Polo kinase is enriched at the kin tochore, where it is thought to 
play a role in the spindle assembly checkpoint through phosphorylation of BubR1, a 
member of the APC (Matsumura et al. 2007). At anaphase it accumulates at the 
spindle mid-body where it interacts with centralspindlin and Ect5, which have a 
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pivotal role in the assembly of the cortical actin ring at the future cleavage furrow 
site (Brennan et al. 2007; Santamaria et al. 2007; Petronczki et al. 2008). In all roles 
Polo kinase acts via well characterised mechanisms which involves interaction with 
its targets via a C-terminal polo-box domain [PBD]. The PBD binds to phospho-
peptides that are present within a S-SP/TP-P-X/R consensus site (Elia et al. 2003a; 
Elia et al. 2003b). The inclusion of S/TP-P within this binding site means that 
substrates must be primed before they interact with the PBD e.g. NEDD1 is 
phosphorylated be CDK1 prior to phosphorylation by PLK-1, and event that is 
required to target the γ-TuRC to the centrosome in mitosis (Zhang, X. et al. 2009). 
The optimal PLK-1 phosphorylation sequence was ident fi d as [D/E]-X-[pS/pT]-Φ-
[D/E]-[D/E] (Nakajima et al. 2003), where the presence of acidic residues at either 
+2 or -2/-3 positions constitute the minimum requirement for PLK-1 phosphorylation 
(Dephoure et al. 2008). Dobbelaere and colleagues performed an RNAi screen to 
identify proteins required for centrosome maturation and duplication in D. 
melanogaster, and identified Cnn as a key component of this process (Dobbelaere et 
al. 2008). They later went on to show that phosphorylation of Cnn by Polo kinase is 
essential for centrosome maturation, a process that describes the recruitment of MT 
nucleation machinery to the centrosome. More recently it has been shown that Pcp1 
is also phosphorylated by Plo1 (Fong, C. S. et al. 2009a).    
 This data supports the idea that temporal regulation of MT nucleation may be 
achieved through phosphorylation of the Mto1/2 complex. Phosphorylation of Mto1 
has yet to be observed, however, when analysed by a western blot Mto2 is present in 
several isoforms that are likely to represent different phosphorylation states of Mto2 
(Samejima et al. 2005; Venkatram et al. 2005).  
 
1.10 Human disorders associated with the γ-TuC associated proteins 
 
 A number of human genetic disorders have been found to be associated with 
factors related to targeting of the γ-TuC and efficient MT nucleation, including 
CDK5RAP2, the human homolog of Mto1. CDK5RAP2/Cep215 was initially 
identified in a yeast-2-hybrid screen to identify interactors of the CDK5-regulatory 
protein 1 in rat cerebral cortex (Ching et al. 2000). Mutations found within this 
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protein lead to a condition called primary microcephaly. This is an autosomal 
recessive disorder physiologically characterised by a reduction in the size of the 
cerebral cortex and an associated mental retardation. In addition to 
CDK5RAP2/MCPH3, genetic mutations have been mapped to several other 
recessive loci, which result in a number of indistinguishable disorders. All encoded 
proteins have found to localise to the centrosome, wh re they are involved in 
nucleation and/or organisation of the mitotic spindle. The MCPH phenotype is 
thought to arise during division of the neuronal progenitor cells in the ventricular 
zone of the embryonic brain. When cell division is compromised this leads to a 
reduction in cell number and consequently brain size. Despite this, other aspects of 
cerebral development remain unaffected.   
 MCPH1 [microcephalin] is linked to other syndromes where DNA 
checkpoint dependent processes have been perturbed such as Seckel syndrome, 
which is characterised by defective ATR signalling (Jackson et al. 2002; Alderton et 
al. 2006). Studies have shown that cells derived from MCPH-1 patient lines display 
premature chromosome condensation (Trimborn et al. 2004). In wild-type cells, 
microcephalin prevents premature entry into mitosis by targeting Chk-1 to the 
centrosome during interphase (Tibelius et al. 2009). Chk-1 is a G2-M checkpoint 
kinase which inhibits Cdc25B, preventing Cdc25B from activating centrosomal 
CDK1-Cyclin B. Upon entry into prophase, Aurora A phosphorylates Cdc25B, 
activating CDK1-Cyclin B which then commits the cell to mitosis resulting in 
chromosome condensation and centrosome separation (Kramer et al. 2004).
 MOPD II [microcephalic osteodysplastic primordial dwarfism type Majewski 
II] is another primary microcephalic disease and is also characterised by the inability 
to recruit CDK1-Cyclin B to the centrosome. MOPD II is caused by mutations in 
pericentrin [PCNT], a binding partner of microcephalin (Rauch et al. 2008; Tibelius 
et al. 2009; Willems et al. 2009). 
 Other MCPH-associated genes include MCPH5/abnormal spindle-like, 
microcephaly associated [ASPM], MCPH6/centromere protein J [CENPJ], and the 
recently identified MCPH7/STIL. The D. melanogaster homolog of ASPM, asp, has 
been shown to be required for organisation of MTs at the spindle poles and central 
spindle during mitosis (Wakefield et al. 2001), and it is predicted that ASPM has a 
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similar role. The STIL protein mutated in MCHP7, has been found to have a related 
function, where it localised to the spindle-poles during metaphase in HeLa cells, and 
is required for mitotic spindle organisation in Danio rerio (Pfaff et al. 2007). 
MCPH6/CENPJ is a centrosomal protein that is associated with the γ-TuRC. 
Analysis of the C. elegans homolog suggests that CENPJ may have a role in 
centrosome duplication in early mitosis. 
   
1.11 Project aims and objectives 
 
 Many of the proteins involved in MT nucleation have been identified. This 
has allowed researchers to begin to determine how tese factors may function 
together to form an active nucleation complex. Studies on purified γ-tubulin 
containing-complexes in higher eukaryotes have ident fi d two complexes that are 
able to nucleate MTs. The γ-TuRC appears to be the main active complex in these 
organisms and has a nucleation activity that is significantly higher than its composite 
γ-TuSC. The situation is very different in S. cerevisiae, where the γ-TuSC/Tub4 
complex is the main nucleation complex. The nature of the nucleation complex 
formed in S. pombe is less clear, as there is evidence to suggest that both complexes 
may be active.  
 The Sawin lab among others, have identified Mto1 and Mto2, which are 
proteins required to recruit the γ-TuC to the MTOC. In this project I want to examine 
the properties of the complex formed by Mto1 and Mto2. It was proposed that Mto2 
may promote co-operative binding of the γ-TuSC components to Mto1/2 (Samejima 
et al. 2008). I predict that this may result in the assembly of a large complex 
containing many molecules of Mto1/2 that may act in aγ-TuRC-like fashion. 
Deletion of the non-core γ-TuRC components results in a 30% reduction in MT 
nucleation from non-SPB iMTOCs, this is compared with 100% reduction in 
nucleation in either mto2∆ or mto1∆. This suggests that the Mto1/2 complex may be 
able to compensate for the loss of non-core components by promoting higher-order 
assembly of the γ-TuSC. Examination of the size of the Mto1/2 complex may offer 
evidence to reinforce an Mto1/2 directed γ-TuSC multimerisation, and provide a 
better understanding of the nature of the nucleation complexes formed in S. pombe. 
   32  
 Additionally, I aim to investigate the role of Mto2 in Mto1/2 complex 
multimerisation. It has been demonstrated that Mto2 is not required to localise Mto1 
to the MTOCs, therefore it does not act simply as atargeting factor. Instead, it is 
proposed that Mto2 may promote Mto1/2 complex assembly. I plan to investigate the 
effect of Mto2 on the multimerisation state of Mto1, and whether this is instigated by 
its own multimerisation. 
 The Mto1/2 complex is responsible for nucleation from MTOCs that are 
active at different points in the cell cycle. Ensuring that certain types of MT arrays 
are restricted to specific stages of the cell cycle is ssential, as ectopic nucleation 
events may have drastic effects. For example, nucleation of a cytoplasmic array 
during mitosis may titrate αβ-tubulin dimers away from the nucleus and compromise 
the formation of the spindle. The changing pattern of active MTOCs suggests that the 
Mto1/2 complex may be subject to levels of cell cycle-dependent regulation. Several 
mechanisms of regulation have been suggested, includ g phosphorylation of both 
Mto1 and Mto2. In this thesis I am going to concentration on Mto2 phosphorylation, 
and investigate the consequence of this on the Mto1- to2 interaction as well as the 
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CHAPTER TWO 




2.1.1 General materials used 
 
 Unless otherwise stated all analytical and reagent rade chemicals were 
purchased from Sigma-Aldrich. General labware and disposables including plastic 
and glassware were supplied by Fisher Scientific, U.S.A. Nitrocellulose membrane 
and broad range molecular weight markers, in addition to western blotting apparatus 
for 8.3 x 7.3 cm and 16 x 20 cm gels were supplied by BioRad [U.S.A.], larger 20.5 
x 10 cm, low-wide gels were cast and run in apparatus supplied by Helena 
Biosciences, U.K. Oligonucleotide primers were produced by Eurofins MWG 
Operon, supplied as lyophilised material, which was then re-suspended in 1 X TE to 
100 µM and stored at -20°C. All DNA was amplified using the PCR performed on a 
DNA Engine Dyad Peltier Thermal Cycler [MJ Research]. Centrifugation of 
microfuge tubes was performed at RT in a Biofuge Pico [Heraeus, Germany], and at 
4°C using a Biofuge Fresco [Heraeus, Germany]. Centrifugation of 15 ml and 50 ml 
tubes was performed in a 5810 R Centrifuge [Eppindorf, Germany]. 
 
2.1.2 Grades of water used 
 
 All pure water was generated by the Purite Bio unit [Pur1te, U.K.]. Common 
buffers [Section 2.1.4] were made up using Grade II quality water [1-15 MΩ.cm]. 
Ultrapure deionised water with a resistivity of 18.2 MΩ.cm was used for molecular 
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2.1.3 Solution sterilisation 
 
 All standard buffers [used for molecular biology/cell culture], media and 
plastic/glassware were sterilised prior to use. This was done by autoclaving at 120°C 
for 30 min at 15 psi [BMM Western, U.K.]. Specialised buffers were sterilized by 
filtration through 0.22 µm filter [VWR international]. 
 
2.1.4 Common Buffers  
 
TE [Tris EDTA pH 8.0]  10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0 
Tris-buffered saline [TBS]  50 mM Tris base, 150 mM NaCl. pH is adjusted to 7.6 
    with 10 N HCl 
TAE     40 mM Tris base, glacial acetic acid, 1 mM EDTA.  
Laemmli Sample Buffer 2% [w/v] SDS, 10% [v/v] glycerol, 100 mM DTT,     
    60 mM Tris-HCl pH 6.8, 0.01% [w/v] bromophenol 
    blue 
Laemmli Running Buffer 25 mM Tris-base, 192 mM glycine, 0.1% [w/v] SDS. 
    pH is adjusted to 8.3 with 10 N HCl. 
CAPS transfer Buffer   10 mM CAPS pH 11.0 [pH adjusted with 10 N NaOH], 
    10% [v/v] MeOH 
Coomassie Stain   50% [v/v] methanol, 10% [v/v] acetic acid, 0.25%  
    [w/v] Brilliant Blue R-250]  
Coomassie Destain  25% [v/v] methanol, 10% [v/v] acetic acid 
Ponceau S Stain  0.2% [w/v] Ponceau S, 3% [w/v] trichloroacetic acid, 
    3% [w/v] sulfosalicylic acid] 
Ponceau S Destain  5% [v/v] acetic acid 
 
2.1.5 Antibodies used in this study 
 
Primary antibodies        Dilution 
anti-Myc 9E10 mouse monoclonal      1:1000 
anti-GFP sheep polyclonal (Sawin et al., data unpublished]   1:500 
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anti-Mto1 sheep polyclonal (Sawin et al. 2004)    1:1000 
anti-Mto2 sheep polyclonal (Samejima et al. 2005)    1:1000 
anti-Alp4 sheep affinity purified polyclonal (Samejima et al. 2008)  1:300 
anti-Alp6 sheep affinity purified polyclonal (Samejima et al. 2008)  1:300 
anti-γ-tubulin GTU-88 mouse monoclonal [Sigma, U.S.A.]   1:1000 
anti-Nop1 mouse polyclonal [Gift from D. Tollervey]   1:1000 
anti-phospho-tyrosine mouse monoclonal [Upstate, U.S.A]   1:1000 
 
Secondary/tertiary antibodies [Sigma, U.S.A.] 
GT-34 mouse anti-sheep/goat IgG monoclonal    1:10,000 
GT-34-HRP mouse anti-sheep/goat IgG monoclonal HRP linked   1:10,000 
Sheep anti-mouse IgG       1:10,000 
anti-mouse IRDye800 [Licor Bioscience, U.S.A.]    1:5000 
anti-mouse IRDye600 [Licor Bioscience, U.S.A.]    1:5000 
 
2.1.6 Yeast media 
 
 Media used for fission yeast growth and manipulation are as described in 
Moreno et al (Moreno et al. 1991).  
 
YE5S/4XYE5S 0.5% [w/v] Difco Yeast Extract, 3.0% [w/v] glucose,  
   250 mg/l adenine/leucine/histidine/lysine hydrochl ride,  
   and uracil. Where 4 X applies to all ingredients. 5 mg/l  
   phloxin B, 150 mg/l G418 [Geneticin], 100 µg/ml   
   hygromycin/neomycin were added where required. 
 
EMM-N [Edinburgh Minimal Media] 
   NH4Cl [2.2 g/l] or L-glutamic acid monosodium salt  
   [3.75 g/l]. 14.7 mM potassium hydrogen phthallate,  
   15.5 mM Na2HPO4, 2% glucose, 1 X salts [50 X stock  
   solution: 52.5 g/l MgCl2•6H2O, 0.735 mg/l CaCl2•2H2O, 50 
   g/l KCl, 2 g/l Na2SO4], 1 X vitamins [1000 X stock: 1 g/l  
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   pantothenic acid, 10 g/l nicotinic acid, 10 mg/l biotin] and   
   1 X minerals [10,000 X stock:5 g/l boric acid, 4 g/l MnSO4, 
   4 g/l ZnSO4•7H2O, 2 g/l FeCl2•6H2O, 0.4 g/l molybdic  
   acid, 1  g/l KI, 0.4 g/l CuSO4•5H2O and 10 g/l citric acid].  
 
SILAC media  EMM + 6 mM NH4Cl, 40 mg/ml 
13C615N4-arginine, 30  
   mg/ml 13C615N2-lysine 
 
SPA agar   1% glucose, 1 g/l KH2PO4, 1 X vitamins [as above], 45   
   mg/l amino acid supplements [as above], 2% [w/v] Difco  
   Bacto agar.  
 
2.1.7 Bacteria Media 
 
SOC (Sambrook et al., 2001)  
   Difco Bacto tryptone [20 g/l], Difco Bacto yeast extract      
   [5 g/l], NaCl [10 mM], KCl [2.5 mM]. After autoclaving and 
   cooling to 50°C, sterile MgCl2 and MgSO4 were added to a  
   final concentration of 10 mM. Sterile glucose was added to a 
   final concentration of 20 mM. 
 
Luria-Bertani Medium [LB] [Miller, 1972] 
   Difco Bacto tryptone [10 g/l], Difco Bacto yeast extract   
   [5 g/l], NaCl [5 g/l]. Before autoclaving the pH was   
   adjusted to 7.2 using 10 M NaOH. Solid LB agar pl tes are  
   made by adding 2% [w/v] Difco Bacto agar to the m dia. 
 
2.1.8 Antibiotics used this study 
  
Antibiotics were supplied by Melford, U.K. Antibiotcs used for bacterial selection 
were Ampicillin [100 µg/ml], Chloroamphenicol [25 µg/ml] and Kanamycin [50 
µg/ml].  
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2.1.9 Escherichia coli strains and genotypes 
 
One Shot® TOP10 Chemically competent E. coli [Invitrogen]  
  F- mcrA ∆φ80lacZ∆M15 ∆lacΧ74 recA1 araD139 ∆[ara-leu] 7697 
  galU galK rpsL [StrR] endA1 nupG λ-
XL10-Gold Ultracompetent E. coli [Stratagene]  
  TetrD[mcrA]183 D[mcrCB-hsdSMR-mrr]173 endA1 supE44 thi-1  
  recA1 gyrA96 relA1 lac Hte [F´ proAB lacIqZDM15 Tn10 [Tetr] Amy 
  Camr]. 
BL21-CodonPlus[DE3]-RIL E. coli [Stratagene]  
  B F– ompT hsdS[rB– mB–] dcm+ Tetr gal endA Hte [argU ileY  
  leuWCamr] 
 
2.2 MOLECULAR BIOLOGY METHODS 
 
2.2.1 Manipulation of bacteria 
 
2.2.1.1 Growth of E. coli strains 
 
 All bacterial strains were grown at 37°C unless otherwise stated. E. coli 
grown on LB-Agar was incubated for 1 - 2 days then stored at 4°C. Liquid cultures 
were grown in LB on a shaker at 200 rpm. Cells intended for plasmid purification 
were grown until stationary phase.  
 
2.2.1.2 Preparation of transformation-competent cells 
 
 Single colonies were used to inoculate 5 ml of LB culture. The resultant 
stationary phase culture was used to inoculate 500 ml of LB which was grown to 
OD650nm = 0.5. Culture was transferred into 450 ml centrifuge bottles and incubated 
on ice for 10 min. Culture was then spun at 24000 rpm at 4°C for 15 min [Beckmann 
Avanti J-25 centrifuge using a JLA 10-500 rotor]. Supernatant was removed and 
pellet re-suspended in 165 ml Buffer A. Cells were incubated on ice for 45 min. 
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Culture was then spun at 24000 rpm at 4°C for 15 min [Beckmann Avanti J-25 
centrifuge using a JLA 10-500 rotor] and cells were re-suspended in 40 ml Buffer B, 
and incubated on ice for a further 15 min. Aliquots f 200 µl were transferred to a 
screw-cap tube, then frozen in liquid nitrogen and stored at -80°C. Buffer A: 100 
mM RbCl, 50 mM MnCl2, 30 mM potassium Acetate, 10 mM CaCl2, 15% [v/v] 
glycerol. Buffer B: 10 mM MOPS, 10 mM RbCl2, 75 mM CaCl2, 15% [v/v] glycerol. 
Buffers were pH adjusted to 5.8 and 6.8 respectively.  
 
2.2.1.3 Transformation of E. coli 
 
 200 µl aliquots of frozen competent cells were thawed on ice. 50 – 200 ng of 
DNA was added to the cells, mixed by inversion and incubated on ice for 30 min. 
Cells were then transferred to 42°C heat-block for 45 sec then incubated on ice for a 
further 2 min. 0.8 ml of SOC medium was added to the cells and incubated at 37°C 
for 1 hr on an incubation shaker. Cells were then centrifuged [13,000 g, 15 sec, RT] 
and pellet was re-suspended in 200 µl of SOC. The suspension was spit 1:9 between 
two LB-agar plates containing an appropriate antibio c. Acid-washed glass beads 
were used to spread the cells on to the plates and were incubated O/N.  
 
2.2.1.4 Isolation of plasmid DNA from E. coli 
 
 Plasmid DNA was isolated from bacteria using the Nucleospin Plasmid Kit 
[Machery-Nagel, Germany]. Cells from 1 - 2 ml of culture were centrifuged [11,000 
g, 1 min, RT], and re-suspended in 250 µl P1 containing RNAse. 250 µl of buffer P2 
was added and the cells were mixed by inversion. The debris was removed by 
centrifugation [11,000 g, 10 min, RT], and the clear supernatant was applied to a 
QIAprep spin column. The plasmid DNA was bound to the column by centrifugation 
[11,000 g, 1 min, RT], and the eluate was discarded. 750 µl of buffer PE was applied 
to the column and the column was washed twice by centrifugation [11,000 g, 30 sec 
RT then 11,000 g, 1 min, RT]. The column was transferred to a sterile microfuge 
tube. 30 µl of buffer EB was applied to the centre of the column matrix and left to 
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stand at RT for 1 min. The plasmid DNA was eluted into the microfuge tube by 
centrifugation [11,000 g, 1 min, RT] and stored at -20°C. 
 
2.2.2 Manipulation of DNA 
 
2.2.2.1 Calculation of oligonucleotide primer concentration 
 
 To calculate the amount of each oligonucleotide prime  to be added to each 
PCR reaction [in pmoles] the following equation was used to normalise the amount 
of oligonucleotide primer present in each PCR reaction where the length in 








2.2.2.2 PCR amplification from plasmid DNA 
 
 PCR from plasmid DNA was used to add HTB/TAPS tags following the 
protocol described by Bahler and colleagues (Bahler et al. 1998). DNA containing 
HTB/TAPS tag flanked by pFA6 multiple cloning site and the kanamycin resistance 
gene [KanMX6] were amplified from pKS466 (Tagwerker et al. 2006) and pKS422 
(Cheeseman et al. 2001), respectively. Oligonucleotide primers OKS257 and 
OKS258 were used for the amplification form both plasmids. OKS257 contained in 
5’-3’ direction, 80bp of the SPBC902.06 exon, excluding the TAG STOP codon, and 
20bp of the pFA6a module. OKS258 contained in 3’-5’ direction, 80bp of the 
SPBC902.06 3’UTR and 20bp of the KanMX6 module. This allowed amplification 
of TAG-KanMX6 from each plasmid flanked by homologous Mto2 sequence. The 
polymerase reaction contained 400 ng of plasmid template DNA, 0.2 µM of each 
oligonucleotide, 500 µM of each dNTP, 3.5 mM MgCl2, 75 mM Tris-HCl pH8.8, 20 
                                                   ng of oligo 
   330 x No. of bases in the oligo 
X pmoles of oligo = X 1000 
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mM [NH4]2SO4, 0.01% [v/v] Tween® 20, 200 units of Taq DNA Polymerase, 250 U 
of Pwo diluted 1:60 in Pwo buffer [200 mM Tris-HCl pH 8.8, 100 mM KCl, 100 mM 
[NH4]2SO4, 20 mM MgSO4, 1.0% [v/v] Triton X-100 and 1 mg/ml nuclease-free 
BSA] in a total volume of 1 ml. Cycling parameters were as follows: 1] 2 min at 
95°C, 2] 15 sec at 95°C. 3] 30 sec at 60°C, 4] 2 min extension at 72°C, which was 
repeated 25 times from step 2, then final extension for 5 min at 72°C.  
 
2.2.2.3 PCR amplification from cell lysate (Chen et al. 1995) 
 
 A match-head sized patch of cells from a colony were suspended in 30 µl of 
0.25% [w/v] SDS, 1 X TE pH 8.0. Solution was then incubated at 100°C for 5 min. 
Boiled cells were then spun in a centrifuge [13,000 g, 1 min, RT] and 20 µl of the 
supernatant was transferred to a fresh tube. The reaction mix contained 1 µl of 
genomic template DNA, 75 mM Tris-HCl pH8.8, 20 mM [NH4]2SO4, 0.01% [v/v] 
Tween® 20, 0.5 µM of each oligonucleotide primer, 200 µM dNTPs, 1.5 mM MgCl2, 
1% [v/v] Triton X-100, 5 U Taq polymerase, 0.075 U of the proof-reading 
polymerase from Pyrococcus furiosus Pfu [Promega, USA] diluted 1:60 in Pfu buffer 
[200 mM Tris-HCl pH 8.8, 100 mM KCl, 100 mM [NH4]2SO4, 20 mM MgSO4, 1.0% 
[v/v] Triton X-100 and 1 mg/ml nuclease-free BSA]. Cycling parameters used for 
amplification were as follows: 1] 94°C for 2 min, 2] 94°C for 15 sec, 3] 50°C for 30 
sec, 4] 68°C for 3 min, which was repeated 35 times from step 2 followed by a final 
extension at 68°C for 10 min.   
 
2.2.2.4 Site Directed Mutagenesis 
 
 Site Directed Mutagenesis was performed using kits provided by Stratagene, 
USA. Amplification was performed using the following parameters: 1] 95°C for 30 
sec, 2] 95°C for 30 sec, 3] 55°C for 1 min, 4] 68°C for 5 min, this was repeated 12 
times from step 2 with a final 5 min extension at 68°C. 10 U of Dpn1 restriction 
enzyme was added to the mix and incubated at 37°C for 1 hr to digest un-
mutagenised, methylated dsDNA template. The nicked mutagenised dsDNA was 
then transformed into XL1-Blue super-competent cells. Single-site directed 
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mutagenesis reactions contained 50 ng of dsDNA template, 125 ng of each 
oligonucleotide primer. 1 µl of the dNTP mix provided in the kit was used per 
reaction in addition to 1 X Reaction Buffer [10 mM KCl, 10 mM [NH4]2SO4, 20 mM 
Tris-HCl pH 8.8, 2 mM MgSO4, 0.1% [v/v] Triton X-100, 0.1 mg/ml nuclease-free 
BSA]. Multi-site directed mutagenesis was performed in a final volume of 25 µl and 
contained 100 ng of dsDNA template, 100 ng of each oligonucleotide primer. 1 µl of 
the dNTP mix provided in the kit was used per reaction in addition to 2.5µl of 10 X 
Reaction Buffer, 0.5 µl of QuickSolution [components unknown] and the 1µl of the 
QuickChange Multi enzyme mix [other than the presence of Pfu Turbo DNA 
polymerase, the exact components are unknown]. Table 2.1 lists the oligonucleotide 
combinations used for the generation of all mutants alysed in this study.  
 
2.2.2.5 Sequencing of plasmids  
 
 DNA sequencing was carried out on in house ABI 3730 capillary sequencing 
instruments [Applied Biosystems, USA]. The sequencing reaction contained 250 ng 
plasmid DNA, 3.2 pmol of primer, 1 X BigDye Terminator v3.1 [Applied 
Biosystems] 10 mM Tris-HCl pH 8.5, 2.5 mM MgCl2 in a final volume of 10 µl. The 
sequencing reaction was carried out using the following parameter: 24 cycles of 1] 
96°C for 30 sec, 2] 50°C for 15 sec and 3] 60°C for 4 min. Digital output file of the 
DNA sequence was then further analysed using Seqman sequence analysis software 
[DNASTAR Inc.] 
 
2.2.2.6 Extraction of amplified DNA fragments from agarose gel 
 
 PCR products that had been separation by electropho esis were purified using 
the QIAquick PCR Purification Kit [Qiagen, USA]. The band of DNA was cut from 
the agarose gel, placed in a sterile microfuge tubeand weighed. 3 volumes of buffer 
QC were added, where 1 g of DNA / gel = 1 ml buffer QC. The mixture was 
incubated at 50°C for 10 min, until the agarose had fully dissolved, and 1 X volume 
of 100% [v/v] isopropanol was added. The DNA was bound to the column by 
centrifugation [11,000 g, 10 min, RT] and the eluate was discarded. 750 µl buffer PE  























was applied to the column twice [11,000 g, 30 sec, RT then 11,000 g, 2mins, RT]. 
The column [bound with plasmid DNA] was transferred to a sterile microfuge tube. 
30 µl of buffer EB was applied to the centre of the column and left to stand at RT for 
1 min. The DNA was eluted into the microfuge tube by centrifugation [11,000 g, 1 
min, RT] and stored at -20°C. 
 
2.2.2.7 Phenol chloroform extraction 
 
 This technique was used to isolate 5-20 µg of DNA amplified by PCR. An 
equal volume of phenol/chloroform/isoamyl alcohol [25:24:1] was added to the PCR 




T35A OKS1251, OKS1252 [sdm] pKS535 pKS1059 
S179A OKS1253, OKS1254 [sdm] pKS535 pKS1060 
S220A OKS1255, OKS1256 [sdm] pKS535 pKS1061 
S366A OKS1257, OKS1258 [sdm] pKS535 pKS1062 
T396A OKS1259, OKS1260 [sdm] pKS535 pKS1063 
5A: T35A, S179A, 
S220A, 
S366A ,T396A 
OKS1252, OK1254, OKS1256, 
OKS1260 [msdm] 
pKS1062 pKS1064 
Y168F OKS1408, OKS1409 [sdm] pKS535 pKS1084 
Y269F OKS1410, OKS1411 [sdm] pKS535 pKS1085 




OKS1780 [msdm] pKS535 pKS1071 
Block 2: S275A, 
S276A, S282A, 
S284A 
OKS1781 [msdm] pKS535 pKS1072 
Block 3: S361A, 
S362A, S366A, 
S369A 
OKS1782 [msdm] pKS535 pKS1073 
Block 1: S169D, 
T174D, S176D, 
S179D 
OKS1783, OKS1831, OKS1832 
[msdm] 
pKS535 pKS1074 
Block 2: S282D, 
S284D 
OKS1784 [msdm] pKS535 pKS1075 
Block 3: S366D, 
S369D 
OKS1785 [msdm] pKS535 pKS1076 
Table 2.1 Oligonucleotide primer combinations used for site-directed 
mutagenesis [sdm] and multi-site directed mutagensis [msdm] reactions 
performed in this study. 
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reaction in a microfuge tube, mixed and spun in a table-top centrifuge [13,000 g, 5 
min, RT]. The upper aqueous layer was recovered leaving the phenol, chloroform 
and isoamyl alcohol in the tube. This was repeated. Chloroform alone was then 
added to the supernatant, mixed, spun [13,000 g, 5 min, RT] and new supernatant 
was recovered. NaOAc was added to a final concentration of 0.3 M, solution mixed 
and then 2 X volumes of ethanol was added. This was agitated at RT for 5 min. 
Precipitated DNA was then spun in a centrifuge [13,000 g, 1 min, 4°C]. The DNA 
pellet was washed with 1 ml 70% ethanol, and supernatant removed leaving the 
pellet to air dry. DNA was then re-suspended in 50 µl 1 X TE, and stored at -20°C. 
 
2.2.2.8 Determination of DNA concentration 
 
 Absorbance at 260nm was measured using a Nanodrop™ 1000 
Spectrophotometer [Thermo Scientific, USA]. Concentration was calculated using 
the Beer-Lambert Law:  
 
 Where c is the nucleic acid concentration in ngµl-1, A is the absorbance in 
AU, ε is the wavelength-dependent extinction coefficient n ng-1cmµl-1 and l is the 
length of the light path in cm. The extinction co-efficient for dsDNA is 50 ng-1cmµl-1.  
Nanodrop™ 1000 Spectrophotometer is washed with 2 µl dH2O, then blanked with 1 
µl buffer EB [or dH2O]. 1 – 2 µl of DNA solution is then used per measurement, 
which is taken 3 times, and the instrument is blanked with buffer EB or 1 X TE 
between each measurement. 
 
2.2.2.9 Electrophoresis of DNA on agarose gels 
 
 1% [w/v] agarose gels were prepared using agarose I [Amresco, USA]. 
Agarose was dissolved in 1 X TAE buffer by heating i  a microwave then cooled to 
approximately 60°C. 0.4 µg/ml EtBr was added to the solution and it was poured into 
a gel tray and left to solidify at RT. DNA was diluted in 6 X DNA loading buffer 
[0.05% [w/v] Orange G, 5% [w/v] glycerol] and loaded into the gel which was run at 
100 V. DNA was examined under UV illumination at 360nm. 1 kb ladder was used 
c  =  [ A x ε ]  /  l   
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for all applications containing; 10.0 kb, 8.0 kb, 6.0 kb, 5.0 kb, 4.0 kb, 3.0 kb, 2.0 kb, 
1.5 kb, 1.0 kb and 0.5 kb fragments. 0.5 µg of marker was loaded per gel.   
 
2.2.2.10 Restriction enzyme digestion  
 
 Reactions were set up that contained 5 µg of plasmid DNA, 2 µl of 10 X NE 
Buffer 3 [100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT pH 7.9] and 
10 U of restriction enzyme [typically Not I] in a final volume of 20 µl. This was 
incubated at 37°C for 1 hr. Digestion efficiency was analysed on a 1% [w/v] agarose 
gel.  
 
2.2.3 Gateway® cloning 
 
 The Gateway® cloning Technology developed by Invitrogen is based on site-
specific recombination system used by Phage I to integrate DNA into E. coli 
chromosomes. Both Phage and E. coli DNA contain specific recombination sites, 
attP and attB, respectively. Additionally, they each encode lysogenic enzymes: the 
phage I Int [Integrase] and the E. coli protein IHF [Integration Host Factor]. 
Following integration into the bacteria, recombinaton occurs between attB and attP 
sites to generate attL and attR sites that flank the integrated piece of Phage DNA on 
the E. coli chromosome (Landy 1989). This reaction has been usd to develop an in 
vitro system which allows efficient transfer of DNA betwen plasmids containing 
modified versions of the recombination sites (Hartley et al. 2000). The Gateway 
recombination system is schematically represented i Figure 2.1. 
 
2.2.3.1 Construction of Entry vectors 
 
2.2.3.1.1 Generation of Mto2 containing attB1/2 flanking sites 
 
 Primer design and amplification procedure were based on guidelines from 
accompanying literature from BP Clonase™ II mix [Invitrogen, USA] and Phusion® 
Hot Start High-Fidelity DNA Polymerase [Finnzymes, Finland]. Amplification of  


















DNA containing flanking attB1/2 sites, required oligonucleotides incorporating 
sequence covering 31bp of attB1/2 sequence and ~20 bp of template specific 
sequence. In order to avoid the use of long [ > 50bp] oligonucleotide primers a two-
step amplification strategy was used. Reaction mix for step 1 contained 10 ng of 
template DNA, 1 X Phusion HF Buffer [containing 1.5 mM MgCl2], 10 pmoles of 
primers, 200 µM dNTPs, and 1 U of Phusion® Hot Start High-Fidelity DNA 
Polymerase [Finnzymes, Finland] in a final volume of 50µl. Thermal cycling 
parameters for step 1 were set as follows: 1] 98°C for 30 sec, then 20 cycles of a 2] 
98°C for 10 sec, 3] 50°C for 30 sec, 4] 72°C for 20 sec, then a final extension at 
72°C for 5 min. In step 2 of the amplification reaction, 10 µl of the reaction mix from 
the first step was transferred to 15 µl of the above reaction mix, containing 40 
pmoles of each adaptor primer [OKS1204 and OKS1205]. Cycling parameters for 
the second step were set as follows: 1] 98°C for 30 sec, then 5 cycles of 2] 98°C for 
10 sec, 3] 45°C for 30 sec, 4] 72°C for 20 sec, then a further 20 cycles at an 
annealing temperature of 55°C before a final extension for 10 min at 72°C. AttB1/2 
 BP recombination 
 
  LR recombination 
 
Figure 2.1 The Gateway Recombination system. Figure modified from 
Invitrogen. [A] Schematic representation of the BP recombination reaction to 
create entry clone from DNA amplified with attB1 and attB2 flanking sequence. 
[B] LR recombination where genes within entry clones can be transferred to 
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flanked DNA was then run on 1% [w/v] agarose gel and DNA band was excised 
from the gel and purified. Using primers OKS1201 and OKS1202, this method was 
used to create DNA encoding for attB1/2 flanked Mto2 that contained 2 X TAG 
STOP codons. This DNA was then used to generate plasmids containing N-terminal 
tagged and un-tagged Mto2. 
 
2.2.3.1.2 Generation of Mto2 truncations containing attB1/2 flanking sites 
 
 Mto2 truncations were constructed using PCR amplificat on of Mto2 ORF 
sequence flanked by attB1/2 sites. Positions of oligonucleotide primers used for the 






















Figure 2.2 Construction of Mto2 truncations. Schematic diagram epresenting 
PCR amplification of C1-3 / N1-3 truncations from pKS121 using oligonucleotide 
primers OKS1201, OKS1202 and OKS1340-45. Primers wee d signed to include 
18 bp of attB1/2 sequence which is extended to the full 36 bp upon a second 
round of PCR using adapter primers OKS1203 and OKS1204.  
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2.2.3.1.3 Generation of TEV-Mto2 containing attB1/2 flanking sites 
 
 AttB1/2 flanked DNA was synthesised using oligonucleotide primers 
OKS1684/OKS1202 and adaptor primers OKS1203/OKS1204. This placed the TEV 
site 5’ of the start methionine of the mto2 ORF. 
 
2.2.3.2 BP recombination reaction 
 
 The reaction mix contained 50 fmoles of attB1/2 flanked PCR product and 50 
fmoles of pDONR™221 donor vector, 1 X TE Buffer pH 7.0 and 2 µl BP Clonase™ 
II enzyme mix in a final reaction volume of 10 µl. The recombination mix was 
incubated at 25°C O/N. The reaction was stopped by adding 2 µg of Proteinase K 
and incubating the mix at 37°C for 1 hr. 5 µl of the reaction was then transformed 
into TOP10 E. coli, where the ccdB gene from the pDONR211 plasmid provided 
negative selection against empty vector. 
 
2.2.3.3 Construction of Destination vectors 
 
2.2.3.3.1 LR recombination reaction 
 
 The reaction mix was prepared in a microfuge as follows: 150 ng of 
pDONR221 containing Mto2 template flanked by attL1/2 sites, 150 ng of 
Destination vector containing attR1/2 sites, 1 X TE pH 8.0 and 2 µl of LR Clonase™ 
II enzyme mix in a final volume of 10µl. Microfuge tube was gently agitated and 
then incubated O/N at 25°C. 2 µg of Proteinase K was added to the mixture and 
incubated for 1 hr at 37°C. 10 µl of the reaction mix was then transformed into One 
Shot® TOP10 E. coli which were plated onto LB agar plus the appropriate antibiotic. 
The ccdB gene from the pDONR211 plasmid and destination vectors provided 
negative selection against empty vector. 
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2.2.3.2.2 LR recombination using pDUAL tagging vectors (Matsuyama et al. 
2004) 
 
 pDUAL vectors allow addition of a number of different tags under different 
strengths of thiamine inducible promoters [nmt81/nmt41/nmt1] on both the N- and C-
termini. These plasmids can then be integrated in the S. pombe genome by 
homologous recombination at the leu1 locus. Integrants are maintained due to the 
presence of 5’region of leu1 ORF, which when integrated into strains containing the 
leu1-32 autotrophic allele, results in leucine prototrophy. Table 2.1 lists the LR 


















2.2.3.2.3 LR recombination into pHGWA bacterial expression vectors (Busso 
et al. 2005) 
 
 Plasmids pKS1034 and pKS1035 encoding N-terminal tagged versions of 
Mto2 were created by an LR recombination reaction between pKS1032 and 
pDUAL vector pDONR vector Construct 
pDUAL-HFG81c pKS1032 nmt81:HFG-Mto2 
pDUAL-HFG81c pKS1036 nmt81:HFG-Mto2 N1 
pDUAL-HFG81c pKS1037 nmt81:HFG-Mto2 N2 
pDUAL-HFG81c pKS1039 nmt81:HFG-Mto2 C1 
pDUAL-HFG81c pKS1048 nmt81:HFG-Mto2 L133DL137D 
pDUAL-HFG41c pKS1048 nmt41:HFG-Mto2 L133DL137D 
pDUAL-HFG81c pKS1071 nmt81:HFG-Mto2 1A 
pDUAL-HFG81c pKS1072 nmt81:HFG-Mto2 2A 
pDUAL-HFG81c pKS1073 nmt81:HFG-Mto2 3A 
pDUAL-HFG81c pKS1074 nmt81:HFG-Mto2 1D 
pDUAL-HFG81c pKS1075 nmt81:HFG-Mto2 2D 
pDUAL-HFG81c pKS1076 nmt81:HFG-Mto2 3D 
pDUAL-HFG81c pKS1059 nmt81:HFG-Mto2 T35A 
pDUAL-HFG81c pKS1060 nmt81:HFG-Mto2 S179A 
pDUAL-HFG81c pKS1061 nmt81:HFG-Mto2 S220A 
pDUAL-HFG81c pKS1062 nmt81:HFG-Mto2 S366A 
pDUAL-HFG81c pKS1063 nmt81:HFG-Mto2 T394A 
pDUAL-HFG81c pKS1064 nmt81:HFG-Mto2 5A 
pDUAL-HFG81c pKS1084 nmt81:HFG-Mto2 Y168F 
pDUAL-HFG81c pKS1085 nmt81:HFG-Mto2 Y269F 
Table 2.2 LR recombination reactions between pDONR entry vector and pDUAL 
plasmids and their resulting constructs. 
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pHNGWA / pHMGWA. 2 – 3 single colonies from each reaction were isolated and 
the protein expression was tested by SDS-PAGE analysis of total protein from 1 ml 
of cells induced using 1 mM IPTG. MBP-TEV-Mto2 was created through the LR 
recombination reaction with pKS1057 containing attL1/2 flanked mto2 with amino 
terminal TEV cleavage and pHMGWA.  
 
2.2.4 Gene synthesis 
 
 Mto2 mutants were supplied by GENEART [Germany]. Lyophilised plasmid 
DNA was re-suspended in 1 X TE to 100 ng/µl. Sequences contained the 
mutagenised Mto2 ORF, within a pMK [KanR] derived vector. This was used as a 
template for PCR amplification to generate tB1/2 flanking sequence [section 
2.2.3.1.1]. Linear DNA was purified by agarose gel extraction and used in a BP 
recombination reaction with pKS535. 
 
2.3 FISSION YEAST METHODS 
 
2.3.1 Growth on Agar 
 
 Non-ts strains were grown at 30°C. Once woken up from -80°C storage, yeast 
cells were grown on YE5S-agar until colonies were visible. For strains containing 
selective markers, these were replica-plated onto non-selective plates then back onto 
selective media and YE5S plus phloxin B to test for stability, where dark pink 
phloxin B staining indicated dead cells. Once stable strains were acquired, these were 
incubated at RT for a maximum of 1 week, after which plates were stored at 4°C for 
up to 1 month. 
 
2.3.2 Growth in media  
 
 When proteins were expressed under nmt41/nmt81 thiamine repressible 
promoters, following initial inoculation of 5 ml of EMM plus appropriate nitrogen 
source and amino acid supplements, cultures were grown O/N at 32°C. To ensure 
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expression culture was diluted 1:50 and cells were grown O/N or for at least 16 hrs at 
32°C (Maundrell 1990).  
 
2.3.3 Growth of SILAC strains 
 
 Pre-cultures of KS5477 and KS5479 were diluted into the required amount of 
media, and were grown for at least six generations t  an OD595nm 0.4. KS5477, which 
did contain the nda3-KM311 allele was grown in unlabelled SILAC media and 
KS5477, which did not contain nda3-KM311 was grown in heavy labelled SILAC 
media. Cultures were agitated in a temperature controlled incubator at 18°C for 9 hr. 
After 9 hr cultures had reached mid-log phase [OD595 nm = 0.8]. Normalised cells 
cultures were combined and then harvested.  
 
2.3.4 Strain construction 
 
2.3.4.1 Transformation of yeast by lithium acetate (Bahler et al. 1998) 
 
 Yeast strains were cultured in YE5S medium at 32°C to an OD595nm of 0.8. 20 
ml [~ 107 cells] were used per transformation. Cells harvested by centrifugation 
[4,000 g, 3 min, RT]. Cell pellet was re-suspended in 20 ml dH2O and spun again 
[4,000 g, 3 min, RT]. Pellet was re-suspended in 1 ml dH2O and transferred to a 
microfuge tube. Cells were spun again [5,000 g, 1 min, RT] then re-suspended in 1 
ml 100 mM LiOAc, 1 X TE pH 7.5. Cells were spun again [5,000 g, 1 min, RT] and 
re-suspended in 100 mM LiOAc, 1 X TE pH 7.5, up to a volume of 100 µl. 20 µg of 
DNA was then added to the cells and incubated at RT for 10 min. 260 µl of 40% 
[w/v] PEGMW4000, 100 mM LiOAc, 1 X TE pH 7.5, was then added to the cells, 
mixed then incubated at 30°C. After 45 min, 43 µl of DMSO was added and cells 
were heat-shocked at 42°C for 5 min in a heat block. Transformed cells were then 
spun in a microfuge [5,000 g, 1 min, RT] and washed in 1 ml dH2O, cells are then 
spun again and re-suspended in 0.5 ml.  2 X 250 µl of cell suspension are then plated 
out onto YE5S agar using acid washed glass beads to spread the cells, and the plates 
are incubated overnight at 32°C. 
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2.3.4.2 Transformation of linearised Mto2 from pDUAL vectors 
 
 5µg of pDUAL plasmid containing Mto2 was subject to Not I restriction 
enzyme digestion, then linear DNA was transformed into mto2∆ strains. Following 
transformation, yeast were spread onto EMM agar + 10 mM glutamate + 
ade/ura/his/lys [250 µg/ml]. Integrants were selectd for leucine prototrophy. 
 
2.3.4.3 Mating of yeast 
 
 h+ and h- fission yeast mating type strains are spotted ontoa SPA agar plate 
and mixed together with 5 µl of dH2O. Plates are incubated at 30°C for 48 hr. For 
mating determination, mated cells are examined under a light microscope or are 
exposed to iodine vapour from iodine pellets spread on the lid of a petri-dish, 
whereby the iodine strongly stains spore walls found in cells that have undergone 
meiosis.  
 
2.3.4.4 Tetrad dissection 
 
 Mated cell populations are streaked down the middle of a YE5S agar plate 
and incubated for 1 hr at 37°C. Spores are then separated using a Singer MSM 300 
dissection microscope [Singer Instruments, U.K.]. Spores from non-ts mutants are 
incubated at 30°C for 3-4 days, or until colonies are visible.   
 
2.4 PROTEIN BIOCHEMISTRY 
 
2.4.1 Preparation of protein extracts 
 
2.4.1.1 Preparation of soluble native extracts from yeast 
 
 Typically 50 ml of yeast were grown to an OD595nm of 0.8 [mid-log phase ~ 
107 cells ml-1]. Cells were then harvested using centrifugation [4,000 g, 4 min, RT]. 
Cell pellet was transferred to a 2 ml conical screw cap tube and washed with 1 ml of 
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lysis buffer by centrifugation [5,000 g, 4 min, RT]. Pellet was then re-suspended in 
equal volume of lysis buffer. 0.5 mm Zirconia/Silica beads [BioSpec Products, 
U.S.A.] were added to the meniscus and cells were dis upted in a Ribolyser [Hybaid, 
U.K.] for 30 sec at a speed of 6.5 at 4°C.  The bottom of the tube was then pierced 
with a hot sterile needle and the tube was placed in a 5 ml polyethylene tube and 
extract was collected by centrifugation [1,500 g, 2 min, RT]. Isolated cell extract was 
transferred to a fresh microfuge tube and cleared by centrifugation [13,000 g, 15 min, 
4°C]. Supernatant was transferred and lysates were sto d at -20°C.  
 
2.4.1.2 Preparation of total protein extracts from yeast 
 
 Typically 20 ml of yeast were grown to an OD595nm of 0.8 [mid-log phase ~ 
107 cells ml-1]. Cells were then harvested using centrifugation [4,000 g, 4 min, RT]. 
Cell pellet was transferred to a 2 ml conical screw cap tube and washed with 1 ml of 
dH2O by centrifugation [5,000 g, 4 min, RT]. Pellet was then re-suspended in equal 
volume of dH2O and incubated at 100°C for 7 min. 0.5 mm Zirconia/Silica beads 
[BioSpec Products, U.S.A.] were added to the boiled extract up to the meniscus and 
cells were disrupted in a Ribolyser [Hybaid, U.K.] for 30 sec at a speed of 6.5.  The 
bottom of the tube was then pierced with a hot needle and the tube was placed in a 5 
ml polyethylene tube and extract was collected by centrifugation [1,500 g, 2 min, 
RT]. Isolated cell extract was the diluted with 1 X volume of 2 X Sample buffer [ - 
DTT and bromophenol blue] and transferred to a fresh microfuge tube and boiled for 
5 min. Extract was then cleared by centrifugation [13,000 g, 15 min, RT]. 
Supernatant was transferred to a fresh tube and stored at -20°C. 
 
2.4.1.3 Preparation of large scale fission yeast extracts  
 
 Culture was grown to an OD595nm = 0.8 [1 X YE5S] or OD595nm = 12 [4 X 
YE5S]. For cultures [ < 6 L] cells were harvested using Beckmann Avanti J-25 
centrifuge using a JLA 10-500 rotor [10,000 rpm, 10 min, 4°C], for culture > 6 L, 
cells are harvested using a Beckmann Avanti J-25 centrifuge using a JLA 8.1000 
rotor [5,000 rpm, 15 min, 4°C]. Pellet was re-suspended in 0.1 X culture volumes of 
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20 mM HEPES pH 7.6, and cells were collected as before. Cell pellet was then re-
suspended in 0.3 X cell volumes of 20 mM HEPES pH 7.6. Cell solution was then 
frozen, drop-wise into a sieve immersed in liquid nitrogen. Balls of cells were then 
stored in 15 / 50 ml tubes at -80°C. 5 – 40 g of frzen cells were ground in a Retsch 
RM100 electric mortar-grinder [Retsch, Germany]. The balls of cells were poured 
into the Retsch Grinder, which had been pre-cooled to -80°C with liquid nitrogen. 
Cells were ground until > 70% disruption had been achieved as assessed by 
examination under light microscope. Cell powder wasthen stored at -80°C. The 
required amount of disrupted cell powder was acquired by weighing aliquots into a 
cooled tube. Powder was then thawed on ice for 5 min, and re-suspended in 2 X lysis 
buffer [50 mM HEPES pH  7.6, 75 mM KCl, 1 mM MgCl2, 1mM EGTA, 0.1% [v/v] 
Triton X-100, 0.5 mM DTT, 1 mM PMSF, 1 mM benzamidine, 10 µg/ml CLAAPE]. 
Cell suspension was cleared in a table-top centrifuge [13,000 g, 5 min, 4°C], extract 
supernatant was transferred to a fresh tube and spun again [13,000 g, 10 min, 4°C]. 
The cleared supernatant was recovered and transferred to a fresh microfuge tube.  
 
2.4.1.4 Induction of protein expression in E. coli 
 
 BL21- CodonPlus® competent E. coli [Stratagene, USA] were chosen as an 
expression strain as they express from a pACYC based plasmid containing argU, 
ileY, leuW tRNA genes to provide extra copies of rare tRNAs which frequently limit 
translation during high-level expression. The E. coli strain also contains the T7 
promoter where expression of the T7 phage RNA polymerase is driven by the 
lacUV5 promoter in response to IPTG. Stationary culture was diluted 1:50 and 
grown for 2 hr at 37°C. Protein expression was then induced using 0.05 mM IPTG 
[Melford, U.K.] and shifted to 18°C and incubated O/N. For small cultures [ < 200 
ml] cells pellets from 1-5 ml aliquots are collected by centrifugation [13,000 g, 2 min, 
RT] and stored in microfuge tube. For large cultures [ > 200 ml] cells were harvested 
using Beckmann Avanti J-25 centrifuge and JLA 10-50 rotor [10,000 rpm, 10 min, 
4°C], for culture > 6 L, cells are harvested using a Beckmann Avanti J-25 centrifuge 
using a JLA 8.1000 rotor [5,000 rpm, 15 min, 4°C]. Cell pellet was then collected 
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with a spatula and spread onto a polythene sheet. Cll pellet was sealed within the 
sheet using an Impulse heat sealer. Bags were stored at -80°C. 
 
2.4.1.4.1 Preparation of native extracts from bacteria 
 
 Aliquots of frozen cells were thawed on ice and cell p llet was re-suspended 
in a Tris-based binding buffer [see section 2.4.4.1]  400 µl of buffer was added to the 
cell pellet for every 1 ml of culture. Suspension was then sonicated using a Branson 
Sonifer at 4 X 10 sec cycles at 30% output, duty cycle of 3. Lysate was cleared by 
centrifugation [13,000 g, 15 min, 4°C]. 
 
2.4.1.4.2 Preparation of total protein extracts from bacteria 
 
 Total protein extracts were made to test protein expression levels. Cell pellets 
from induced BL21-RIL strains were re-suspended in 1 X TBS [200 µl per ml of 
cultured cells]. Re-suspended cells were boiled at 100°C for 5 min. Lysate was 
cooled to RT then sonicated using a Branson Sonifer at 4 X 10 sec cycles at 30% 
output, duty cycle of 3. Equal volume of 2 X SB was then added to the lysate, and 
boiled at 100°C for 5 min. 
 
2.4.2 Measurement of protein concentration 
 
2.4.2.1 Bradford Assay (Bradford 1976) 
 
 The Bradford Assay was used to determine protein concentration for soluble 
native extracts. Protein solution was diluted 1:5 with dH2O and 2 µl was added to 1 
ml of the Bradford reagent [diluted 1:5 with dH2O] [BioRad, U.S.A.]. OD595 nm was 
measured using a spectrophotometer. Concentration was calculated based on 
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2.4.2.2 Bicinchoninic acid protein assay (Smith et al. 1985) 
 
 The BCA assay was used to measure protein concentratio  for total protein 
extracts. 20 µl of 4% [w/v] copper [II] sulphate solution was added to 1 ml 
Bicinchoninic acid, 1 µl of protein solution was adde  to the assay and incubated at 
65°C for 15 min. OD562 nm was then measured using a spectrophotometer. Protein 
concentration was based on calibration with BSA [data not shown] where 1 µg/µl of 
BSA gave an OD562 nm = 0.04. 
 
2.4.2.3 Determination of protein concentration by comparison with BSA 
calibration curve 
 
 10 mg/ml BSA [NEB, U.S.A.] was used to create a dilution series from 0.01 
µg/µl to 1 µg/µl. 10 µl of each BSA solution was loaded onto a 10% SDS-PAGE gel. 
Gel was stained with Coomassie, and the signal was qu ntified using Odyssey V3.0 
software. Gels were placed in the Odyssey flatbed scanner and were kept moist with 
1 X TBS during the analysis. Scans were performed using the 700 channel under 
medium quality resolution [192 µm]. The integrated intensity for each band was 
measured and used to create a standard curve against protein concentration.  
 




2.4.3.1.1 Preparation of polyacrylamide gel 
 
 Separating gel was poured and over-layed with 0.5 – 5 ml dH2O saturated n-
butanol, and gel was incubated until polymerised. Separating gel was then rinsed 
with dH2O, and the stacking gel poured on top. Appropriate comb was inserted into 
the stacking gel and assembly was incubated at RT until gel had polymerised. Comb 
was removed and wells were washed out with 1 X Laemmli running buffer (Laemmli 
1970).  
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8% 5ml 10ml 20ml 
H2O 2.3 4.6 9.3 
30% Acrylamide Mix 1.3 2.7 5.3 
1.5M Tris pH 8.8 1.3 2.5 5.0 
10% SDS 0.05 0.1 0.2 
10% APS 0.05 0.1 0.2 
TEMED 0.003 0.006 0.012 
10% 5ml 10ml 20ml 
H2O 2.0 4.0 7.9 
30% Acrylamide Mix 1.7 3.3 6.7 
1.5M Tris pH 8.8 1.3 2.5 5.0 
10% SDS 0.05 0.1 0.2 
10% APS 0.05 0.1 0.2 
TEMED 0.002 0.004 0.008 
12% 5ml 10ml 20ml 
H2O 1.6 3.3 6.6 
30% Acrylamide Mix 2.0 4.0 8.0 
1.5M Tris pH 8.8 1.3 2.5 5.0 
10% SDS 0.05 0.1 0.2 
10% APS 0.05 0.1 0.2 
TEMED 0.002 0.004 0.008 
 
2.4.3.1.2 Loading of samples and electrophoresis 
 
 All protein samples were diluted in SB and boiled for 5 min at 100°C before 
loading onto the acrylamide gel. 60 µg of total protein was loaded for all input 
samples. 1 X SB was used to fill empty lanes. Mini-PROTEAN gels were run at 35 
mA per gel, low-wide gels were run at 60 mA per gel and PROTEAN II XL gels 
were run at 300 V, or until the loading buffer dye front had run off the gel. 
 
2.4.3.1.3 Staining with Coomassie 
 
 Coomassie brilliant blue stain was used to detect proteins at levels > 0.1 µg. 
SDS-PAGE gel was incubated in a tray containing 100 ml of Coomassie stain then 
placed in a microwave [900 W] for 30 sec on high power. The tray was then 
incubated on a gyro-rocker at RT for 10 min. Staining solution was replaced with 
100 ml Coomassie destain, absorbent paper towel was placed in the tray and gel was 
STACKING 1ml 2ml 5ml 
H2O 0.68 1.4 3.4 
30% Acrylamide Mix 0.17 0.33 0.83 
1.0 M Tris pH 6.8 0.13 0.25 0.63 
10% SDS 0.01 0.02 0.05 
10% APS 0.01 0.02 0.05 
TEMED 0.001 0.002 0.005 
Table 2.3. Recipe for polyacrylamide 
gel solutions. Modified from Harlow, 
E and Lane, D. 1988. 
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then microwaved for 30 sec at high power. Gel was incubated in destain on a gyro-
rocker at RT for 10 min. The destain wash was repeat d until adequate contrast was 
achieved between gel and protein bands. 
 
2.4.3.1.4 Staining with silver nitrate 
 
 Silver staining was used to detect protein in SDS-PAGE gels at levels > 0.5 
ng. Gel was washed on a gyro-rocker for 10 min at RT in 100 ml of successive 
solutions: 1] 50% [v/v] methanol, 2] 5% [v/v] methanol, 3] 3.2 µl of 1 M DTT in 100 
ml of dH2O, and 4] 0.2% [w/v] AgNO3. The gel was then washed 3 X 5 sec in 100 ml 
dH2O. Following a brief wash in developer solution [3% [w/v] Na2CO3, 50 µl 37% 
[v/v] formaldehyde in 100 ml], the gel was re-incubated in dH2O. Gel was then 
transferred to developer solution and incubated at RT for up to 10 min or until 
adequate contrast is observed between gel and protein bands. Reaction was quenched 




2.4.3.2.1 Transfer onto Nitrocellulose Membrane 
 
 A wet-transfer system was used to transfer SDS-PAGE gels onto 
nitrocellulose membrane. A transfer sandwich soaked in CAPS transfer buffer was 
set up inside a gel holder cassette to be aligned from negative electrode to positive 
electrode as follows: 1 X 10 cm x 9 cm fibre pads, 2 X 10 cm x 9 cm 3MM paper 
[Whatmann, USA], polyacrylamide gel, 10 cm x 9 cm nitrocellulose membrane, 2 X 
10 cm x 9 cm 3MM paper, 2 X 10 cm x 9 cm fibre pads. Sandwich was then placed 
in buffer tank and immersed in CAPS transfer buffer. When using the Mini Trans-
Blot Cell [BioRad] a Bio-Ice cooling unit is placed in the tank during transfer. 
Voltage and transfer times were tailored for each experiment. When immunoblotting 
against Mto2 [45 kDa], proteins were transferred for 60 min at 60 V, when 
immunoblotting against Mto1 [120 kDa] the gel was transferred at 90 V for 90 min. 
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Other proteins analysed had a molecular weight betwe n 45 kDa and 120 kDa and 
their transfer parameters were adjusted accordingly.  
 
2.4.3.2.2 Ponceau S Staining 
 
 Membrane was incubated in 1 X Ponceau S stain for 10 min at RT on shaker. 
Stain was then replaced with destain and incubated for a further 10 min or until there 
is adequate contrast between the membrane and protein bands. To remove the protein 
staining completely, the membrane was washed in dH2O and then incubated in 1 X 
TBS. 
 
2.4.3.2.3 Antibody incubation 
 
 All short [1-2 hr] incubations were carried out at RT and longer incubations 
were carried out at 4°C. Membranes were first incubated in blocking soluti n [2% 
[w/v] milk, 0.2% [v/v] Tween-20, 1 X TBS]. Membranes were then incubated with 
primary antibody diluted in buffer [2% milk, 0.02% [v/v] Tween-20, 1 X TBS]. 
Following incubation, membranes were washed 3 X 100 ml wash buffer [1 X TBS, 
0.02% [v/v] Tween-20]. Membranes were then transferred to secondary antibody 
diluted in buffer [2% [w/v] milk, 0.02% [v/v] Tween-20, 1 X TBS]. Following 
incubation, membranes were washed 3 X 100 ml wash buffer [1 X TBS, 0.02% [v/v] 
Tween-20]. For membranes incubated with IRDye conjugated IgG, the final wash 
was without Tween-20.  
 
2.4.3.2.4 Enhanced Chemiluminescence [ECL] detection 
 
 Excess wash buffer was blotted off the membrane and then the membrane 
was incubated in 10 ml ECL [100 mM Tris-HCl pH 8.5, 2.5 mM luminol, 0.4 mM p-
coumaric acid, 0.02% [v/v] H2O2] for 5 min. Excess ECL was removed and 
membrane was placed between a Saran wrap sandwich, and secured into an exposure 
cassette with tape. Blue sensitive X-ray film [A. Somerville Ltd. U.K.] was then 
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placed on top of the membrane before being processed by the SRX-101A tabletop 
film processor [Konica, U.S.A.].  
 
2.4.3.2.5. Protein quantification by fluorescence 
 
 Donkey anti-mouse IRDye800 were used for fluorescence quantification by 
the Odyssey Scanner and software [Odyssey V2.0]. GT-34 secondary was used 
[mouse anti-sheep IgG] for immunoblots probed with anti-sheep polyclonal 
antibodies. IRDye800 was directly incubated with membrane probed with mouse 
monoclonal antibodies [GTU-88, 9E10]. Membranes were placed in the flatbed 
scanner and were kept moist with 1 X TBS during the analysis. Scans were 
performed using the 800 channel under medium quality resolution [192 µm] Images 
were adjusted using only linear contract enhancement with Odyssey V2.0 or 
Photoshop [Adobe] software. 
 
2.4.4 Protein-Protein Interaction Assays 
 
2.4.4.1 MBP pulldown assay 
 
 Soluble extracts are made from 1 – 2 ml of induced BL21- CodonPlus® 
Competent cells [Stratagene, U.S.A] containing MBP- or NusA-tagged protein. 
Concentration of the tagged protein was estimated by comparison with a BSA 
calibration curve. 50 µl of packed amylose resin was used per pulldown. Beads are 
washed with 3 X 1 ml dH2O by centrifugation [4,000 g, 1 min, RT] and pre-
equilibrated by centrifugation [4,000 g, 1 min, 4°C] in 1 X 1 ml binding buffer 
containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 5% [v/v] glycerol, 1 mM BME, 
0.2% [v/v] Triton X-100, 1 mM PMSF, 1 mM aprotinin. Normalised levels of 
cleared cell lysate [~400 µl] were added to the resin and incubated for 1 hr at 4°C on 
a rotating wheel. Following incubation, amylose resin was washed 5 X 1 ml binding 
buffer by centrifugation [4,000 g, 1 min, 4°C]. Protein was eluted by adding 20 µl of 
binding buffer plus 10 mM maltose to the resin and incubating on a rotator for 10 
min at 4°C. Eluate was collected boiled at 100°C for 5 min in 50 µl 2 X SB. 
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2.4.4.2 Antibody immunoprecipitation 
 
 Soluble extracts were made from 0.5 g of ground yeast strains. 
Approximately 3 x 107 of Protein G-Dynabeads [Invitrogen, U.S.A.] were usd per 
IP. Beads were washed 3 X 1 ml dH2O by performing a brief centrifugation [< 4,000 
g] to remove solution from the lid of the tube then incubated on a Magnetic Particle 
Concentrator [Invitrogen, U.S.A.]. Dynabeads were th n equilibrated with 2 X 1 ml 
IP buffer using the same method. 1.2 µg of sheep anti-GFP 3.0 antibody or affinity 
purified anti-Mto2 were used per IP. Antibody was added to the beads in 500 µl of IP 
buffer and incubated for 30 min on a rotator at RT.Following incubation with 
antibody, beads were washed with 2 X 1 ml IP buffer using the same method as 
described above. Normalised amounts of cleared cell extract [typically 20 – 40 mg 
total protein] were added to the Protein G-Dynabeads and incubated on a rotator at 
4°C for 1 hr. After incubation, the supernatant was removed, and each IP was 
washed 3 X 1 ml IP buffer, using the method described above. Beads were 
transferred into a fresh screw-cap tube and then washed a further 3 X 1 ml IP buffer. 
Beads were then re-suspended in 30 µl of 1 X SB [ - DTT and bromophenol blue] 
and incubated at 50°C for 10 min. Eluate was transferred to a fresh tube and DTT 
and bromophenol blue was added to a final concentration of 100 mM and 0.01% 
[w/v] respectively. Samples were then incubated at 100°C for 5 min and stored at -
20°C. 
 
2.4.4.3 TAPS affinity tag pulldown 
 
 Soluble extracts were made from 0.5 g of cell powder from a strain 
containing TAPS tagged protein. Resultant protein co centration of extract was 
typically 20 – 50 µg/µl. ~3 x 107 of IgG-linked-Dynabeads [Invitrogen, U.S.A.] were 
used per pulldown. Dynabeads were washed with 3 X 1 ml dH2O by performing a 
brief centrifugation [<  4,000 g] to remove solution from the lid of the tube then 
incubation on a Magnetic Particle Concentrator [Invitrogen, U.S.A.]. Dynabeads 
were then equilibrated with 2 X 1 ml IP buffer using the same method. Normalised 
extract [typically 20 – 40 mg] was added to the beads nd agitated at 4°C for 1 hr. 
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After incubation, the supernatant was removed and ech IP was washed 3 X 1 ml IP 
buffer using the method described above. Beads weretransferred into a fresh screw-
cap tube and then washed a further 3 X 1 ml IP buffer. Beads were then re-suspended 
in 30 µl of 1 X SB [ - DTT and bromophenol blue] and i cubated at 50°C for 10 min. 
Eluate was transferred to a fresh tube and DTT and bromophenol blue was added to a 
final concentration of 100 mM and 0.01% [w/v] respectively. Samples were then 
incubated at 100°C for 5 min.  
 
2.4.5 Large scale protein purification 
 
2.4.5.1 Large scale purification of Mto2 from bacteria 
 
 4 X pellet volumes of lysis buffer [50 mM Tris-HCl pH 8.0, 150 mM NaCl, 
0.2% [v/v] Triton X-100, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 1 mM 
benzamidine, 10 µg/ml CLAAPE] were added to fragmented bacterial pellet at 4°C. 
Once cells were re-suspended, they were passed through a glass homogeniser [VWR 
International, U.S.A] 30 X loose pestle, 30 X tight pestle. Cells were disrupted using 
a cooled French Pressure Cell Press [ThermoSpectronic, U.S.A.]. 30 ml of cell 
suspension were passed through the press in each batch at 15,000 psi between 3 – 5 
times, until the viscosity of the solution was sufficiently reduced that it passed drop-
wise in to the collecting vessel. 3 U of benzonase nuclease [Novagen, Germany] 
were added per ml of culture, in addition to 6 mM of MgCl2 and incubated at 4°C for 
1 hr. Cell lysate was then cleared by centrifugation using a Beckmann Avanti J-25 
centrifuge with a JA-20 rotor [Beckmann] [20,000 rpm, 20 min, 4°C]. Supernatant 
then underwent a second clearing step in a Beckmann XL-100 Ultracentrifuge with a 
Type 45Ti rotor, [40,000 rpm, 1 hr, 4°C]. Amylose resin was added to a 20 ml 
general purpose chromatography column to a 2 ml bead volume [one column per 20 
ml lysate] which was washed with 50 ml of lysis buffer. 20 ml of cleared extract was 
added to each column which was then sealed and incubated on a rotator O/N at 4°C. 
Column was secured and stopper was released to allow the lysate to drain through. 
Resin was then washed with 100 ml TEV cleavage buffer [50 mM Tris-HCl pH 8.0, 
150 mM NaCl, 0.2% [v/v] Triton X-100, 1 mM EDTA, 1 mM DTT] or until OD280 
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nm = 0.00 for three consecutive readings following 10 ml washes measured using a 
NanoDrop Spectrophotometer. Resin from each column was combined into a single 
10 ml column and re-suspended in 5 ml TEV Cleavage Buffer. 500 U of AcTEV 
protease [Invitrogen, U.S.A.] was added to the suspen ion. Cleavage reaction was 
incubated for 72 hr at 4°C. Column was placed in a 15 ml falcon tube and 
supernatant was recovered by centrifugation [1,500 g, 2 min, 4°C]. Isolated cleavage 
product [~5 ml] was then transferred to an Amicon Ultra-4 Centrifugal Filter Device 
30,000 NMWL [Millipore, U.S.A.], and centrifuged for [4,000 g, 20 min, 4°C] after 
which the final volume of cleavage product had been reduced to 250 µl. 250 µl of 
100% [v/v] glycerol was added to the purified protein and this was stored at -80°C. 
 
2.4.5.2 Large Scale purification of Mto2 from yeast 
 
2.4.5.2.1 Two-step denaturing purification of Mto2  
 
 Denaturing purification was performed using 35 g of r und cell powder. 
Powder was re-suspended in 70 ml denaturation buffer [6 M GuHCl, 25 mM Tris-
HCl pH 7.5, 300 mM NaCl, 20 mM imidazole]. Extract was cleared in a Beckmann 
Avanti J-25 centrifuge using a JA25.50 rotor [8000 rpm, 20 min, 4°C], then 
supernatant was transferred to a fresh tube and centrifugation step was repeated at 
[20,000 g, 30 min, 4°C]. 1 ml bead volume HisBind Fractogel [Novagen, Germany] 
was washed with 3 X 10 ml dH2O by centrifugation [4,000 g, 3 min, RT] and 
activated with 1 ml 0.5 M NiSO4 and incubated for 10 min at RT. Resin was then 
washed 6 X 5 ml dH2O   [4,000 g, 3 min, RT], and 2 X 5 ml denaturation buffer 
[4,000 g, 3 min, RT]. Beads were split between two 50 ml tubes and 35 ml of cell 
extract was added to both, and tubes were agitated for 3 hr at 4°C. Resin was then 
batch washed with consecutively weaker concentration of GuHCl. 2 X 10 ml Buffer 
1 [6 M GuHCl, 25 mM Tris-HCl pH 7.5, 300 mM NaCl, 20 mM imidazole], 2 X 10 
ml Buffer 2 [3 M GuHCl, 25 mM Tris-HCl pH 7.5, 300 mM NaCl, 20 mM 
imidazole], 2 X 10 ml Buffer 3 [1 M GuHCl, 25 mM Tris-HCl pH 7.5, 300 mM 
NaCl, 20 mM imidazole], then 3 X 10 ml Buffer 4 [25 mM Tris-HCl pH 7.5, 300 
mM NaCl, 20 mM imidazole]. Protein was eluted from the Fractogel in 5 ml elution 
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buffer [25 mM Tris-HCl pH 7.5, 300 mM NaCl, 300 mM imidazole. 1 mM DTT, 1 
mM PMSF, 1 mM benzamidine, 10 µg/ml CLAAPE, 60 mM β-glycerol phosphate, 
15 mM PNPP, 10 mM sodium orthovanadate].  ~4.5 x 108 beads of MyOne 
Streptavidin C1 Dynabeads [Invitrogen, U.S.A.] were us d in the second purification 
step. Dynabeads were washed with 3 X 1 ml dH2O by performing a brief 
centrifugation [< 4,000 g] to remove solution from the lid of the tube then incubation 
on a Magnetic Particle Concentrator [Invitrogen, U.S.A.]. Dynabeads were then 
equilibrated with 2 X 1 ml IP buffer using the same thod. 5 ml Fractogel elution 
was added to the beads and incubated on a rotator for 2 hr at 4°C. Dynabeads were 
washed as described above with 3 X 2 ml Tris binding buffer [ - protease inhibitors], 
then 3 X 2 ml of TEV cleavage buffer [25 mM Tris-HCl pH 8.0, 150 mM NaCl, 
0.1% [v/v] Triton X-100, 0.5 mM EDTA, 1 mm DTT]. Beads were re-suspended in 
500 µl of TEV cleavage buffer and 500 U of AcTEV protease [Invitrogen, U.S.A.] 
was added. The cleavage reaction was left O/N at 4°C. TEV cleavage product was 
recovered from the beads and concentrated using TCA precipitation. Protein pellet 
was re-suspended in 30 µl 1 X SB.  
 
2.4.5.2.1.1 Trichloroacetic acid precipitation [TCA] 
 
 100% [w/v] TCA was added to the protein solution t a final concentration of 
10% and incubated for 30 min on ice. If solution cotained urea or guanidine, it was 
diluted to < 0.2 M before addition of TCA. Precipitated protein was collected by 
centrifugation [13,000 g, 15 min, 4°C]. Protein pellets were then washed with 2 X 1 
ml ice-cold wash buffer [70% [v/v] acetone, 20% [v/v] ethanol, 10 mM Tris-HCl pH 
7.5, 0.0025% [w/v] bromophenol blue] using centrifugation [13,000 g, 10 min, 4°C]. 
Pellets were then left to air dry. Acidic pellets were neutralised with ammonium 
hydroxide vapours then re-suspended in 1 X SB and boiled for 5 min.   
 
2.4.5.2.2 Large Scale Mto2-TAPS affinity purification from SILAC strains  
 
 15 g of cell powder containing cells from both mitotic non-labelled and 
isotope labelled asynchronous culture were used for the purification. Cell powder 
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was re-suspended in 20 ml of phosphate buffer [15 mM Na2HPO4, 10 mM NaH2PO4, 
150 mM NaCl, 2 mM EDTA, 1% [v/v] NP-40, 2 mM benzamidine, 2 mM PMSF, 1 
mM DTT, 60 mM β-glycerol phosphate, 5 mM sodium azide, 10 mM sodium 
fluoride, 1 mM sodium orthovanadate, 50 nM calyculin, 50 nM okadaic acid, 10 µM 
cyclosporin, 10 µg/ml CLAAPE]. Cell lysate was then clarified by centrifugation 
using a JA 25-50 rotor in a Beckmann Avanti J-25 centrifuge [20,000 rpm, 10 min, 
4°C]. 1.5 x109 IgG-linked Dynabeads [Invitrogen, U.S.A.] were washed with 3 X 1 
ml dH2O by performing a brief centrifugation [< 4,000 g] to remove solution from 
the lid of the tube then incubation on a Magnetic Particle Concentrator [Invitrogen, 
U.S.A.]. Dynabeads were then equilibrated with 2 X 1 ml lysis buffer using the same 
method. Beads were added to cleared cell lysate and incubated on a roller for 1.5 hr 
at 4°C. Supernatant was removed and Dynabeads were washed wit  5 X 10 ml lysis 
buffer [without protease inhibitors], using the Magn bot large volume separation 
device [Promega, U.K.]. TAPS-tagged protein was eluted by re-suspension in 1 X 
SB and incubated at 50°C for 15 min. Eluate was recovered into a fresh microfuge 
tube and stored at -20°C. 
 
2.4.6 Hydrodynamic analysis  
 
2.4.6.1 Sucrose Density Gradient Analysis 
 
 2 ml gradients were made in Ultra-Clear Tubes [11 x 34 mm] [Beckman, 
U.S.A.]. 0.5 ml of 20%, 15%, 10%, 5% [w/w] sucrose solutions were carefully 
layered into the tube with a blunt P1000 pipette tip. Sucrose solutions were made up 
with the same buffer as the sample to be analysed. Each gradient was incubated at 
RT for 1 hr, then prior to centrifugation incubated in an ice-water bath for 10 min. A 
gradient containing molecular weight markers [Sigma, U.S.A.] accompanied each 
analysis [see Appendix I and II]. 2 ml gradients were spun in an OptimaMax 
Ultracentrifuge [Beckman Coulter, U.S.A.] using a TLS-55 swinging bucket rotor 
assembly. 2 mg of total soluble protein was analysed in each gradient. Analyses of 
complexes > 20 S gradients were spun at 55,000 rpm for 30 min. Analyses of 
complexes < 20 S gradients were spun at 55,000 rpm for 3.5 hr. Following 
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sedimentation, 100 µl gradient fractions were manually removed with a blunt P200 
pipette tip and were stored at 4°C. For immediate analysis fractions were added to 
100 µl 2 X SB and boiled for 5 min. Pellet fraction was obtained by re-suspending 
pellet in 200 µl 1 X SB.  
 
2.4.6.1.1 Preparative sucrose gradients 
 
 14 ml gradients were made in polyallomer centrifuge tubes [14 x 95 mm] 
[Beckman, U.S.A.]. 7 ml of 20% and 5% sucrose soluti ns, made with TEV cleavage 
buffer, were poured into the tube. Solutions were saled inside the tube and the 
gradient was established using a Gradient Master 107 [Biocomp, U.S.A.]. Gradients 
were incubated in an ice-bath for 10 min prior to use. 500 ml of sucrose solution was 
removed from the top of the gradient to allow space for sample. Centrifugation was 
carried out in a Beckmann XL-100 Ultracentrifuge using SW-40 Ti swinging bucket 
rotor [Beckman, U.S.A]. This was spun for at 35,000 rpm for 16 hr at 4°C. 
Following sedimentation 0.5 ml fractions were collected, these were stored at 4°C. 
For immediate analysis fractions were added to 0.5 ml 2 X SB and boiled for 5 min.  
 
2.4.6.2 Size-exclusion gel chromatography 
 
 Size-exclusion gel chromatography was performed on usi g a BioLogic 
Duoflow chromatography system [BioRad, U.S.A], where p otein samples were 
analysed on a Superose 6 10/300GL high performance column [GE healthcare, 
U.S.A]. The HPLC system and column were stored in 20% [v/v] ethanol at 4°C. All 
water and buffers were filter sterilised using a 0.2µm filter unit [Nalgene, U.S.A.] 
and de-gassed using a vacuum pump. Prior to use, the HPLC system and column 
were washed with 70 ml dH2O. System and column were then equilibrated with 48 
ml lysis buffer. Yeast lysates were run on KS1 Superos  6, and purified protein was 
run on KS2 Superose 6. Soluble native extracts weresubject to a pre-clearing 
centrifugation step [13,000 g, 15 min, 4°C]. Then a second clearing step was 
performed using the OptimaMax Ultracentrifuge in a TLA-100.3 fixed angle rotor 
[50,000 rpm, 20 min, 4°C]. Supernatant was collected and filtered through a 0.22µm 
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cellulose acetate membrane by centrifugation [13,000 g, 5 min, 4°C]. Protein 
concentration of the flow through was measured by Bradford assay, and solution was 
diluted to 0.2 mg/ml. 100 µl [2 mg] of protein extract was loaded onto the column 
using an AVR7-3 sample injection valve. For KS1, flow rate was established at 0.3 
ml/min [136 psi], for KS2 for fractionation of purified protein, column was run at 0.4 
ml/min [107 psi]. 30 ml of lysis buffer was passed through the column. 1 ml fractions 
were collected using an automated fraction collector. C llection started at 6 ml where 
void volume eluted at 7 ml [KS1] and 8 ml [KS2]. 30X 1 ml fractions were collected 
in total. 25 µl of 5 X SB [- DTT] are added to the fractions and stored at -80°C. 
Molecular weight standards [GE Healthcare/Sigma] were run on both columns to 
determine a calibration curve [see Appendix III and IV]. Loading of cell lysate to the 
Superose-6 column [GE Healthcare] and subsequent fractionation was performed by 
A. Anders. All samples from sucrose gradient analysis and gel-filtration 
chromatography were analysed by western blot on the low-wide system. 
 
2.4.7 Protein Phosphorylation Analysis 
 
2.4.7.1 λPPase treatment 
 
 Total protein extracts were prepared from KS516. Extract buffer contained 20 
mM Tris-HCl pH7.5, 150 mM NaCl, 0.1 mM EGTA, 2 mM DTT, 0.01% TX-100, 2 
mM MgCl2, 1 mM PMSF, 1 mM benzamidine, 10 µg/ml
 CLAAPE. In buffer that 
contained phosphatase inhibitors the following was also added: 10 mM Na3VO4, 10 
mM EDTA, 60 mM β-glycerol-phosphate, 5 mM NaN3, 10 mM NaF, 50 nM 
calyculin, 50 nM, okadaic acid. For extract to be trea ed with phosphatase 2 mM 
MnCl2 was also added. The protein concentration of extracts was measured by 
Bradford Assay. 400 U of λ-PPase [N.E.B., U.S.A] was heat inactivated by 
incubation with 10 mM EDTA at 65°C for 1 hr. 400 U of λ-PPase or HI enzyme was 
then added to normalised protein extracts in 50 µl fina volume and incubated at 
30°C for 30 min. The reaction was stopped by the addition of 50 µl 2 X SB and 
boiled for 5 min.  
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2.4.7.2 CDK1-Cyclin B kinase assay of purified Mto1/2 complex 
 
 0.5 g of cell powder from KS3476 [Mto1 [1-800]-TAPS] and KS516 were re-
suspended in lysis buffer [20 mM Tris-HCl pH 7.5, 6 mM MgCl2, 150 mM NaCl, 
0.05% [v/v] Triton X-100, 2 mM DTT, 10% [v/v] glycerol, 1 mM PMSF, 1 mM 
benzamidine, 10 µg/ml CLAAPE]. A TAPS affinity purification was performed 
using IgG-linked-Dynabeads [Invitrogen, U.S.A.] After incubation, the beads were 
transferred into a fresh screw-cap tube re-suspended i  50 µl of extract buffer and 
200 µM final concentration of dATP was added to each sample. 5µl of beads were 
then taken and protein eluted for input. 100 ng of CDK1-Cyclin B [Invitrogen, 
U.S.A.] was added to the beads, and agitated for 30 mins in a 30°C water bath. CDK 
kinase supernatant was recovered into a fresh microfuge tube. 50 µl of 2 X SB was 
added and incubated at 100°C for 5 min. The remaining beads were washed in 3 X 1 
ml extract buffer by centrifugation using the method described above. Dynabeads 
were re-suspended in 100 µl of 1 X SB and incubated t 50°C for 10 min. 
Supernatant was recovered using a brief centrifugation [13,000 g] and incubation on 
the Magnetic Particle Concentrator. Eluate was thenincubated at 100°C for 5 min. 
 
2.4.7.3 cdc25-22ts G2 block and release 
 
 cdc25-22ts strains were grown at 25°C O/N to an OD595 nm = 0.2. Temperature 
was shifted to 35.5°C and culture was grown for 4 h. Culture was then returned to 
permissive temperature by brief incubation in an ice slurry, then into a water bath at 
25°C. T0 time point was taken on temperature shift, successiv  time point were taken 
every 20 min for 180 min. At each time point 40 ml of culture was collected and 
washed with 10 ml STOP buffer [150 mM NaCl, 50 mM NaF, 10 mM EDTA, 1 mM 
NaN3] and 5 ml HB salts buffer [25 mM MOPS pH 7.2, 15 mM MgCl2, 15 mM 
EGTA, 1 mM DTT] using a Büchner funnel and 0.45 µm Durapore membrane filters 
[MILLIPORE, U.S.A.]. Cells are transferred to a screw-cap microfuge tube in 1 ml 
HB salts, and cell pellet was snap frozen in liquid nitrogen.  
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2.4.7.3.1 Determination of septation index 
 
 500 µl aliquots were taken from each cell cycle block and release time point. 
0.1% [w/w] glyceraldehyde final concentration was added to the cells and they were 
incubated on a rotator at RT for 20 min. Fixed cells were washed with 1 ml 1 M 
sorbitol using a tabletop centrifuge, re-suspended in 30 µl of 1 M sorbitol and stored 
at 4°C. 5µl of cell solution were incubated with 5µl fluorescent brightener [0.1% 
fluorescent brightener, 10 mM Tris HCl pH 7.5] for 10 min at RT. 5 µl of cells were 
placed on a microscope slide and examined under the wide-field microscope using a 
DAPI filter set. ~ 200 cells were counted where the percentage of cells which had a 
septum was calculated for each time point. Those cells which had formed a septum, 
but had started to separate or had been released from sister cells were not counted. 
 
2.4.7.4 nda3-KM311 metaphase arrest 
 
 nda3-KM311 cold-sensitive allele was used to arrest cells in metaphase. 
Cultures were grown at 32°C to an OD595 nm = 0.2. Cultures were then quickly cooled 
to 18°C using an ice bath and incubated at 18°C for 9 hr. The extent of the arrest was 
assessed by light-microscopy, where arrested cells w re longer than wild-type and 
had a low septation index.  
 
2.5 MASS SPECTROMETRY ANALYSIS 
 
All mass spectrometry analyses were performed by Flavia Alves and Juri Rappsilber.  
 
2.5.1 Sample Preparation 
 
 Protocol as described in (Pidoux et al. 2009). Coomassie strained band 
corresponding to the expected molecular weight was excised from the gel cut into 
small pieces. Proteins were then reduced in 20 mM DTT for 30 min at 37°C, 
alkylated in 50 mM iodoacetamide for 30 min at RT in the dark, and incubated with 
12.5 ng/µl trypsin O/N at 37°C (Shevchenko et al. 1996). The digestion medium was 
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then acidified to 0.1 [v/v] % of trifluoroacetic acid and spun ont StageTips 
(Rappsilber et al. 2003). Peptides were eluted in 20 µl 80% [v/v] acetonitrile, 0.5% 
[v/v] acetic acid and were concentrated to 2 µl [concentrator 5301; Eppendorf AG, 
Hamburg, Germany]. They were then diluted to 5 µl with 0.1% [v/v] trifluoroacetic 
acid for liquid chromatography-tandem mass spectroscopy [LC-MS-MS] analysis. 
 
2.5.2 Mass spectrometry analysis  
 
 LC MS/MS was performed on an LTQ-Orbitrap mass spectrometer 
[ThermoElectron] that was coupled online to an Agilent 1100 binary nanopump [Palo 
Alto, CA] and an HTC PAL autosampler [CTC, Zwingen, Switzerland]. A C18 
material LC column [3-µm ReproSil-Pur C18-AQ; Maisch GmbH, Ammerbuch-
Entringen, Germany] was used to separate peptides prior to ESI. Raw files were 
processed using DTAsupercharge 0.62 [a kind gift from M. Mann]. The generated 
peak lists were searched against protein databases using Mascot 2.0. The results were 
parsed through MSQuant [http://msquant.sourceforge.net/]  A significance score was 
given to each phosphorylated residue based on comparison with a target-decoy 
database (Elias et al. 2007). Peptides with scores 25 and higher were report d and 




2.6.1 Equipment and image analysis 
 
 Prior to imaging, cells were placed on a 2% [w/v] agarose/EMM pad. 
Coverslips were secured onto the slide using liquid VALAP [33% [w/w] Vaseline, 
33% [w/w] lanolin, 33% [w/w] paraffin] which had been melted at 70°C.  
Wide-field images were acquired used a Nikon 100x/1.40 NA Plan Apo objective on 
a Nikon TE300 inverted microscope. This was connected to a Coolsnap HQ CCD 
camera [Photometrics]. Confocal images were acquired using a Nikon 100x/1.45 NA 
Plan Apo objective on a Nikon TE2000 inverted micros pe, connected to a 
Yokogawa CSU-10 spinning disc confocal head [Visitech] and a Coolsnap HQ CCD 
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camera. Image acquisition, processing and analysis were carried out using 
Metamorph software [Molecular Devices]. Microscope images were adjusted using 
only linear contract enhancement with Metamorph [Molecular Devices] or 
Photoshop [Adobe] software. Time-lapse images to compare samples were imaged 
under identical illumination conditions; the brightness and contrast was later scaled 
using consistent values to allow accurate comparisons t  be made. 
 
2.6.2 Image parameters 
 
 All wide-field images in this study are maximal projections of Z-sections. 8 
Z-sections were taken over a range of 4.2 µm, with a 0.6 µm step size. 800 ms 
exposure time was used for illumination at 488 nm. Images were subject to 2X2 pixel 
binning. 
 All images taken on the spinning disk confocal are maximal projections of Z-
sections. 11 Z-sections were taken over a range of 4 µm, with a 0.4 µm step size. 200 
ms exposure time was used for illumination at 488 nm. 500 ms exposure time was 
used for illumination at 561 nm. EM Gain was 300 ms. These images were subject to 
1X1 pixel binning. 
 
2.7 BIOINFORMATIC ANALYSIS 
 
2.7.1 Mto2 homolog identification using BLASTP 
 
 The S. japonicus homologues of S. pombe Mto2 was identified as 
SJAG_03264.2 by performing a BLASTP search (Altschul et al. 1997) with 
SPBC902.06 against the S. japonicus genome available online from the Broad 
Institute Sequencing database at: http://www.broadinstitute.org/annotation/genome/ 
schizosaccharomyces_group/MultiHome.html. The e - score for the High Scoring 
segment pairs [HSPs] alignment was 1e-24. An E - score describes the number of 
sequence Pairs in the database which would align as ood as or better by chance, 
therefore the lower the e - score the higher the significance of the hit. SJAG_03264.2 
and Mto2 amino acid sequences were entered into the CLUSTALW2 alignment 
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program (Larkin et al. 2007) available from the European Bioinformatics In titute 
[http://www.ebi.ac.uk/]. The Schizosaccharomyces octosporus homolog 
SOCG_01774.2 was identified from the BLASTP server at the Broad Institute as 
described above. Other fungal homologs of Mto2 were identified using a BLASTP 
search using SPBC902.06 as bait against all non-redundant sequence databases 
available from the NCBI [available online at http://blast.ncbi.nlm.nih.gov/Blast.cgi].    
 
2.7.2 Coiled-coil prediction by PAIRCOIL2 
 
 The PAIRCOIL2 coiled-coil prediction software was developed at the 
Massachusetts Institute of Technology to predict the presence of coiled-coils in 
amino acid sequences (McDonnell et al. 2006). The program algorithm is based on 
pairwise residue correlations from a coiled-coil datab se (Berger et al. 1995). 
PAIRCOIL2 is available at http://groups.csail.mit.edu/cb/paircoil2/.  
Helical wheel projections were generated using online software available at 
http://cti.itc.virginia.edu/~cmg/Demo/wheel/wheel App.html. Sequential 18aa 
regions of the coiled-coil sequence identified by PAIRCOIL2 were entered into the 
applet generating a series of wheel projections. 
 
2.7.3 Mto2 secondary structure prediction by Jpred3 
 
 Secondary structure was predicted using online software Jpred3 (Cole t al. 
2008). Jpred3 is available at http://www.compbio.dun ee.ac.uk/www-jpred/.  
 
2.7.4 Phosphorylation site scoring using NetPhos 2.0 
 
 The NetPhos 2.0 software is available at 
http://www.cbs.dtu.dk/services/NetPhos/ (Blom et al. 1999). The NetPhos program is 
a neural network that uses sequence and structural dat  from a database of known 
phosphorylated sites to NetPhos was used to generat a score for each S/T/Y amino 
acid that describes the probability that that residue is phosphorylated.  
 




Plasmid Description/ Markers Source 
pKS422 pFA6-TAPS:KanMX6 (Brune et al. 2005) 
pKS466 pFA6-HTB:KanMX6 (Tagwerker et al. 2006) 
pKS121 c902 cosmid Sanger Institute, U.K 
pKS535 pDONR221 KanR Invitrogen, U.S.A. 
pKS1032 pDONR221 Mto2-STOP KanR This study 
pKS537 p0GWA N-terminal His6  AmpR (Busso et al. 2005) 
pKS545 pHNGWA His6-NusA AmpR (Busso et al. 2005) 
pKS544 pHMGWA His6-MBP AmpR (Busso et al. 2005) 
pKS1034 His6-MBP-Mto2 AmpR This study 
pKS1035 His6-NusA-Mto2 AmpR This study 
pDUAL29 pDUAL-HFG41c AmpR (Matsuyama et al. 2004) 
pDUAL31 pDUAL-HFG81c AmpR (Matsuyama et al. 2004) 
pDUAL40 pDUAL-GFH81c AmpR (Matsuyama et al. 2004) 
pKS1036 pDONR221 Mto2 N1  KanR  This study 
pKS1037 pDONR221 Mto2 N2  KanR  This study 
pKS1038 pDONR221 Mto2 N3  KanR  This study 
pKS1039 pDONR221 Mto2 C1  KanR  This study 
pKS1040 pDONR221 Mto2 C2  KanR  This study 
pKS1041 pDONR221 Mto2 C3  KanR  This study 
pKS1042 His6-MBP-Mto2 N1 AmpR This study 
pKS1043 His6-MBP-Mto2 N2AmpR This study 
pKS1044 His6-MBP-Mto2 N3 AmpR This study 
pKS1045 His6-MBP-Mto2 C1 AmpR This study 
pKS1046 His6-MBP-Mto2 C2 AmpR This study 
pKS1047 His6-MBP-Mto2 C3AmpR This study 
pKS1048 pDONR211 Mto2-L133DL137D KanR This study 
pKS1049 His6-MBP-Mto2 L133DL137D AmpR This study 
pKS1050 nmt81:HFG-Mto2  AmpR This study 
pKS1051 nmt81: HFG-Mto2 L133DL137D  AmpR This study 
pKS1052 nmt41: HFG-Mto2 L133DL137D  AmpR This study 
pKS1053 nmt81: HFG-Mto2 N1  AmpR This study 
pKS1054 nmt81: HFG-Mto2 N2  AmpR This study 
pKS1055 nmt81: HFG-Mto2 C1  AmpR This study 
pKS1056 His6-MBP-TEV-Mto2  AmpR This study 
pKS1057 pDONR221 TEV-Mto2  KanR This study  
pKS1059 pDONR221 Mto2 T35A  KanR This study 
pKS1060 pDONR221 Mto2 S179A  KanR This study 
pKS1061 pDONR221 Mto2 S220A  KanR This study 
pKS1062 pDONR221 Mto2 S366A  KanR This study 
pKS1063 pDONR221 Mto2 T395A  KanR This study 
pKS1064 pDONR221 Mto2 5A  KanR This study 
pKS1065 nmt81: HFG-Mto2 T35A  AmpR This study 
pKS1066 nmt81: HFG-Mto2 S179A  AmpR This study 
pKS1067 nmt81: HFG-Mto2 S220A  AmpR This study 
pKS1068 nmt81: HFG-Mto2 S366A  AmpR This study 
pKS1069 nmt81: HFG-Mto2 T395A  AmpR This study 
pKS1079 nmt81: HFG-Mto2 5A  AmpR This study 
Table 2.4 List of plasmids used in this study. Database name, genotype, source and 
are listed. 
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pKS1071 pDONR221 Mto2 1A  KanR This study 
pKS1072 pDONR221 Mto2 2A  KanR This study 
pKS1073 pDONR221 Mto2 3A  KanR This study 
pKS1074 pDONR221 Mto2 1D  KanR This study 
pKS1075 pDONR221 Mto2 2D  KanR This study 
pKS1076 pDONR221 Mto2 3D  KanR This study 
pKS1077 nmt81: HFG-Mto2 1A  AmpR This study 
pKS1078 nmt81: HFG-Mto2 2A  AmpR This study 
pKS1079 nmt81: HFG-Mto2 3A  AmpR This study 
pKS1080 nmt81: HFG-Mto2 1D  AmpR This study 
pKS1081 nmt81: HFG-Mto2 2D  AmpR This study 
pKS1082 nmt81: HFG-Mto2 3D  AmpR This study 
pKS1083 His6-MBP-Mto2 1D AmpR This study 
pKS1084 pDONR221 Mto2 Y168F KanR This study 
pKS1085 pDONR221 Mto2 Y269F KanR This study 
pKS1086 nmt81: HFG-Mto2 Y168F AmpR This study 
pKS1087 nmt81: HFG-Mto2 Y269F AmpR This study 
pKS1088 pDONR221 Mto2 V1 STOP KanR This study 
pKS1089 pDONR221 Mto2 V2 STOP KanR This study 
pKS1090 pDONR221 Mto2 V3 STOP KanR This study 
pKS1091 pDONR221 Mto2 V4-STOP  KanR This study 
pKS1092 pDONR221 Mto2 V5-STOP  KanR This study 
pKS1093 pDONR221 Mto2 V6-STOP  KanR This study 
pKS1094 pDONR221 Mto2 V7-STOP  KanR This study 
pKS1095 nmt41:Mto2-V1-STOP  AmpR This study 
pKS1096 nmt41:Mto2-V2-STOP  AmpR This study 
pKS1097 nmt41:Mto2-V3-STOP  AmpR This study 
pKS1098 nmt41:Mto2-V4-STOP  AmpR This study 
pKS1099 nmt41:Mto2-V5-STOP  AmpR This study 
pKS1100 nmt41:Mto2-V6-STOP  AmpR This study 





Number Genotype Source 
515 ade6-M216 ura4-D18 leu1-32 h+ Laboratory Stock 
516 ade6-M210 ura4-D18 leu1-32 h- Laboratory Stock 
976 h- mto2∆::kanMX6 ade6-M216 leu1-32 ura4-D18  Laboratory Stock 
977 h+ mto2∆::kanMX6 ade6-M216 leu1-32 ura4-D18 Laboratory Stock 
1017 h+ mto1∆::kanM X6 ade6-M216 leu1-32 ura4-D18 Laboratory Stock 
1235 h+ kanMX::nmt81::GFP-atb2 ade6-M210 leu1-32 ura4-D18 Laboratory Stock 
1238 h- nda3-km311 ade6-M210 leu1-32 ura4-D18 Laboratory Stock 
1239 h- mto1∆::kanMX nda3-km311 ade6-M210 leu1-32 ura4-D18 
Laboratory Stock 
1280 h- cdc25-22 ade6-M216 leu1-32 ura4-D18 Laboratory Stock 
1409 h- mto2∆::kanMX6 kanMX:nmt81:GFP-atb2 ade6-M210 
leu1-32 ura4-D18 
Laboratory Stock 
1457 h- mto2:GFP:KanMX mto1∆::kanM X6 ade6-M216  ura4-D18 
Laboratory Stock 
1460 h- mto2:GFP:KanMX6 Laboratory Stock 
Table 2.5 List of fission yeast strains used in this study. Database name, genotype, 
and source are listed. 
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1504 h– mto2:myc:kanMX ade6-M210 leu1-32 ura4-D18  m Laboratory Stock 
1507 h+ mto1-13myc:kanMX ade6-M216 leu1-32 ura4-D18 Laboratory Stock 
1567 h- alp16∆::kanMX ade6-M210 leu1-32 ura4-D18 Laboratory Stock 
1956 h+ mto1 [1-800]:ura4+ ade6-210 leu1-32 Laboratory Stock 
1999 h- mto1 [1-800]-GFP:kanMX6 ade6-M210 leu1-32 ura4-D18 Laboratory Stock 
2007 h+ mto1[9A1] ade6-M216 leu1-32 ura4-D18 Laboratory Stock 
2739 h- tea1-TAPS:kanMX6 ade6-M210 leu1-32 ura4-D18 Laboratory Stock 
3475 
h+ mto1 [1-1051]-TAPS:kanMX6 ade6-M216 leu1-32 ura4-
D18 
Laboratory Stock 
3476 h+ mto1 [1-800]-TAPS:kanMX6 ade6-M216 leu1-32 ura4-D18 
Laboratory Stock 
3524 h+ mto1-TAPS:kanMX6 ade6-M216 leu1-32 ura4-D18 Laboratory Stock 
3575 








h- nmt81:His6FLAG:GFP-mto2 mto2∆::kanMX6 ade6-M216 
leu1-32 ura4-D18  
This study 
3920 
h- nmt81:His6FLAG:GFP-mto2 mto2-myc:kanMX6 ade6-
M210 leu1-32 ura4-D18  
This study 
3923 
h- nmt81:His6FLAG:GFP-mto2-T35A mto2∆::kanMX6 
ade6-M216 leu1-32 ura4-D18  
This study 
3925 
h- nmt81:His6FLAG:GFP-mto2-S179A mto2∆::kanMX6 
ade6-M216 leu1-32 ura4-D18  
This study 
3927 
h- nmt81:His6FLAG:GFP-mto2-S220A mto2∆::kanMX6 
ade6-M216 leu1-32 ura4-D18  
This study 
3929 
h- nmt81:His6FLAG:GFP-mto2-S366A mto2∆::kanMX6 
ade6-M216 leu1-32 ura4-D18  
This study 
3931 
h- nmt81:His6FLAG:GFP-mto2-T394A mto2∆::kanMX6 
ade6-M216 leu1-32 ura4-D18  
This study 
3933 
h- nmt81:His6FLAG:GFP-mto2-5A mto2∆::kanMX6 ade6-
M216 leu1-32 ura4-D18  
This study 
3943 h+ cdc25-22 mto2∆::kanMX6 ade6-M216 leu1-32 ura4-D18 Laboratory Stock 
3953 h- mto2-HTB:kanMX6 ade6-M210 leu1-32 ura4-D18 This study 
3956 




h- nmt81:His6FLAG:GFP-mto2-Y168F mto2∆::KanMX6 
ade6-M216 leu1-32 ura4-D18 
This study 
4186 
h- nmt81:His6FLAG:GFP-mto2-Y269F mto2∆::KanMX6 
ade6-M216 leu1-32 ura4-D18 
This study 








h- nmt41:mto1-GFP-FLAG-His; mto1-13myc:KanMX6; 
mto2∆:KanMX6 ade6-M216 leu1-32 ura4-D18 
This study 
4450 
h- nmt81:His6FLAG:GFP-mto2 mto2∆::kanMX6 




mto2∆::KanMX6 ade6-M216 leu1-32 ura4-D18  
This study 
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4463 
h- nmt81:His6FLAG:GFP-mto2L133DL137D 
mto2∆::KanMX6 nmt81:atb2-GFP ade6-M216 leu1-32 ura4-
D18  
This study 
4466 h- nmt81:His6FLAG:GFP-mto2-1A mto2∆::KanMX6 nmt81:atb2-GFP ade6-M216 leu1-32 ura4-D18 
This study 
4469 
h- nmt81:His6FLAG:GFP-mto2-2A mto2∆::KanMX6 
nmt81:atb2-GFP ade6-M216 leu1-32 ura4-D18  
This study 
4472 h- nmt81:His6FLAG:GFP-mto2-3A mto2∆::KanMX6 nmt81:atb2-GFP ade6-M216 leu1-32 ura4-D18  
This study 
4475 
h- nmt81:His6FLAG:GFP-mto2-1D mto2∆::KanMX6 
nmt81:atb2-GFP ade6-M216 leu1-32 ura4-D18  
This study 
4478 
h- nmt81:His6FLAG:GFP-mto2-2D mto2∆::KanMX6 
nmt81:atb2-GFP ade6-M216 leu1-32 ura4-D18  
This study 
4481 
h- nmt81:His6FLAG:GFP-mto2-3D mto2∆::KanMX6 
nmt81:atb2-GFP ade6-M216 leu1-32 ura4-D18  
This study 
4596 




h- nmt81:His6FLAG:GFP-mto2-1D+2 mto2∆::KanMX6 
nmt81:atb2-GFP ade6-M216 leu1-32 ura4-D18  
This study 
4603 
h- nmt81:His6FLAG:GFP-mto2-1-320 [T1] mto2∆::KanMX6 
ade6-M216 leu1-32 ura4-D18   
This study 
4606 
h- nmt81:His6FLAG:GFP-mto2-89-397 [T4] 
mto2∆:;KanMX6 ade6-M216 leu1-32 ura4-D18   
This study 
4609 
h- nmt81:His6FLAG:GFP-mto2-180-397 [T5] 
mto2∆::KanMX6 ade6-M216 leu1-32 ura4-D18   
This study 
4612 
h- nmt81:His6FLAG:GFP-mto2-1-320 [T1] mto2∆::kanMX6 
nmt81:GFP-atb2 ade6-M216 leu1-32 ura4-D18  
This study 
4615 
h- nmt81:His6FLAG:GFP-mto2-89-394 [T4] mto2∆::kanMX6 
nmt81:GFP-atb2 ade6-M216 leu1-32 ura4-D18  
This study 
4618 
h- nmt81:His6FLAG:GFP-mto2-180-394 [T5] 





mto2∆::KanMX6 ade6-M216 leu1-32 ura4-D18   
This study 
4627 
h- nmt41:mto1-GFP-FLAG-His; mto1-13myc:KanMX6 ade6-
M216 leu1-32 ura4-D18 
This study 
4973 
h- mto1-TAPS:kanMX6 nmt81:His6FLAG:GFP-mto2 




L133DL137D mto2∆::KanMX6 ade6-M216 leu1-32 ura4-
D18 
This study 
5050 h+ arg1-230 car2∆::KanMX4 lys3-37 nda3-km311 Laboratory Stock 
5349 








h+ mto1-TagRFP-T:natMX6 hphMX6:nmt81-GFPabt2 ura4-
D18 leu1-32 ade6-M210 
Laboratory Stock 
5477 
h- car2∆::KanMX4 mto2-TAPS:KanMX6 lys3-37 arg1-230 
nda3-KM311 
This study 
5479 h- car2∆::KanMX4 mto2-TAPS:kanMX6 arg1-230 lys3-37 This study 
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5572 
h- nmt81:His6FLAG:GFP-mto2 L133DL137D 








h- nmt81:His6FLAG:GFP-mto2 mto2-13myc:kanMX 
mto1∆::kanMX6 ade6-M216 leu1-32 ura4-D18 
This study 
5575 
h- nmt81:His6FLAG:GFP-mto2 L133DL1337 mto2-




h- mto1-TagRFP-T:natMX6 hphMX6:nmt81-GFP-abt2 
mto2∆::kanMX6 ura4-D18 leu1-32 ade6-M210 
This study 
5578 
h- mto1[1-1051]-TAPS:kanMX6 mto2∆::kanMX6 ade6-
M216 leu1-32 ura4-D18 
Laboratory Stock 
5579 
h- mto1-TAPS:kanMX6 nda3-km311 mto2∆::kanMX6 ade6-
M216 leu1-32 ura4-D18 
Laboratory Stock 
5580 
h- mto1[1-1051]-TAPS:kanMX6 nda3-km311 
mto2∆::kanMX6 ade6-M216 leu1-32 ura4-D18 
Laboratory Stock 
5609 h+ mto1[1-549]-GFP:kanMX6 ade6-M210 leu1-32 ura4-D18 Laboratory Stock 
5647 




h-  nmt81:His6FLAG:GFP-mto2 mto2∆::kanMX6 
kanMX::nmt81::GFP-atb2 ade6-M210 leu1-32 ura4-D18 
This study 
5784 




h-  nmt81:mto2-L133DL137D mto2∆::KanMX6 
mto1∆::KanMX6 nda3-km311 ade6-M216 ura4-D18  
This study 
5787 
h-  nmt81:mto2-L133DL137D mto2∆::KanMX6  
mto1∆::KanMX6 ade6-M216 ura4-D18 
This study 
5795 h- mto1-TAPS:kanMX6 cdc25-22 ade6-M216 ura4-D18 This study 
5801 
h- natMX6:nmt81:mto1[1-549]-GFP:kanMX6 




mto2∆::KanMX6 ade6-M210 leu1-32 ura4-D18 
This study 
5803 
h- mto1[1-549]-GFP:kanMX6 kanMX6:nmt41:mto2 ade6-
M210 leu1-32 ura4-D18 
This study 
5920 
h- mto2∆::KanMX6 cut-12tdT:KanMX6 natMX6:nmt81:mto1 
[1-549]-GFP:KanMX6 ade6-M210 leu1-32 ura4-D18 
Lynch et al., 
data unpublished 
5972 
h-  nmt81:mto2-varient 1 mto2∆::KanMX6 mto1∆::KanMX6 
nda3-km311 ade6-M216 ura4-D18 
This study 
5973 
h-  nmt81:mto2-varient 2 mto2∆::KanMX6 mto1∆::KanMX6 
nda3-km311 ade6-M216 ura4-D18 
This study 
5974 
h-  nmt81:mto2-varient 3 mto2∆::KanMX6 mto1∆::KanMX6 
nda3-km311 ade6-M216 ura4-D18 
This study 
5975 
h-  nmt81:mto2-varient 4 mto2∆::KanMX6 mto1∆::KanMX6 
















































Table 2.6 Oligonucleotides used in this study. Allocated number, sequence and 
section reference for all of the oligonucleotides used in this study. 
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CHAPTER THREE 




 In higher eukaryotes several copies of the γ-TuSC in addition to a number of 
non-core components [e.g. GCP4/5/6 and GCP-WD] are ass mbled into a large 
complex called the γ-TuRC (Oegema et al. 1999; Gunawardane et al. 2000b). 
Electron microscopy studies have shown that the γ-TuRC forms a 3-start helix or 
ring structure that can associate with the minus ends of MTs (Moritz et al. 1995a; 
Oegema et al. 1999; Moritz et al. 2000). Two models have been proposed that 
describe the mechanism by which the γ-TuRC is able to facilitate the nucleation of 
MTs, and both of these models involve some level of γ-TuSC multimerisation 
(Zheng et al. 1995; Erickson et al. 1996a). In budding yeast, the γ-TuSC/Tub4 
complex is the only source of MT nucleation as the proteins required for γ-TuRC 
assembly are not conserved (Geissler et al. 1996; Spang et al. 1996). The nature of 
the nucleation complex formed by the γ-TuSC components in S. pombe has yet to be 
determined. Conservation of many of the γ-TuRC components suggests that, like 
higher eukaryotes, a ring structure is formed. However, deletion of non-core γ-TuRC 
components has only minor effects on MT nucleation fr m non-SPB iMTOCs, and 
nucleation from other MTOCs remains unaffected (Fujita et al. 2002; Venkatram et 
al. 2004; Anders et al. 2006). This indicates that either formation of the γ-TuRC is 
not required for MT nucleation in S. pombe, or that the cell is able to compensate for 
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the loss of non-core component- mediated assembly of γ-TuRC by promoting γ-
TuSC multimerisation via other mechanisms. 
 I predict that multimerisation of the complex formed by Mto1 and Mto2 [the 
Mto1/2 complex], due to the presence of the γ-TuSC interaction domain in the N-
terminus of Mto1, could potentially interact with many γ-TuSCs and promote γ-
TuSC multimerisation. Unlike the non-core components, the deletion phenotype of 
both Mto1 and Mto2 suggest that the Mto1/2 complex is absolutely required for MT 
nucleation at non-SPB iMTOCs. This could indicate that the Mto1/2 complex may 
form the primary template structure, and the efficien y of the subsequent assembly 
and/or stabilisation of γ-TuSCs is increased by the presence of the non-core 
components.  
 Alternative to acting as a direct template, the Mto1/2 complex may instead 
function as a targeting factor and, by increasing the local concentration of the γ-
TuSC at the MTOC, may promote self-assembly of the γ-TuRC [in the presence or 
absence of non-core components].  
 A structural analysis of the Tub4 complex has demonstrated that the lateral 
distance between γ-tubulin molecules is too large to facilitate the lateral association 
of αβ-dimers (Kollman et al. 2008). This has suggested that an additional change in 
conformation in the γ-TuSC may be required for MT nucleation. I hypothesis  that 
the interaction with the Mto1/2 complex, as well as promoting γ-TuSC assembly, 
may also induce the structural rearrangement of the γ-TuSC required to form an 
active MT nucleation complex.   
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3.1.1 Aims and Objectives 
 
 In this chapter I aim to investigate the nature of the Mto1/2 complex, 
concentrating on the copy number of each protein requi d to form an active 
nucleation complex, with the hope of providing insight into the structure of the 
complex and how it might relate to the assembly of the γ-TuSC. For example, if the 
Mto1/2 complex is comprised of several copies of Mto1, this might support a 
template model for γ-TuRC assembly via the Mto1/2 complex.  
 
I will use the following approaches to address thisproblem: 
 
• Hydrodynamic analysis of the Mto1/2 complex to investigate the size of the 
complex, and whether it is altered by the presence of the γ-TuSC. 
• Hydrodynamic analysis of an Mto1/2 complex whose loca isation is restricted 










   82  
3.2 RESULTS 
 
3.2.1. Mto1 and Mto2 co-fractionate within a 60 – 80 S complex  
 
 In order to investigate the size and stoichiometry of Mto1 and Mto2 proteins 
within the Mto1/2 complex, a fission yeast extract was subject to sucrose density 
gradient centrifugation. Figure 3.1, Panel A shows that the majority of signal from 
Mto1 and Mto2 did not co-fractionate, indicating that the proteins are present in 
independent complexes. The peak fractions were compared with a calibration curve 
based on markers of known S-value [Appendix II]. Mto2 sedimented at ~5.6 S, while 
Mto1 sedimented at between 10 – 14 S. In both cases the distribution of protein was 
spread across multiple fractions, indicating that te calculated S-values are likely to 
represent the average size of a mix of heterogeneous protein complexes. Despite a 
pre-clearing spin to remove large particles [ > 100S], there was a large proportion of 
both Mto1 and Mto2 in the pellet fraction. The nature of the pellet material was 
investigated by subjecting the sucrose gradients to a short spin that allowed 
resolution of complexes larger than 20 S. Commercially available molecular weight 
markers are limited to 19 S, therefore the 90 S pre-ribosomal component Nop1 
(Schimmang et al. 1989) was used to resolve the gradient within this range. Figure 
3.1, Panel B shows that in wild-type extract, the majority of both Mto1 and Mto2 
were found in fractions corresponding to 60 – 80 S. The sedimentation pattern of 
Mto1 was not altered in mto2∆, indicating that Mto2 is not required for Mto1 to be
present in this large complex. However, Mto1 was required for the inclusion of Mto2 
in the 60 – 80 S complex, as in mto1∆ extracts Mto2 peaked in a fraction 
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representing protein complexes smaller than 19 S. The presence of an Mto2-
independent Mto1 60 - 80 S complex was unexpected as previous observations have 
suggested that Mto2 may act to promote assembly of the Mto1/2 complex (Samejima 
et al. 2005; Samejima et al. 2008). For the purpose of this study the 60 – 80 S 
complex formed by Mto1 will be called the Mto1/2 60 – 80 S complex. 
 Mto1 and Mto2 were distributed over several fractions of the gradient, 
suggesting that the 60 – 80 S complex is unlikely to contain proteins in a defined 
stoichiometry. The unusually large size of the Mto1/2 60 – 80 S complex indicates 
that it is likely to contain multiple copies of Mto1 in addition to several other protein 
complexes. Alternatively, it is possible that the 60 – 80 S may arise from the 
association of Mto1 with large fragments of cellular debris such as the SPB. 
 
3.2.2 Mto2 and Mto1 interact within the 60 – 80 S complex 
 
 Mto1 is required for Mto2 to be present within the60 - 80 S complex. To 
confirm that Mto1 and Mto2 interact within this range an Mto1-TAPS pulldown was 
performed on an extract pre-fractionated by sucrose gradient centrifugation. Figure 
3.2 shows that the inputs of Mto1-TAPS and Mto2 were present in fractions 6 - 12, 
corresponding to 60 – 80 S, as previously observed in Figure 3.1. The distribution of 
Mto1 in the eluates reflected the distribution of material in the input, however, only 
Mto2 present within the 60 – 80 S range was found to co-precipitate with Mto1. This 
result confirms that the inclusion of Mto2 within the 60 – 80 S is likely to occur as a 
result of an interaction with Mto1.  
 


























Figure 3.1 Sucrose gradient centrifugation analyses of endogen us Mto1 and Mto2. 
An extract was subject to centrifugation at 55,000 rpm for [A] 3.5 hr or [B] 30 min 
in a Beckman TLS-55 rotor [Strains KS516, KS976 andKS1017]. The fractions 
including the pellet [P] were analysed by 10% SDS-PAGE and the western blot was 
probed with anti-Mto1 and anti-Mto2 antibodies. The signal intensities were 
detected using the Odyssey V3.0 software. The peak loc tions for molecular weight 
standards run on parallel gradients are indicated [black arrows]. The western blot 
was also probed with anti-Nop1 antibody. Nop1 peak intensity is also indicated 
[90S]. Images represent typical results obtained from two experiments. 
B 
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Figure 3.2 Analysis of the Mto1-Mto2 interaction within the 60 – 80 S complex. 
The extract [KS3524] was fractionated by sucrose gradient centrifugation at 55,000 
rpm for 30 min in a Beckman TLS-55 rotor. Every third fraction was pooled and 
incubated with IgG-linked Dynabeads. Non-fractionated extract from untagged 
Mto1 was used as a negative control [KS516]. The input sample was taken from 
non-fractionated extract prior to centrifugation. The samples were analysed by 10% 
SDS-PAGE and the western blot was probed with anti-Mto1 and anti-Mto2 
antibodies. The signal from GT-34-HRP was detected by ECL. The peak locations 
for Thyroglobulin [19S] and Nop1 [90S] are indicated [black arrows]. Images 
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3.2.3 The Mto1/2 60 – 80 S complex is formed independently of the γ-TuC 
 
 The Mto1/2 60 – 80 S complex potentially could include several copies of the 
γ-TuSC, and therefore represent a γ-TuRC-like complex. This would support my 
proposed template model for Mto1/2 induced γ-TuRC assembly. To test this idea, the 
fractionation patterns of members of the γ-TuSC were compared in wild-type, mto1∆ 
and alp16∆ backgrounds. Alp16 is required for the interaction of the other non-core 
components with the γ-TuC (Anders et al. 2006). Therefore, as the non-core 
components of the γ-TuRC are not able to associate in the absence of Alp16, the size 
of the resulting Mto1/2 60 – 80 S complex may be reduc d. This does not exclude 
the possibility that several copies of the γ-TuSC may be able to associate with Mto1 
independently of non-core γ-TuRC components.   
 Figure 3.3 shows that in the wild-type extract both γ- ubulin and Alp6 
proteins were distributed along a number of fractions within the same 60 – 80 S 
range as Mto1, indicating that the γ-TuSC proteins are present in a complex of 
similar size. The distribution of γ-tubulin and Alp6 was not significantly altered in 
mto1∆, implying that Mto1 is not required for the inclusion of the γ-TuSC proteins in 
the 60 – 80 S complex. This observation is supported by the analysis of Mto1-9A1, a 
variant of Mto1 that contains mutations in the CM1 domain that prevent Mto1 from 
interacting with the γ-TuSC (Samejima et al. 2008). Mto1-9A1 was also found 
within the 60 – 80 S range, which suggests that the γ-TuSC components are not 
required for the inclusion of Mto1 in the Mto1/2 60– 80 S complex. The 
sedimentation pattern of Mto1 in alp16∆ was similar to wild-type, indicating that the 
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non-core components also do not contribute significantly to the presence of Mto1 
within the Mto1/2 60 – 80 S complex.  
 Interestingly in alp16∆, Alp6 and γ-tubulin peaked in a fraction representing 
a smaller molecular weight complex than observed in wild-type extracts. This 
suggests that assembly of the 60 – 80 S complex containi g the γ-TuSC is partly due 
to the inclusion of non-core components. Previous estimates have indicated that the 
γ-TuRC from D. melanogaster has an S-value of approximately 35 S (Oegema t al. 
1999). Therefore the unusually large size of the S. pombe 60 – 80 S γ-TuC is unlikely 
to reflect the equivalent γ-TuRC of higher eukaryotes. It is possible that the 60 – 80 S 
γ-TuC complex includes other protein complexes and cellular debris.  Alternatively, 
the substantial distribution of material along the gradient suggests that the 60 – 80 S 
complex may represent several unstable copies of the γ-TuC that may have 
associated during the cell lysis procedure.   
 Unfortunately the poor resolution of the gradients i  Figure 3.3 has prevented 
any conclusive statements from being made regarding the behaviour of the γ-TuSC 
and the Mto1/2 complex within the 60 – 80 S range. Additionally, without knowing 
the copy number of proteins present within the complex it is not possible to 
distinguish between Mto1 60 – 80 S complex formation as a result of protein 
aggregation or association with large fragments of cellular debris. This is important 
as removal of proteins present in low copy number would not significantly alter the 
size of the 60 – 80 S complex and correlate with the results described above. In order 
to determine the true nature of both the Mto1/2 and γ-TuSC complexes this analysis 
needs to be performed with reconstituted complex constructed from purified protein.  
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 3.2.4. The Mto1/2 60 – 80 S complex formation is promoted by Mto1 
localisation to the SPB 
 
 In addition to potential protein aggregation, it is postulated that the Mto1/2 60 
– 80 S complex may result from association with soluble fragments of the SPB 
and/or other soluble cellular debris. This association may be physiologically relevant 
to Mto1/2 function, e.g. it may provide a way to cons lidate excess Mto1 protein, in 
order to restrict the number of cytoplasmic MTs. Alternatively localisation to the 
SPB may promote Mto1 aggregation due to an increase in local concentration. To 
test SPB-dependent Mto1/2 60 – 80 S formation, a truncated version of Mto1 [1-
1051] was analysed that lacks the C-terminal domain required for Mto1 localisation 
to the eMTOC and SPB (Samejima et al., manuscript in preparation). If the Mto1/2 
60 – 80 S complex is formed as a consequence of assci tion with the SPB, then it 
should not be present in Mto1 [1-1051].  
 Figure 3.4 shows that compared with full length protein, the amount of Mto1 
[1-1051]-TAPS found within fractions 1-3 [< 20 S] was increased. This result 
suggests that formation of the Mto1/2 60 – 80 S complex is partially due to 
localisation of the Mto1 to the SPB. This indicates that either Mto1 aggregation is 
promoted by SPB association, or the Mto1/2 60 – 80 S complex may represent Mto1 
association with fragments of the SPB. To test this one could examine the 
sedimentation pattern of other SPB-associated proteins such as Sad1 (Hagan et al. 
1995). The presence of residual 60 – 80 S complex indicates that Mto1 can also form 
large associations in the absence of SPB localisation.  
 

























Figure 3.3 60 – 80 S complex formation in γ-TuC mutants. The extracts were 
subject to sucrose gradient centrifugation at 55,000 rpm for 30 min in a Beckman 
TLS-55 rotor. [Strains KS516, KS1017, KS2007 and KS1567]. The fractions 
including the pellet [P] were analysed by 10% SDS-PAGE and the western blot 
was probed with anti-Mto1, anti-Alp6, and anti-γ-tubulin [GTU-88] antibodies. 
The signals from GT-34-HRP and anti-mouse IgG-HRP antibodies were detected 
using ECL. The peak locations for Thyroglobulin [19S] and Nop1 [90S] are 
indicated [black arrows]. Image represents result obtained from a single 
experiment. 
Figure 3.4 60-80 S formation in Mto1 [1-1051]-TAPS. The extracs were subject 
to sucrose gradient centrifugation at 55,000 rpm for 30 min in a Beckman TLS-55 
rotor. [Strains KSKS3475 and KS5578]. The fractions including the pellet [P] 
were analysed by 10% SDS-PAGE and the western blot was probed with anti-
Mto1 antibody. Integrated intensity of the signals from IRDye800 were measured 
using Odyssey V3.0. The peak locations for Thyroglobu in [19S] and Nop1 [90S] 
are indicated [black arrows].  Image represents result obtained from a single 
experiment. 
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3.2.5 Foci formed by Mto1-tdRFP at non-SPB iMTOC are weakened in the 
absence of Mto2 
 
 To investigate the function of the Mto1/2 60 - 80 S complex in vivo, the 
properties of fluorescently tagged Mto1 were examined in mto2+ and mto2∆ 
backgrounds. As biochemical analysis has shown that the Mto1 60 - 80 S complex is 
assembled in both mto2+ and mto2∆, only Mto1 structures present in both 
backgrounds [apart from SPB/eMTOC associated protein] can be considered as 
Mto1/2 60 – 80 S candidates. 
 Figure 3.5, Panel A, demonstrates that wild-type strains contained the 
canonical 3 – 4 bundles of MTs per cell and Mto1-tdRFP satellite foci decorated the 
whole length of each MT bundle in addition to bright signals at the SPB and eMTOC 
[fig 3.5, Panel B]. As previously documented, mto2∆ cells contained 1 – 2 
hyperstable MT bundles, which curved around the cell tip (Samejima et al. 2005). 
Only a small proportion of MT bundles were decorated with Mto1-tdRFP satellite 
foci, and the signal from these foci was significantly less intense than wild-type. The 
presence of bright Mto1-tdRFP signals from the SPB and eMTOCs in mto2∆ 
supports the conclusion that a proportion of the Mto1/2 60 – 80 S complex may 
result from Mto1 association with the SPB and eMTOC [fig 3.5, Panel B]. The only 
non-SPB/eMTOC associated Mto1-tdRFP foci present in both backgrounds were 
faint satellites found along pre-existing MTs. It is possible that these structures may 
represent the 60 – 80 S complexes. The intensity of these foci suggest that they 
represent a relatively small number of Mto1 moleculs that are stably associated with 
other large cellular debris or protein complexes that are yet to be identified. 







































































Figure 3.5 Microscopic analysis of Mto1-tdRFP demonstrates that Mto2 is 
required for the assembly of bright foci at non-SPB iMTOCs. Images were taken 
on a spinning disk confocal microscope. Maximum projections of [A] whole field 
or [B] single cells expressing nmt81:mto1-tdRFP and nmt81:atb2-GFP in either 
mto2+ or mto2∆ background [Strains KS3470 and KS5576]. Single cell 
projections are representative of three different cll cycle stages as indicated. 
Scale bars = 10µm. 
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 Due to the size of the complex, I believe that the 60 – 80 S complex most 
likely represents an aggregated form of Mto1 formed during the cell lysis procedure. 
Mto1 may be prone to aggregation due to the presenc of extensive regions of coiled-
coil along the length of the protein. Aggregation may be promoted when Mto1 is 
present at high concentrations, [for example, at the SPB and eMTOC], which is 
consistent with the observation that Mto1 60 – 80 S formation is reduced in Mto1 [1-
1051]. To test this prediction, one needs to examine 60 - 80 S formation in a version 
of Mto1 that lacks its coiled-coil domains.  
 In addition, this in vivo analysis has demonstrated that Mto2 functions as an 
Mto1/2 complex assembly factor, as in the presence of Mto2 the Mto1-tdRFP 
satellite foci observed at non-SPB iMTOCs were significantly brighter. The function 
of Mto2 within the Mto1/2 complex will be discussed further in chapter four.  
 
3.2.6 Mto1 [1-800] interacts with Mto2 to form a complex smaller than 60 – 
80 S  
 
 Evidence collected so far suggests that the Mto1/2 60 – 80 S complex may 
not be assembled in vivo and instead may result from aggregation of proteins during 
cell lysis. To test this, an extract containing a truncation mutant of Mto1, Mto1 [1-
800], that lacked a large portion of the C-terminal coi ed-coil domains predicted to 
promote Mto1 aggregation [fig 3.6, Panel A], was analysed by sucrose gradient 
centrifugation. Figure 3.6, Panel B shows that in comparison to full length GFP-
Mto1, the majority of GFP-Mto1 [1-800] was found within fractions 1-6, which 
correspond to protein complexes < 20 S. This indicates that removal of sections of 
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coiled-coil from Mto1 prevent it from forming the large 60 - 80 S complex. To 
confirm that Mto1 [1-800] and Mto2 form a complex tha  is smaller than 60 - 80 S, 
an interaction assay was performed with an extract f om Mto1 [1-800]-TAPS that 
had been pre-fractionated by sucrose density centrifugation. Figure 3.6, Panel C 
shows that only Mto2 present in fractions 1-6 were found in the co-precipitate, and 
confirms that the complex formed by Mto1 [1-800] and Mto2 is smaller than 60 - 80 
S. 
 These results support the prediction that the coiled-coil domains in the Mto1 
C-terminus lead to the formation of the Mto1 60 – 80 S complex. Analysis of Mto1 
[1-800] phenotype has demonstrated that Mto1 [1-800] is sufficient to induce MT 
nucleation (K. Sawin, personal communication).  This indicates that Mto1 and Mto2 
do not need to be present within a 60 – 80 S complex to form an active complex, and 
further demonstrates that the 60 - 80 S complex may not be a physiological 
phenomenon. 
   
3.2.7 Hydrodynamic analysis of the Mto1 [1-800] / Mto2 complex indicates 
that it is a heterotetramer 
 
 Analysis of the MTs behaviour in an Mto1 [1-800] background indicate that 
the truncated protein is able to promote MT nucleation. Biochemical analysis has 
shown that when in complex with Mto2, Mto1 [1-800] forms a complex that is 
smaller than 20 S. This smaller complex lies within t e resolution range of the 
sucrose gradient centrifugation and gel filtration analyses, therefore one can 
accurately measure its molecular weight. This information can then be used to  






























































































































Figure 3.6 Removal of Mto1 coiled coil prevents Mto1/2 60 – 80 S formation. [A] 
Schematic map of Mto1 depicting PAIRCOIL2 predicted coiled-coil domains 
[pink] and regions of overlap [purple] with protein interaction domains [blue]. 
Amino acid residue numbers are indicated including the 1-800 truncation [black 
arrow]. [B] The extract was analysed by sucrose gradient centrifugation at 55,000 
rpm for 30 min in a Beckman TLS-55 rotor. [Strains KS4230 and KS1999]. 
Fractions including the pellet [P] were analysed by 10% SDS-PAGE and the 
western blot was probed with anti-Mto1 antibody. The signal from GT-34-HRP 
secondary antibody was detected by ECL. Image repres nts result obtained from a 
single experiment. [C] The extract from KS3476 was fr ctionated by sucrose 
gradient centrifugation at 55,000 rpm for 30 min in a Beckman TLS-55. Every 
third fraction was pooled and incubated with IgG-linked Dynabeads. Non-
fractionated extract from untagged Mto1 [KS516] was used as a negative control. 
The input sample was taken from a non-fractionated extract prior to 
centrifugation. The samples were analysed by 10% SDS-PAGE and the western 
blot was probed with anti-Mto1 and anti-Mto2 antibodies. Signal from GT-34-
HRP was detected by ECL. Peak locations for Thyroglobulin [19S] and Nop1 
[90S] are indicated [black arrows]. Image represent typical result obtained from 
two experiments. 
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calculate the number of molecules present within the complex. Figure 3.7, Panels A 
and C show the sucrose gradient centrifugation analyses where in mto2+ background 
Mto1 [1- 800] peaked in fraction 8.2 whereas Mto2 peaked in fraction 7. When 
compared with a calibration curve in Appendix II, this corresponded to a 
sedimentation co-efficient for Mto1 [1-800] of 8 S. In mto2∆, Mto1 [1-800] peaked 
in fraction 6.2 which corresponded to an S-value of 5.9 S. The incomplete co-
fractionation of Mto2 is likely to represent a mixture of complexed Mto2 [8 S] and 
un-complexed Mto2 [5.6 S] [fig 3.1, Panel A]. Extracts from Mto1 [1-800] were also 
analysed by gel filtration. Figure 3.7, Panels B and D show that in both the presence 
and absence of Mto2, Mto1 [1-800] peaked in fraction 5.6, which, when compared to 
a calibration curve generated from molecules weight markers of known Stokes’ 
radius [Appendix III], corresponded to a Stokes’ Radius of 10.1 nm.  
 A theory developed by Seigel and Monty allows one to calculate the 
molecular weight of proteins based on their Sedimentation coefficient and Stokes’ 
Radius using the equation below (Siegel et al. 1966): 
 
   M = 6πηN•a•s / [1-ν2ρ] 
 
 Where M is molecular mass, η is viscosity [0.01g cm-1s-1 for weak aqueous 
solutions], N is Avogadro’s constant [6.02x1023], a is the Stokes radius [cm], s is the 
sedimentation co-efficient [sec], ρ is the density of the solvent [1.0 g/cm3 for dH20], 
and ν is the partial specific volume [ν2ρ = 0.73 cm
3g-1].  
 
Given the constants of known value the equation can be summarised as: 
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M = 3909 • a • s  
 
Mto1 [1-800] / Mto2: 
M = 3909 • a • s 
M = 3909 • 10.1 nm • 8.0 S 
M = 315.9 kDa 
 
Mto1 [1-800]: 
M = 3909 • a • s 
M = 3909 • 10.1 nm • 5.9 S 
M = 232.9 kDa 
 
 The presence of Mto2, which has a theoretical molecule weight of 44kDa, 
increases the molecular weight of the Mto1 [1-800] complex by 83 kDa, indicating 
that there are approximately 1.88 molecules of Mto2 present. 
Therefore, given that the theoretical molecular weight of Mto1 [1-800] is 92.27 kDa, 
this indicates that there are approximately 2.52 molecules of Mto1 [1-800] per 
complex. 
 These calculations assume that Mto1 and Mto2 are the only proteins that 
contribute to the molecular weight of the complex. Based on this result it is likely 
that the complex formed by Mto1 [1-800] and Mto2 contain two molecules of Mto2 
and two molecules of Mto1. This result suggests that Mto1 [1-800] is able to form 
dimers in the absence of Mto2, therefore there are regions of the protein outside of 
the coiled-coil domain [800-1115 aa] that contribute to the Mto1-Mto1 interaction.  
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Figure 3.7 Hydrodynamic analysis of the Mto1 [1-800] / Mto2 complex indicates 
that it is a heterotetramer. [A] Extracts were subject to sucrose gradient 
centrifugation at 55,000 rpm for 30 min in a Beckman TLS-55 rotor. [B] Extracts 
were analysed by gel filtration on a Superose-6 column [KS1] [Strains KS1956 
and KS5354]. Fractions including the pellet [P] were analysed by 10% SDS-
PAGE and the western blot was probed with anti-Mto1 and anti-Mto2 antibodies. 
[C and D] The integrated intensity of signal from IRDye800 was measured using 
Odyssey V3.0. The peak locations for molecular weight standards run on parallel 
gradients are indicated [black arrows]. Standards in [B] are indicated in nm. 
Mto2D = mto2∆. Images represent typical results obtained from two experiments. 
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The small size of the Mto1 [1-800] / Mto2 heterotetramer indicates that it may 
represent a ‘sub-complex’ or minimal function unit. It is likely that the C- terminal 
coiled-coil domains of full length Mto1, in addition to association of Mto2  
with Mto1, facilitate the multimerisation of the Mto1/2 heterotetramers into larger 
assemblies that may resemble a template structure for γ-TuSC association.  
  
3.2.8 Mto2 interaction efficiency with Mto1 [1-800] is comparable to full length 
protein 
 
 Hydrodynamic analysis of the Mto1 [1-800] / Mto2 complex has 
demonstrated that it is smaller than the Mto1/2 complex containing full length Mto1. 
To test whether the efficiency of the Mto1-Mto2 interaction has been altered in the 
Mto1 [1-800] / Mto2 complex, the levels of Mto2 co-precipitated by Mto1-TAPS 
were compared between full length Mto1 and Mto1 [1-800]. Figure 3.8 Panel A and 
B show the integrated intensity of the Mto2 signal i  the pulldown, which has been 
normalised relative to the levels of Mto1-TAPS. The levels of Mto2 pulled down by 
full length Mto1-TAPS and Mto1 [1-800]-TAPS were comparable, indicating that 
truncation of Mto1 does not affect the stability of the interaction with Mto2. This 
data also suggests that the ratio of Mto1 to Mto2 mlecules within the Mto1 [1-800] / 
Mto2 complex is comparable to full length Mto1/2. This supports the prediction that 





























Figure 3.8 The efficiency of the Mto1-Mto2 interaction is not affected by 
heterotetramer formation. Extracts were incubated with IgG-Dynabeads [Strains 
KS516, KS3524, KS4323 and KS34760]. [A] Eluates were analysed by 10% 
SDS-PAGE and the western blot was probed with anti-Mto2 and anti-Mto2 
antibodies. [B] Integrated intensities of IRDye800 signal were measured using 
Odyssey V3.0. Mto2 signal was normalised relative to the signal from Mto1. 
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3.2.9 The Mto1-Mto1 interaction is independent from Mto2 
 
 Hydrodynamic analysis of the Mto1 [1-800] / Mto2 complex has suggested 
that Mto1 [1-800] exists as a dimer and that this interaction is independent from  
Mto2. The Mto1-Mto1 interaction was confirmed by performing an anti-GFP 
immunoprecipitation in a strain that contained Mto1-GFH expressed from an nmt41 
thiamine repressible promoter at the leu1 locus and Mto1-13myc expressed from the 
endogenous mto1 promoter. Figure 3.9 shows that in the absence of Mt 1-GFH, 
Mto1-13myc was not co-precipitated, however, in the pr sence of Mto1-GFH, Mto1-
13myc was present in the eluate. The levels of Mto1-13myc that interacted with 
Mto1-GFH did not change in mto2∆. This result confirms that Mto1 can self-interact. 
 
3.2.10 Mto2 can self-interact in vitro 
 
 The presence of dimeric Mto2 within the Mto1 [1-800] / Mto2 heterotetramer 
suggests that Mto2 can also self-interact, however, it is not known whether Mto1 is 
required for this interaction. To investigate this, an interaction assay was performed 
in vitro. Mto2 was tagged with N-terminal MBP by Gateway recombination (Busso 
et al. 2005), to allow expression of soluble protein that could be purified on amylose 
resin. Mto2 was also tagged with NusA to allow exprssion of soluble protein with a 
larger molecular weight that could be distinguished from MBP-Mto2 upon SDS-
PAGE analysis. Figure 3.10 shows the Coomassie stained SDS-PAGE gel of the 
MBP-pulldown assay. When NusA-Mto2 was incubated with the MBP-Mto2 bound 
amylose resin, significantly more NusA-Mto2 was present compared with amylose 
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resin alone. This result indicates that recombinant MBP-Mto2 can interact with 
NusA-Mto2, although it does not discount the possibility that the NusA tag may be 
binding to MBP-Mto2 and not Mto2. This discrepancy can be clarified in future 
experiments by using a NusA only control. This in vitro experiment indicates that the 
Mto2-Mto2 interaction is direct.  
 
3.2.11 The Mto2-Mto2 interaction is independent from Mto1 
 
 To confirm the Mto2-Mto2 interaction i  vivo, an anti-GFP 
immunoprecipitation was performed on a strain that contained two copies of Mto2, 
either endogenously tagged with 13myc or tagged with a HFG-tag. HFG-tagged 
protein was constructed by Gateway recombination of Mt 2 into nmt81:HFG 
tagging vector. This sequence was transformed into an mto2∆ strain at the leu1 locus 
and was then crossed with Mto2-13myc. Figure 3.11 show  that Mto2-13myc did not 
bind to the anti-GFP linked Dynabeads in the absence of HFG-Mto2. However, 
Mto2-13myc was found in the co-precipitate of HFG-Mto2 both in mto1+ and mto1∆. 
This indicates that Mto2 is able to self-interact in vivo, and confirms that this 
interaction is independent from Mto1. This Mto2-Mto2 interaction may be required 
for multiple aspects of Mto2 function within the Mto1/2 complex. This interaction 






























Figure 3.10 Mto2 can self-interact in vitro. Bacterial extracts expressing MBP-
Mto2, NusA-Mto2 or a combination of both tagged proteins were incubated with 
amylose resin. Eluates were analysed by 10% SDS-PAGE and gel was stained 
with Coomassie. Image represents a typical result obtained from three 
experiments. 
Figure 3.9 Mto1 can self-interact independently from Mto2. Yeast extracts were 
incubated with anti-GFP linked Protein G Dynabeads [Strains KS4230, KS1507, 
KS4627 and KS4373]. The eluates were analysed by 8% and 10% SDS-PAGE 
and the western blot was probed with anti-Myc [9E10], anti-GFP and anti-Mto2 
antibodies. The signal from GT-34-HRP and anti sheep-IgG-HRP secondary 
antibodies were detected by ECL. * = non-specific band. Image represents a 
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Figure 3.11 Mto2 can self-interact in vivo independently of Mto1. Yeast extracts 
were incubated with anti-GFP linked Protein G Dynabeads [Strains KS1504, 
KS3915, KS3920, and KS5574]. The eluates were analysed by 10% SDS-PAGE 
and the western blot was probed with anti-Myc [9E10], anti-GFP and anti-Mto1 
antibodies. The signal from GT-34-HRP and anti sheep-IgG-HRP secondary 
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3.3 SUMMARY OF RESULTS  
 
 In this chapter I have investigated the properties of the Mto1/2 complex. 
When analysed by sucrose density gradient centrifugation I demonstrated that both 
Mto1 and Mto2 are present within a very large assembly of approximately 60 – 80 S. 
Inclusion of Mto2 in the 60 – 80 S complex required Mto1 but not vice versa. The 
size of the complex was not affected by the failure of Mto1 to interact with the γ-
TuSC or by the absence of γ-TuRC non-core components, indicating that this large 
complex does not represent the Mto1/2-γ-TuRC complex that I predict may be 
present at the minus ends of MTs.  
 There are two reasons why the Mto1/2 complex and the γ-TuSC might be 
found within separate 60 – 80 S complexes. Firstly, these complexes may arise from 
protein aggregation. Analysis of purified γ-TuSC in other systems has shown that it 
is prone to aggregation (Oegema et al. 1999). The presence of extensive regions of 
coiled-coil in Mto1 is likely to encourage protein association as demonstrated for 
other structural elements of the cytoskeleton that con ain coiled-coils e.g. myosin and 
intermediate filament proteins (Alberts et al., 2002). Secondly, the Mto1/2 complex 
and the γ-TuSC may associate with large cellular particles/dbris that sediment 
within an S-value of 60 – 80 S. The presence of Mto1 within the 60 – 80 S complex 
was partially disrupted when Mto1 was unable to loca ise to the SPB and eMTOC, 
indicating that the 60 – 80 S complex is partially due to association with the SPB. As 
the γ-TuSC localises to the SPB in mto1∆, this suggests that γ-TuSC 60 - 80 S 
complex formation may also be promoted by its associati n with the SPB.   
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 Attempts to visualise the 60 – 80 S complex in vivo revealed that weak Mto1-
tdRFP foci were visible in mto2∆ at non-SPB/eMTOC sites. It is possible that these 
weak foci represent the 60 – 80 S particles, particularly as they are highly variable in 
signal intensity. This correlates with the heterogeneous nature of the complex 
analysed by sucrose density gradient centrifugation. Without knowing how many 
molecules of Mto1-tdFRP are present within these foci, and what other protein 
complexes they may be associating with, it is difficult to say whether these particles 
correspond to the 60 – 80 S complex and whether they are physiologically relevant to 
MT nucleation. However, phenotypic analysis of another Mto1 truncation mutant, 
Mto1 [1-800], which was not present with a 60 – 80 S complex but was able to 
nucleate MTs (Sawin et al., data unpublished), has shown that the presence of the 
Mto1/2 60 – 80 S complex is not required for Mto1/2 complex activity.  
 Alternatively, it is possible that the Mto1/2 60 – 80 S may be a result of 
protein aggregation. During cell harvesting cells are cooled to 4°C and at this 
temperature the MT bundles depolymerise which causes a r -distribution of Mto1 to 
the surface of the nucleus (Sawin et al. 2004). By concentrating Mto1 at the nuclear 
envelope, this may exacerbate the aggregation. Analyses of the D. melanogaster 
Mto1 homolog, Centrosomin [Cnn], have shown that when over-expressed it forms 
large aggregates within the cell, which supports the idea that aggregation of these 
proteins may be promoted by increases in concentration (Kofron et al. 1998; Terada 
et al. 2003).  
  
 In summary, attempts to determine the copy number of molecules within 
Mto1/2 complex containing full length Mto1 have been unsuccessful due to the 
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formation of the Mto1/2 60 – 80 S complex. Additionally, due to its size and 
heterogeneity, it has not been possible to determine whether the Mto1/2 60 – 80 S 
complex has a physiological role in vivo. 
 
 In the second part of this chapter, I performed a hydrodynamic analysis of the 
Mto1 [1-800] / Mto2 complex and demonstrated that it is likely to be composed of 
two molecules of Mto1 and two molecules of Mto2. I demonstrated that both Mto1 
and Mto2 are able to self-interact, independently of each other. This suggests that the 
heterotetramer is composed of independent dimers of both Mto1 and Mto2. I predict 
that this heterotetramer represents the major subunit of the Mto1/2 complex, which 
may then multimerise to provide a template-like structure that can promote γ-TuRC 
assembly. Comparison of the purified Mto1 [1-800] / Mto2 complex with the full 
length Mto1/2 complex indicates that the stable complexes from both contain similar 
levels of Mto1 and Mto2. This further supports the id a that the Mto1/2 complex 
containing full length Mto1 is composed of several copies of the heterotetramer. 
  Examination of the Mto1-GFP foci in vivo has demonstrated that the intensity 
of non-SPB iMTOC foci are comparable between full length Mto1-GFP and Mto1 
[1-800]-GFP (Sawin et al., data unpublished). The bright signals in both 
backgrounds indicate that many molecules are likely to be present at each iMTOC, 
and that the quantitative levels of the Mto1/2 complex at the MTOCs are the same. 
However, as only single heterotetramers were observed in the biochemical analysis 
[most likely as a result of dissociation following the reduction in temperature during 
the cell harvesting and lysis procedure] it has not been possible to determine the copy 
number of each protein within the active nucleation c mplex. 
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 However, it is also possible that Mto1 [1-800] / Mto2 heterotetramers could 
support γ-TuRC assembly without multimerising e.g. by indiviually targeting small 
numbers of γ-TuSC to the non-SPB iMTOC to a concentration sufficient to promote 
γ-TuRC self-assembly. Alternatively, as observed in vitro, a complex containing one 
or two γ-TuSC may be sufficient to nucleate MTs (Oegema et al. 1999). This would 
support the Protofilament Model of MT nucleation (Erickson et al. 1996a).  
 In vitro reconstitution from purified γ-TuSC and the Mto1 [1-800] / Mto2 
heterotetramer would be one way to determine the nature of the complex formed by 
Mto1/2 and γ-TuSC. This would allow examination of the hydrodynamic properties 
of Mto1 [1-800] / Mto2 complex in association with the γ-TuSC. If complexes > 35 S 
were observed, this would favour Mto1/2-directed γ-TuRC assembly, if complexes < 
35 S were observed this would indicate that complexes containing a small number of 
γ-TuSC are sufficient for MT nucleation. 
 The model in Figure 3.12 describes possible arrangements of the Mto1/2 
complex.  Panel A depicts the arrangement of Mto1 and Mto2 in the Mto1 [1-800] 
heterotetramer. This assumes that the Mto1 dimer is configured in a parallel 
arrangement, with the N-terminal γ-TuC interaction domains facing in the same 
direction. Panel B describes a potential explanatio for what happens to Mto1 when 
the 60 – 80 S complex is formed. Multimeric association of Mto1 via its C-terminal 
coiled-coil domains facilitates protein aggregation. This process is promoted by 
localisation to the SPB due to the increase in local concentration of Mto1. Panels C 
and D suggest potential arrangements of the multimeric Mto1/2 heterotetramer 
containing full length Mto1.  
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 There are a number of key points that need to be inv stigated in order to 
conclusively demonstrate the Mto1/2 complex configuration. The analysis of the 
Mto1 60 – 80 S complex described in this chapter indicates that the oligomerisation 
state of Mto1 is going to be very difficult to determine biochemically. Alternatively, 
by using in vivo methods such as Fluorescence Correlation Spectroscopy (FCS) to 
measure the fluorescence of single molecules, it may be possible to estimate the 
numbers of Mto1-GFP at iMTOCs. The orientation of the Mto1 dimers is most likely 
to be parallel, as this would consolidate both the N-t rminal γ-TuC interaction 
domain and the C-terminal localisation signal. Experim nts that involve cross-
linking regions of the protein as described in (Gruber et al. 2006) would be one way 
of addressing this problem.   
 One also needs to address the oligomeric state of Mto2. In Figure 3.5, I 
demonstrated that Mto2 facilitates the multimerisation of Mto1 in vivo, based on the 
increase in Mto1-tdRFP signal in the presence of Mto2. Mto2-induced Mto1 
multimerisation could occur by two mechanisms, either Mto2 binding induces a 
structural change in Mto1 that promotes its multimer sation e.g. exposure of coiled-
coil, or Mto2 itself multimerises and brings multipe molecules of Mto1 together. 
The role of Mto2 oligomerisation in Mto1/2 complex formation will be investigated 


































Figure 3.12 Model of Mto1/2 complex conformation. [A] Heterotetramer 
formation in Mto1 [1-800], where lack of the C-terminal coiled-coil prevents 
multimerisation. [B] Possible configuration of the 60-80S complex which is likely 
to assemble during cell lysis. [C-D] Potential conformations of the Mto1/2 
complex in vivo. 
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CHAPTER FOUR 




 The research presented in the previous chapter attemp ed to address whether 
the Mto1/2 complex is able to assemble into a large  template structure that can 
direct γ-TuSC multimerisation. I found that the Mto1 [1-800] / Mto2 complex is 
likely to be composed of two molecules of Mto1 and two molecules of Mto2. Mto1 
is dimeric and, as Mto2 can self-interact independently of Mto1, it is likely that Mto2 
is also present within the complex as a dimer. Although not shown biochemically, I 
predict that in vivo, several copies of the Mto1/2 heterotetramer associate into a large 
complex. Evidence from chapter three suggests that higher-order multimerisation of 
Mto1 is most likely to be facilitated via its C-terminal coiled-coil domain. However, 
analysis of the signal of Mto1-tdRFP at non-SPB iMTOCs in vivo, show that Mto2 
also contributes to the multimerisation of Mto1.  
 Mto2 may promote Mto1 multimerisation in one of two ays. Firstly, it is 
possible that Mto2 may induce multimerisation through interaction-induced 
structural changes that expose domains on Mto1 that are required for multimerisation. 
Secondly, Mto2 may promote Mto1 multimerisation through its own multimerisation, 
e.g. Mto2 tetramerisation may cause the association of two Mto1/2 heterotetramers.  
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 Biochemical evidence has shown that Mto2 is required for Mto1 to efficiently 
interact with the γ-TuSC (Samejima et al. 2008). However, the mechanism by which 
this occurs, and whether it requires the Mto2-Mto2 interaction is unknown. It is 
possible that Mto2-mediated multimerisation of Mto1 is sufficient to induce a co-
operative increase in the efficiency of Mto1 / γ-TuSC interaction. Alternatively, 
Mto2 may have a more direct role in the γ-TuSC interaction, e.g. by inducing a 
conformation change in Mto1 that may increase the affinity of Mto1 for the γ-TuSC 
or Mto2 itself may contribute to the γ-TuSC interaction interface. 
  
4.1.2 Aims and Objectives 
 
 In this chapter I aim to investigate the stoichiometry of the oligomeric form 
of Mto2 and examine whether disruption of the Mto2-Mto2 interaction has adverse 
effects on the function of the Mto1/2 complex either through loss of Mto1 
multimerisation or loss of interaction efficiency with the γ-TuSC.  
 
I will take the following approaches to investigate this problem: 
 
• Hydrodynamic analysis of Mto2 to determine the multimerisation state of 
purified recombinant protein and endogenous yeast protein 
• Mapping of the Mto2-Mto2 interaction 
• Construction and analysis of Mto2-Mto2 interaction mutants 
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4.2 RESULTS 
 
4.2.1 Hydrodynamic analysis of recombinant Mto2 purified from E. coli 
 
 Hydrodynamic analysis of the active Mto1 [1-800] / Mto2 complex has 
revealed that there are two copies of Mto2 present within the complex. I have shown 
that Mto2 is able to self-interact independently of Mto1, which suggests that Mto2 is 
able to form some higher-order structure. I predict tha  further multimerisation of 
Mto2 may contribute to the association of Mto1/2 heterotetramers.  
 To examine stoichiometry of the Mto2 oligomer, recombinant Mto2 was 
purified and subject to hydrodynamic analysis. Figure 4.1, Panel A and B show that 
Mto2 peaked in fraction 17. When compared to the calibration curve generated from 
molecular weight standards of known S-value [Appendix I] corresponded to 7.25 S. 
Purified Mto2 was also subject to gel filtration chromatography. Figure 4.1, Panel C 
and D show that the integrated intensity of the Mto2 signal peaked in fraction 9.2. 
This was compared with a calibration curve created from markers of known Stokes’ 
radii [Appendix IV] and was found to correlate to a Stokes’ radius of 7.7 nm. 
 
4.2.2 Recombinant Mto2 is tetrameric 
 
 Using the values calculated in section 3.2.7, the molecular weight of 
endogenous Mto2 was calculated as described below: 
 
 





























































































Figure 4.1 Hydrodynamic analysis demonstrates that purified recombinant Mto2 
is a tetramer. [A] 2.5 µg of purified Mto2 was subject to 5 – 20% sucrose density 
gradient centrifugation at 55,000 rpm for 3.5 hr in a Beckman TLS-55 rotor. The 
fractions were analysed by 10% SDS-PAGE and the gel was stained with 
Coomassie stain. A western blot was probed with anti-Mto2 antibody. [B]  The 
integrated intensity from IRDye800 signal was measured using Odyssey V3.0 and 
plotted against gradient fraction. [C] 2.5 µg of purified recombinant Mto2 was 
fractionated by gel filtration using a Superose-6 column [KS2]. The fractions were 
analysed by SDS-PAGE. Silver staining of the gel revealed a protein that was 
confirmed as Mto2 by western blot probed with anti-M o2 antibody. [D] The 
integrated intensity of signal from IRDye800 was measured using Odyssey V3.0 
and plotted against gradient fraction. The peak locati ns for molecular weight 
standards run on parallel fractionations are indicated [black arrows]. Standards in 
[C] indicated in nm. V0 = void volume. Images represent typcial results obtained 
from two experiments. 
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Recombinant Mto2: 
M = 6πηN • a • s / [1-νρ] 
M = 3909 • a • s 
M = 3909 • 7.7 nm • 7.25 S 
M = 218.2 kDa 
 
 The theoretical molecular weight of Mto2 is 44 kDa, this would correspond to 
4.96 molecules of Mto2 per oligomer. This large Mto2 complex lies at the high end 
of the resolution range of the Superose-6 column, therefore it is difficult to assign an 
exact number of molecules to the complex. Subsequently, it is only possible to say 
that purified Mto2 exists as a complex containing 4-6 molecules. Evidence from 
chapter three has demonstrated that the Mto1/2 heterot ramer contains two copies of 
Mto2, therefore it is likely that purified Mto2 is tetrameric.  
 
4.2.3 Hydrodynamic analysis of endogenous Mto2  
  
 Purified recombinant Mto2 forms a homomeric complex that most likely 
contains 4 molecules of Mto2. To confirm this observation in vivo, endogenous Mto2 
from yeast extract was also subject to hydrodynamic analysis. Figure 4.2, Panel A 
shows that following fractionation by sucrose gradient centrifugation, Mto2 peaked 
in fraction 8.5 [obtained by visual estimation]. Using the calibration curve generated 
from molecular weight markers of known S-value [Appendix II], the sedimentation 
co-efficient for Mto2 was calculated as 7.6 S. The Mto2 signal from extract 
fractionated by gel filtration peaked in fraction 8 [fig 4.2, Panel B and C]. When 
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compared to a calibration curve [Appendix III], this corresponded to a Stokes radius 
of 7.5 nm.  
 
4.2.4 Endogenous Mto2 is the same size as recombinant Mto2 
 
 Using the values calculated in section 4.2.3, the molecular weight of 
endogenous Mto2 was calculated as described below: 
 
Native Mto2: 
M = 6πηN • a • s / [1-νρ] 
M = 3909 • a • s 
M = 3909 • 7.5 nm • 7.6 S 
M = 222.8 kDa 
 
 The theoretical molecular weight of Mto2 is 44 kDa, this would correspond to 
5.06 molecules of Mto2 per oligomer. Assuming that no other proteins co-precipitate 
with Mto2, this figure is consistent with the size of complex calculated for purified 
recombinant Mto2 [section 4.2.2]. 
 Both in vitro and in vivo analyses have demonstrated that Mto2 oligomerises 
to form a complex that contains 4-6 molecules of Mto2. This supports the prediction 





























Figure 4.2 Hydrodynamic analyses of endogenous Mto2 demonstrate  that it is 
tetrameric. [A] An extract from KS1017 was subject to sucrose density gradient 
centrifugation at 55,000 rpm for 3.5 hr in a Beckman TLS-55 rotor. Fractions 
including the pellet [P] were analysed by 10% SDS-PAGE and the western blot 
was probed with anti-Mto2 antibody. The signal from GT-34-HRP secondary 
antibody was detected by ECL. Image represents a typical result obtained from 
two experiments. [B] Extract was fractionated by gel filtration using a Superose-6 
column [KS1]. Fractions were analysed by 10% SDS-PAGE and the western blot 
was probed with anti-Mto2 antibody. [C] The integrated intensity from the 
IRDye800 signal was detected using Odyssey V3.0. Image represents result 
obtained from a single experiment. The peak locations f r molecular weight 
standards run on parallel fractionations are indicated [black arrows]. Standards in 
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4.2.5 Mto2 forms a dimer in mitosis 
 
 In addition to investigating the contribution of Mto2 to the nucleation activity 
of the Mto1/2 complex, how this activity is regulated is also of key interest. 
Disruption of the Mto1/2 interaction is the most likely mechanism of Mto1/2 
complex regulation; however, the oligomerisation state of Mto2 may also be 
regulated. Given that non-SPB MTs are not present in mitosis, it is likely that the 
activity of the Mto1/2 complex is down-regulated at this point during the cell cycle. 
To investigate whether the stoichiometry of Mto2 is altered in mitosis, an extract 
from an asynchronous culture was compared with an extract from cells arrested in 
metaphase using the nda3-M311 cold sensitive tubulin allele (Hiraoka et al. 1984). 
Both sucrose gradient centrifugation and gel filtration chromatography demonstrated 
that the mitotic Mto2 oligomer is smaller than Mto2 from an asynchronous extract. 
Sucrose gradient analysis showed that the reduction in complex size was independent 
of Mto1 [fig 4.3, Panel A and C]. Mitotic Mto2 peaked in fraction 5.2, which 
corresponded to a sedimentation co-efficient of 4.3 S [Appendix II]. By gel filtration, 
Mto2 peaked in fraction 9, which corresponded to a Stokes’ radius of 6.4 nm 
[Appendix III] [fig 4.3, Panel B and D]. This was compared to Mto2 from 
asynchronous extract that had an S-value of 7.6 and a Stokes’ radius of 7.5 nm. 
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Mitotic native Mto2: 
M = 6πηN • a • s / [1-νρ] 
M = 3909 • a • s 
M = 3909 • 6.4 nm • 4.3 S 
M = 107.5 kDa 
 
 The theoretical molecular weight of Mto2 is 44 kDa, this would correspond to 
2.44 molecules of Mto2 per oligomer. This is exactly half of the value obtained for 
Mto2 from asynchronous cultures, indicating that mitotic Mto2 is likely to be dimeric. 
 This result confirms the prediction that the oligomerisation state of Mto2 is 
altered during mitosis. The properties of mitotic Mto2 will be investigated further in 
chapter five. 
 
4.2.6 HFG-Mto2 is dimeric 
 
 In addition to endogenous protein, the oligomerisation state of tagged Mto2 
was also analysed. An extract from HFG-Mto2 was subject to sucrose density 
gradient centrifugation [fig 4.4, Panel A]. The signal from the anti-Mto2 antibody 
peaked in fraction 7.75 [as determined by visual estimation], which, when compared 
to a calibration curve [Appendix II] corresponded to a sedimentation coefficient of 
6.8 S. Extract containing HFG-Mto2 and extract from a strain that contained Mto2-
GFP were analysed by gel filtration [fig 4.4, Panel B]. Signals from HFG-Mto2 and 
Mto2-GFP peaked in fraction 10 [determind by visual estimation], which 
corresponded to a Stokes’ Radius of 5.4 nm [Appendix III].   
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Figure 4.3 Comparative hydrodynamic analysis of asynchronous and mitotic 
Mto2 demonstrates that Mto2 is dimeric during mitosis. [A] The extracts were 
subject to sucrose density gradient centrifugation at 55,000 rpm for 3.5 hr in a 
Beckman TLS-55, or [B] fractionated by gel filtration using a Superose-6 column 
[KS1]. [Strains KS1017, KS1238, and KS1239]. The fractions including the pellet 
[P] were analysed by 10% SDS-PAGE the western blot was probed with anti-
Mto2 antibody. [C and D] Integrated intensity of the IRDye800 signal was 
measured using Odyssey V3.0. The peak locations for molecular weight standards 
run on parallel fractionations are indicated [black rrows]. Standards in [B] 
indicated in nm. V0 = void volume. Mto1D = mto1∆. Image represents result 
obtained from a single experiment. 
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The molecular weight of HFG-Mto2 was calculated as de cribed below: 
 
HFG-Mto2: 
M = 6πηN • a • s / [1-νρ] 
M = 3909 • a • s 
M = 3909 • 5.4 nm • 6.8 S 
M = 138.22 kDa 
 
 The theoretical molecular weight of HFG-Mto2 is 74 kDa, this corresponds to 
1.94 molecules of HFG-Mto2 per oligomer. Therefore, in the absence of Mto1, HFG-
Mto2 exists as a dimer. This is a significantly smaller complex than the 4-6 molecule 
complex formed by untagged protein both in vivo and in vitro. This data suggests that 
the 34 kDa GFP protein tag appears to have disrupted the tetrameric Mto2 protein 
complex. The similar behaviour of the C-terminally tagged protein indicates that the 
position of the tag does not affect the oligomeric state of Mto2. This is interesting, as 
previous analyses have not detected altered MT dynamics in the presence of Mto2-
GFP (Samejima et al. 2005; Venkatram et al. 2005), and suggests that Mto2 
tetramerisation is not required for Mto2 activity. Previous research has shown that 
Mto1-YFP foci in the presence and absence of Mto2-CFP are not significantly 
different in localisation or intensity (Samejima et al. 2005). This indicates that 
higher-order multimerisation of Mto2 dimers do not c ntribute to Mto1 
multimerisation. Rather, tetrameric Mto2 may be the pr ferred oligomerisation state 
of un-complexed Mto2, particularly if the Mto1 interaction domain is highly 
hydrophobic and consequently favours a more energetically sheltered conformation. 
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This would suggest that tetrameric Mto2 is a storage form of protein, and may not be 
relevant to the stoichiometry of the Mto1/2 nucleation complex.  
 This hypothesis would indicate that Mto2 dimer-dimer interface overlaps 
with the Mto1-Mto2 interaction interface such that binding of Mto1 to Mto2 would 
disrupt the Mto2 tetramer. Subsequently, failure to te ramerise may result in an 
increase number of Mto2 dimers that more readily associate with Mto1. To test 
whether the prevalence of Mto2 dimers affects Mto1 activity it is necessary to 
compare the MT nucleation dynamics in HFG-Mto2 and mto2+ background. 
 
4.2.7 MT nucleation efficiency and the Mto1 / γ-TuC interaction is wild-type in 
HFG-Mto2 background 
 
 Biochemical analysis has demonstrated that HFG-Mto2 forms a dimer and 
native untagged protein forms a tetramer. To confirm that the constraint on the 
oligomeric state of Mto2 does not have adverse affects on Mto1/2 complex activity, 
the MT nucleation pattern of HFG-Mto2 was examined in strains that contained 
GFP-Atb2. Figure 4.5 and movies 3A and 3B show that in both wild-type Mto2 and 
HFG-Mto2, the MT arrays appeared identical. They both had 3 - 4 bundles per cell, 
which grew and depolymerised as expected. This indicates that the nucleation 
capacity of HFG-Mto2 is not affected by the disruption of the Mto2 tetramer, and 
confirms that tetramerisation of Mto2 is not required for Mto2 function. The 
presence of excess HFG-Mto2 dimers does not appear to alter MT dynamics at a 
detectable level. 
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 This analysis also indicates that the nature of the Mto2 dimers formed in 
mitosis is different to the Mto2 dimers formed in the presence of the HFG-tag, the 
former being unable to support MT nucleation and the latter able to promote MT 
nucleation at wild-type levels. This suggests that e Mto2-Mto2 tetramerisation is 
not a direct target of cell cycle-dependent regulation per se and instead may be a 
consequence of the disruption of the Mto1-Mto2 interaction. 
 The biochemistry of the nucleation complex formed in the presence of 
dimeric Mto2 was also analysed [fig 4.5, Panel B]. Integrated intensities for each 
protein were normalised relative to Mto1 levels in the eluate [data not shown]. Figure 
4.5, Panels C-E show that when compared to mto2+, the interaction between Mto1 
and both Alp4 and Gtb1 in mto2∆ has been reduced 4-fold. In the presence of HFG-
Mto2, the interaction of Alp4 and Gtb1 with Mto1 does not appear to have been 
significantly compromised, however the levels of HFG-Mto2 pulled down by Mto1-
TAPS have been reduced by 50% compared to untagged protein.  
 As the levels of HFG-Mto2 pulled down by Mto1-TAPS did not increase 
compared to wild-type Mto2, this indicates that the pr sence of Mto2 in dimeric form 
[compared to tetrameric protein] does not increase its propensity to interact with 
Mto1. This suggests that the majority of Mto2 is in complex with Mto1, which 
correlates with their co-localisation when analysed by fluorescence microscopy 
(Samejima et al. 2005)  
 The reduction of Mto2 levels in the pulldown may occur due to several 
reasons. For example, loss of Mto2 molecules may reflect a destabilisation of the 
Mto1-Mto2 interaction as a result of steric restrictions imposed by the GFP tag.  
 

























Figure 4.4 Hydrodynamic analysis of tagged Mto2 demonstrates that it is 
dimeric. [A] Extract from KS4450 was subject to sucrose density gradient 
centrifugation at 55,000 rpm for 3.5 hr in a Beckman TLS-55. The fractions 
including the pellet [P] were analysed by 10% SDS-PAGE the western blot was 
probed with anti-Mto2 antibody. Signal from GT-34-HRP was detected with 
ECL. Image represents typical results from two experim nts. [B] The extracts 
were fractionated by gel filtration using a Superos-6 column [KS1] [Strains 
KS4450 and KS1457]. The fractions were analysed by 10% SDS-PAGE the 
western blot was probed with anti-Mto2 antibody. Integrated intensity of the 
IRDye800 signal was measured using Odyssey V3.0. Image represents result 
from single experiment. The peak locations for molecu ar weight standards run on 
parallel fractionations are indicated [black arrows]. Standards in [B] indicated in 
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Figure 4.5 Dimeric HFG-Mto2 does not affect MT nucleation efficiency or the 
Mto1 / γ-TuC interaction. [A] Images acquired using the spinning disk confocal 
microscope. Maximum projections of Atb2-GFP labelled MTs in the presence and 
absence of HFG-Mto2 [Movie 3B and 3C]. Scale bar = 10µm [B] Extracts were 
incubated with IgG-Dynabeads and the eluates were analysed by 10% SDS-PAGE 
[Strains KS516, KS3524, KS4323, KS4973, and KS4976]. The western blot was 
probed with anti-Mto1, anti-Mto2, anti-Alp4 and anti-γ-tubulin [GTU-88] 
antibodies. [C to E] Integrated intensities of signal from IRDye800 were measured 
using Odyssey V3.0. Mto2D = mto2∆. Images represent result from single 
experiment. 
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 Alternatively, the loss may occur through disruption of the Mto2 dimer by the 
HFG-tag [previous analysis has indicated that the full length Mto1/2 complex it is 
likely to contain two molecules of Mto2]. If dimeric Mto2 was disrupted by the 
HFG-tag, the Mto1/2 complex formed in the presence of HFG-Mto2 must contain  
two molecules of Mto1 and one molecule of HFG-Mto2. This supports the model 
that Mto2-induced multimerisation of Mto1 occurs as a result of a conformational 
change and not Mto2 multimerisation. The best way to address this question is to 
analyse the hydrodynamic properties of the Mto1 [1-800] / HFG-Mto2 complex to 
determine the number of molecules of HFG-Mto2.   
 Despite the reduction in Mto2 levels, the Mto1 / γ-TuC interaction remains 
unaffected. This correlates with the microscopy data which shows that there are no 
detectable changes in nucleation dynamics in the presence of dimeric HFG-Mto2.  
 
4.2.8 Mapping of the Mto2-Mto2 interaction domain 
 
4.2.8.1 Regions at the N- and C-terminus are required for the Mto2-Mto2 
interaction in vitro  
 
 This work was performed with the assistance of Struan Murray [summer 
project student, University of Oxford].  
 The research described above suggests that formatin of the Mto1/2 complex 
is unlikely to occur as a result of higher-order multimerisation of Mto2. Alternatively, 
it is possible that Mto2 binding may induce changes in Mto1 structure that promote 
Mto1 self-association. It is unknown whether binding of Mto2 in dimeric form is 
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required or whether individual recruitment of Mto2 would be sufficient [although 
energetically less efficient, given that Mto1 is dimeric] to induce a change in 
conformation of Mto1. To assess the contribution of the dimeric Mto2-Mto2 
interaction to the function of the Mto1/2 complex, a monomeric version of Mto2 is 
required. Identification and mutagenesis of the intraction domains is complicated by 
the fact that there are two Mto2-Mto2 interaction domains, the dimer association 
interface and the dimerisation interface. It is unclear whether Mto2 tetramerisation 
occurs as a successive association of specific dimers, however, I predict that the 
Mto2 dimers that interact with Mto1 are preferentially formed, which then associate 
into tetramers upon release from Mto1. Mutagenesis of the correct Mto2-Mto2 
interaction domain [or both] is essential to generate monomeric Mto2.  
 To identify regions that may be involved in the Mto2-Mto2 interaction, an 
interaction mapping was performed. The Mto2 protein s quence was divided into 
five sections, each section encoding peptides approximately 90 aa in length. Protein 
truncations were made by successive removal of sections from the N- and C- termini 
[fig 4.6, Panel A]. Mto2 truncations were designed around regions of predicted 
secondary structure in order to minimise the disruption of structural domains which 
may be important for protein folding and stability.  
 Five of the six truncations were used in subsequent experiments as N3 [283 – 
397 aa] was found to be expressed at a low level [data not shown]. Mto2 truncations 
were tagged with MBP and used as bait in a pulldown assay with full length Mto2 
tagged with NusA. Figure 4.6, Panel B shows a Coomassie stained SDS-PAGE gel 
of the MBP-pulldown assay. As previously demonstrated in section 3.2.11, NusA-
Mto2 is pulled down by full length MBP-Mto2. Analysis of MBP-Mto2 truncations 
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shows that only MBP-Mto2 N1 [89-397 aa] retained the ability to pull down NusA-
Mto2. Further truncation from the N-terminus and all C-terminal truncations lead to 
failure to interact with NusA-Mto2 above the low level of non-specific binding 
observed in the negative control.  
 This analysis indicates that there are areas in both the N- and C-termini of 
Mto2 that contribute to the Mto2-Mto2 interaction. Assuming that MBP-Mto2 is 
tetrameric, this may correspond to the Mto2 dimer association and the Mto2 
dimerisation interaction. The fact that removal of either of the interacting termini 
disrupts the interaction with full length Mto2 indicates that either form of dimeric 
protein is unstable under these conditions. Alternatively, it is possible that removal of 
large sections of protein has induced a disruption of protein folding that prevents the 
assembly of an Mto2 interaction surface. In this cae, one can not make any 
conclusions regarding the function of each 90 aa domain.  
 It is possible that either Mto2-N2 or C1 truncations are monomeric when in 
complex with Mto1, therefore these truncations were expressed in fission yeast cells, 
in order to analyse their impact on MT nucleation. 
 
4.2.8.2 Mto2 truncations have an mto2∆-like phenotype 
 
 To assess the phenotype of the Mto2 truncations in yeast, N-terminal 
nmt81:HFG-tagged Mto2-N1/N2/C1 were constructed using Gateway recombination 
and the pDUAL vector system (Matsuyama et al. 2004). Sequences were integrated 
into mto2∆ and GFP-Atb2; mto2∆ backgrounds at the l u1 locus [KS976 and 
KS1409]. Figure 4.7, Panel A shows that all of the HFG-Mto2 truncations were able 
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to localise to the SPB, eMTOC and to iMTOCs along pre-existing MTs, although 
compared to full length HFG-Mto2, the signal was quantitatively reduced from all 
MTOCs except the SPB. The MT arrays formed in the presence of truncated HFG-
Mto2 had fewer MT bundles than wild-type, particularly in HFG-Mto2 N2 and HFG-
Mto2 C1 backgrounds, which typically had only 1 MT bundle per cell. The 
phenotype was less severe in HFG-Mto2 N1 positive control, where 2 - 3 bundles 
were present. This indicates that these proteins are not able to efficiently promote 
MT nucleation. 
 The localisation of the Mto2 truncations suggests that they have some 
capacity to interact with Mto1, as Mto2 does not localise to MTOCs in mto1∆ 
(Samejima et al. 2005). However, as a high level of cytoplasmic signal is observed 
for all truncations, including the HFG-Mto2 N1 positive control, this suggests that 
the majority of truncated Mto2 is unable to interact with Mto1.  
 Alternatively, it is possible that these proteins are subject to a high level of 
protein degradation. To assess the stability of the HFG-Mto2 truncations the 
expression level was quantified by western blot. 
 
4.2.8.3 Mto2 truncation phenotype is due to reduced protein stability  
 
 Protein expression levels of HFG-Mto2 truncations were examined by 
western blot of total protein extract. Figure 4.7, Panel B and C show that the nmt81 
driven protein expression was relatively consistent between truncation strains, 
indicating that observed differences in the phenotype of each truncation were not due 
to differences in Mto2 abundance. However, there was a six-fold reduction in protein  



























Figure 4.6 Mapping of the Mto2-Mto2 interaction demonstrates that two regions 
of Mto2 are involved in the Mto2-Mto2 interaction. [A] Schematic representation 
of Mto2 truncations. α-helices [blue cylinders] and β-sheets [red arrows]. The 
secondary structure of Mto2 was predicted using Jpred3. Amino acid residue 
numbers are indicated. Coiled-coil at 117 - 146 aa. [B] Bacterial extracts 
containing MBP-Mto2 truncations and NusA-Mto2 were incubated with amylose 
beads. MBP-Tea1 was used as a negative control. Eluates were analysed by 10% 
SDS-PAGE and the gel was stained with Coomassie. Images represent typical 
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Figure 4.7 Mto2∆-like phenotypes of HFG-Mto2 truncations N1, N2 and C1 were 
due to low protein stability levels. [Strains KS4603, KS4606, KS4609, KS4612, 
KS4615 and KS4618]. [A] Maximum projection wide-field images of HFG-Mto2 
truncations and in the presence and absence of Atb2-GFP. Scale bar = 10µm. [B] 
Total extracts were analysed by 10% SDS-PAGE and the western blot was probed 
with anti-Mto2 antibody. Two isolates from each truncation were analysed to 
confirm protein stability. Left isolate was used for imaging. [C] Integrated 
intensity from the IRDye800 signals were measured using Odyssey V3.0. 
Integrated intensity for C1, N1 and N2 are the mean value of the expression from 
two isolates. Images represent results from single experiment. WCE = whole cell 
extract. 
C 
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levels compared with nmt81:HFG-Mto2. The degradation products observed on the 
western blot indicates that the majority of protein loss is due to a reduction in protein 
stability [data not shown]. Unfortunately, the reduction of Mto2 protein levels is 
likely to explain the loss of nucleation efficiency in the Mto2 truncations therefore 
conclusive statements regarding the relationship between the Mto2-Mto2 interaction 
and the function of Mto2 cannot be made from this analysis. 
 
4.2.9 Identification of the Mto2 coiled-coil domain [130 – 147aa] 
 
 The interaction mapping described in section 4.2.8 indicates that there is a 
region between 89-180 amino acids that is involved in the Mto2-Mto2 interaction.  
PAIRCOIL2 was used to identify a putative N-terminal coiled-coil domain within 
this region [114-147aa]. PAIRCOIL2 prediction scores for Mto2 [104 – 152aa] are 
listed in Appendix VI. Figure 4.8, Panel A shows the Mto2 sequence with the 
predicted coiled-coil highlighted in red. A helical wheel projection was generated 
from a section of the coiled-coil sequence [130 – 147aa]. The projection contained a 
non-polar face that followed a slight left handed pitch common to all coiled-coils [fig 
4.8, Panel B]. The heptad repeats [abcdefg] within this sequence contain non-polar 
residues at positions a and d that are predicted to play key roles in the hydrophobic 






























1    MSEHNYQSDR EVAEDPFLNY EASANQLSSN SRESTPRGSP WRAGMRSASL MTEPLEDSMY 
61   SDNNYLDNGV SFTKDENPLY SPSWPSLADA NVNSMKSNNA IQEHKAAKFV SEKSLEKVST 
121  ADNNLVLQEL ENLRERLNQV ELQLSERPSS YLGYHNNLSP YRSPNSYPSL LPSTHSPHSP 
181  APLSTMQTAL MRLRTYHPSP IILKPVEQAV NHAITLVNTS PSSVVDALCR SLAELCLGLV 
241  QEAIDASILS QQESSNSLDL VRHTPPLNYT SSVDSSPQRM ASDSYGRPSL HLNDPFPSVD 
301  LQSNELSHHN VRTTLFSDDS RFHSKIHTHS TPPSQMYSAA SHFRYRSDPS TRHVSNSTNK 
a b c d e f g a b c d e f g 
SLEKVSTADNNLVLGELENLRERLNQVELQLSER 
Figure 4.8 PAIRCOIL2 coiled-coil prediction of Mto2 protein sequence. [A] 
Mto2 sequence with high-scoring 34-residue domain highlighted in red. [B] 
Helical wheel projection of amino acids 130-147, where the hydrophobic patch is 
highlighted in yellow. [C] 34 aa coiled-coil domain identified by PAIRCOIL2 
where amino acids used for helical wheel projection are underlined with the 
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4.2.9.1 Introduction of the L133DL137D coiled-coil mutations disrupts the 
Mto2-Mto2 interaction in vitro 
 
 Preliminary interaction mapping indicated that a region of Mto2 around the 
predicted coiled-coil [114 – 147 aa] may contribute to the Mto2-Mto2 interaction. To 
test this more rigorously a mutant was constructed that contained polar substitutions 
within the coiled-coil domain, that have previously been shown to disrupt coiled-coil 
interactions (Williams et al. 2008). I predicted that the introduction of polar residues 
into the hydrophobic interface would have a disruptive effect on the hydrophobic 
coiled-coil interaction. Helical wheel projections of a section of the predicted coiled- 
coil sequence [130 – 147 aa], indicated that there were two structurally significant 
hydrophobic leucine residues at positions 133 and 137, which correspond to 
positions a and d of the heptad repeat [fig 4.9, Panel A]. A mutant that contained 
negatively charged aspartic acid substitutions at these sites [Mto2-L133DL137D] 
was created by site-directed mutagenesis. The resultant gene was recombined into an 
N-terminal MBP-tagging vector (Busso et al. 2005), and the Mto2-Mto2 interaction 
was tested by amylose pulldown with full length NusA-Mto2. Figure 4.9, Panel B 
shows that compared to pulldown with MBP-Mto2, co-precipitation of NusA-Mto2 
with MBP-Mto2-L133DL1337D did not occur above levels seen in the MBP-Tea1 
negative control, indicating that the interaction between NusA-Mto2 and MBP-
Mto2-L133DL137D has been disrupted. This result confirms the hypothesis that the 
coiled-coil domain is involved in the Mto2-Mto2 interaction and is consistent with 
the results of the in vivo mapping. However, due to the proposed instability of Mto2 
dimers in vitro [section 4.2.8.1], this result does not distinguish between the 
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involvement of the coiled-coil in the Mto2 dimer association interaction or the Mto2 
dimerisation interaction.  
 
4.2.9.2 Introduction of the L133DL137D coiled-coil mutations did not disrupt 
the Mto2-Mto2 interaction in vivo 
 
 The result of the in vitro MBP pulldown assay in section 4.2.9.1 indicates that
disruption of the hydrophobic face of the coiled-coil disrupts the Mto2 self- 
interaction. To verify these results in vivo, the interaction of Mto2-13myc with the 
HFG-Mto2-L133DL137D was tested using anti-GFP immunoprecipitation. Mto2- 
L133DL137D was N-terminally tagged with HFG by recombination into a 
nmt81:HFG tagging vector (Matsuyama et al. 2004). The sequence was then  
integrated into an mto2∆ strain at the leu1 locus and was crossed with Mto2-13myc 
[KS1504]. All immunoprecipitations were performed in the absence of Mto1. Figure 
4.10 shows that co-precipitation of Mto2-13myc was not evident in strains that did 
not contain HFG-Mto2. However Mto2-13myc was observed in the eluate of both 
wild-type HFG-Mto2 and the HFG-Mto2-L133DL137D mutan  at a comparable 
level, which indicates that HFG-Mto2-L133DL137D is still able to interact with 
wild-type Mto2.  
 The in vitro interaction assay suggests that either the Mto2 dimer association 
or Mto2 dimerisation interaction has been disrupted by the Mto2-L133DL137D 
coiled-coil mutation. The presence of the HFG-tag hs previously been shown to 
disrupt tetramerisation in section 4.2.6, therefore as HFG-Mto2-L133DL137D can 
still self-interact, this indicates that the same int raction is disrupted by both the  



























Figure 4.9 The Mto2-Mto2 interaction is disrupted by Mto2 L133DL137D in 
vitro. [A] Helical wheel projections of residues 130 - 147 in WT Mto2 and Mto2-
L133DL137D showing the impact of the introduction of the polar residues into the 
hydrophobic face of the predicted coiled-coil. [B] Bacterial extract containing 
NusA-Mto2 and either MBP-Mto2 or MBP-Mto2-L133DL137D were incubated 
with amylose beads. MBP-Tea1 was used as a negative control. Eluates were 
analysed by 10% SDS-PAGE and the gel was stained with Coomassie. Image 
represents typical result from three experiments. 









































Figure 4.10 The Mto2-Mto2 interaction was not disrupted by HFG-Mto2 
L133DL137D in vivo. Extracts were incubated with anti-GFP linked Protein G-
Dynabeads [Strains KS516, KS4450, KS5572, KS5573, KS5574 and KS5575]. 
Eluates were analysed by 10% SDS-PAGE and the western blot was probed with 
anti-Mto1, anti-Myc [9E10] and anti-GFP. Signal from IRDye800 was detected by 
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coiled-coil mutation and the HFG-tag. Based on this idea, one would predict that 
both HFG-Mto2-L133DL137D and Mto2-L133DL137D would be dimeric through 
disruption of the dimer association interaction domain. 
 
4.2.9.3 Mto2-L133DL137D coiled-coil mutant is dimeric 
 
 To definitively examine the effect of the coiled-coil mutation on Mto2 
stoichiometry, Mto2-L133DL137D was subject to hydroynamic analysis. An 
untagged version of Mto2-L133DL137D was constructed by recombining the 
sequence containing 2 X TAG stop codons into a C-terminal nmt81:GFH tagging 
vector (Matsuyama et al. 2004). This sequence was then integrated at the leu1 locus 
into both mto1+ and mto1∆ backgrounds. The mto1∆ strain was crossed with nda3-
KM311 [KS1238] so that protein from both asynchronous culture and culture 
arrested in metaphase could be analysed. Figure 4.11, Panel A shows that Mto2-
L133DL137D from asynchronous extract peaked in fraction 5 in both mto1+ and 
mto1∆ strains, which corresponded to an S-value of 4.3 S [Appendix II]. Mto2-
L133DL137D from metaphase arrested cells, peaked in fraction 5.5, which 
corresponded to an S-value of 4.7 S. The S-values of both asynchronous and mitotic 
Mto2-L133DL137D correspond to a range similar to the dimeric complex formed by 
wild-type Mto2 during mitosis [Section 4.2.5]. HFG-Mto2-L133DL137D was also 
analysed. This analysis would reveal whether the same Mto2-Mto2 interaction that is 
affected by the coiled-coil mutation is also disrupted by the HFG tag. Figure 4.11, 
Panel B shows that when tagged with HFG both the coil d-coil mutant and wild-type 
proteins sediment with the same pattern, resulting in an S-value of 5.2 S. Analysis of 
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HFG-Mto2-L133DL137D by gel filtration chromatography [fig 4.11, Panel C] 
showed a small difference between HFG-Mto2 and HFG-Mto2-L133DL137D, where 
the mutant peaked in fraction 9 and wild-type protein peaked in fraction 10. When 
compared to the calibration curve [Appendix III] this corresponded to Stokes’ radii 
of 5.2 nm and 6.4 nm for wild-type and mutant protein r spectively. 
 
 These measurements were used to calculate the molecular weight for HFG-
Mto2-L133DL137D as described below:  
 
HFG-Mto2-L133DL137D: 
M = 6πηN • a • s / [1-νρ] 
M = 3909 • a • s 
M = 3909 • 6.4 nm • 5.2 S 
M = 130.1 kDa 
 
 The theoretical molecular weight of HFG-Mto2 is 74 kDa, this corresponds to 
1.76 molecules of HFG-Mto2-L133DL137D per oligomer. This demonstrates that, 
like wild-type HFG-Mto2, HFG-Mto2-L133DL137D was unable to form a tetramer 
and confirms that the same dimer-dimer interface is disrupted by the HFG-tag and 
coiled-coil mutations. Additionally, as monomeric Mto2-L133DL137D is not present 
in cells arrested in metaphase, this suggests that the same Mto2 dimer-dimer 
interface is also disrupted during mitosis. 
  
  







































Figure 4.11 Hydrodynamic analysis of Mto2-L133DL137D coiled-coil mutant 
demonstrates that it is dimeric. [Strains KS4450, KS4461, KS5784, KS5785 and 
KS5787]. Extracts were subject to sucrose density gradient centrifugation at 
55,000 rpm for 3.5 hr in a Beckman TLS-55. Fractions including the pellet [P] 
were analysed by 10% SDS-PAGE the western blot was probed with anti-Mto2 
antibody. [A] Integrated intensity of the signal from IRDye800 was measured 
using Odyssey V3.0. [B] The signal from GT-34-HRP was detected by ECL. [C] 
The extract was fractionated by gel filtration using a Superose-6 column [KS1]. 
The fractions were analysed by 10% SDS-PAGE the western blot was probed with 
anti-Mto2 antibody. Integrated intensity of the signal from IRDye800 was 
measured using Odyssey V3.0. The peak locations for molecular weight standards 
run on parallel fractionations are indicated [black rrows]. Standards in [C] 
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These results confirm the observation in section 4.2.9.2 which showed that the 
coiled-coil mutant does not fully disrupt the Mto2-Mto2 interaction in vivo, as the 
hydrodynamic analysis demonstrates that HFG-Mto2-L133DL137D is still able to 
form a dimer.  Although the sedimentation pattern of Mto1 was not examined in this 
analysis, the absence of HFG-Mto2-L133DL137D in the pellet fractions in all cases 
indicates that the Mto1-Mto2 interaction may have also been disrupted in this mutant 
[as predicted from the presence of the 60 – 80 S complex described in chapter three]. 
 
4.2.9.4 HFG-Mto2-L133DL137D phenocopies mto2∆ 
 
 To investigate the consequences of disrupting the Mto2 tetramer, the 
phenotype of the Mto2-L133DL137D mutant was analysed. In previous analysis I 
have demonstrated that dimeric Mto2 is sufficient to induce MT nucleation, therefore  
I predict that this mutant should not have any detectable changes in Mto2 function. 
In addition to analysis of nmt81:HFG-Mto2-L133DL137D this strain was crossed 
with a strain that contained Atb2-GFP to allow visualisation of MT dynamics 
[KS1409]. Figure 4.11, Panel A; movie 3C and 3D, show that HFG-Mto2-
L133DL137D localised to the SPB, eMTOC and along pre-existing MTs. However, 
this signal was considerably weaker than HFG-Mto2. Examination of the MTs 
showed that the phenotype was similar to m 2∆ whereby only 1 - 2 MT bundles 
were observed per cell. Astral MTs and the PAA were present, but the cytoplasmic 
MT bundles were thicker and appeared to be hyperstable i.e. bending round cell tips, 
resulting in the curved cell phenotype reminiscent of mto2∆. Cytoplasmic levels of 
HFG-Mto2-L133DL137D were relatively high compared to wild-type, which 
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suggests that a proportion of the protein was unable to ocalise, either through loss of 
the Mto1 interaction or through a reduction in protein stability/folding.  
 To address whether the mto2∆-like phenotype is due to a reduction of Mto2 
protein levels, HFG-Mto2 was placed under an nmt41 promoter, where it is predicted 
that a proportional increase in Mto2 that is able to localise to MTOCs should result in 
a partial rescue of MT nucleation levels. Measurement of the integrated intensity of 
the Mto2 signal showed that the levels of nmt81:HFG-Mto2-L133DL137D were 
higher than endogenous Mto2-GFP indicating that the mto2∆-like phenotype was not 
due to a lower amount of protein. Expression under th  nmt41 promoter gave a 4-fold 
higher level of protein expression than nmt81 and 7-fold increase in expression 
compared to the endogenous promoter [fig 4.12, Panel B and C].  The increased 
expression of nmt41:HFG-Mto2-L133DL137D resulted in a higher signal from the 
SPB, eMTOC and limited number of iMTOCs, as well as increasing the cytoplasmic 
signal, but this did not result in a detectable increase in the number of HFG-Mto2-
L133DL137D foci at non-SPB iMTOCs [fig 4.12, Panel A].  
 Failure of HFG-Mto2-L133DL137D to localise indicates that a large 
proportion of HFG-Mto2-L133DL137D may be unable to interact with Mto1 or 
interacts very weakly with Mto1. Those MTOCs that contained HFG-Mto2-
L133DL137D are likely to have unique properties that facilitate Mto2 localisation. 
This is probably related to Mto1 concentration at MTOCs; if the interaction of HFG-
Mto2-L133DL137D with Mto1 were significantly weakend, areas of high 
concentration of Mto1, such as the SPB, might be the only place where HFG-Mto2-
L133DL137D could be detected.  
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 The phenotype of Mto2-L133DL137D mutant demonstrates that the coiled-
coil domain is required for Mto2 to function, where it appears to be involved in both 
Mto2 dimer association and the Mto1- Mto2 interaction. The analysis of HFG-Mto2 
indicates that dimeric Mto2 is sufficient to promote MT nucleation. Therefore, the 
mto2∆-like phenotype of HFG-Mto2-L133DL137D suggests that it is disruption of 
the Mto1-Mto2 interaction and not disruption of tetramerisation that causes the 
mto2∆ phenotype, although these events are not mutually exclusive. 
  
4.2.9.5 The Mto1 / γ-TuC interaction is disrupted in the Mto2-L133DL137D 
coiled-coil mutant 
 
 To confirm biochemically whether the mto2∆ - like phenotype of HFG-Mto2-
L133DL137D results from the disruption of the Mto2-Mto1 interaction, an Mto1-
TAPS pulldown was performed. Figure 4.13 shows that t e levels of HFG-Mto2-  
L133DL137D in the pulldown were reduced compared to the levels of wild-type 
HFG-Mto2. This was also true for members of the γ-TuSC. This result suggests that 
the Mto1-Mto2 interaction has been weakened in the coil d-coil mutant, leading to 
the loss of interaction between Mto1 and the γ-TuC. This observation is consistent 
with the reduction in the nucleation efficiency and low level of HFG-Mto2-
L133DL137D localisation in the cell [fig 4.12, Panel A].  
 This result indicates that the coiled-coil domain of Mto2 is required for the 
Mto1-Mto2 interaction and that this interaction domain overlaps with a region of the 
protein that, based on the in vitro interaction assays, is also required for the 
interaction of Mto2 dimers.  
*  




































































































Figure 4.13 Analysis of Mto1 / γ-TuC interaction indicated that the interaction is 
perturbed in the Mto2-L133DL137D mutant. [Strains KS3915, KS4973 and 
KS4976]. The extracts were incubated with IgG-linked Dynabeads. The eluates 
were analysed by 10% SDS-PAGE and the western blot was probed anti-Mto2, 
anti-γ-tubulin [GTU-88], anti-Alp4 and anti-Mto1 antibodies. GT-34-HRP signal 
was detected with ECL. Image represents typical result obtained from two 
experiments. 
Figure 4.12 The phenotype of HFG-Mto2-L133DL137D is reminiscent of mto2∆. 
[Strains KS516, KS3915, KS4461, KS4463, KS4621 and KS5712] [A] Maximum 
projections of wide-field images of HFG-Mto2-L133DL137D expressed from 
nmt81 and nmt41 promoters in the presence and absence of Atb2-GFP. Also see 
movie 3C. Scale bar = 10 µm. [B] Total extracts, including two isolates of 
nmt81:HFG-Mto2-L133DL137D [left isolate used in microscopy], were analysed 
by 10% SDS-PAGE and the western blot was probed with an i-Mto2 antibody. 
[C] Integrated intensity of IRDye800 signal was measured using Odyssey V3.0. 
nmt81:HFG-Mto2-L133DL137D signal represents the aver g  signal of the two 
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4.3 SUMMARY OF RESULTS  
 
 The main objective of the research described in this c apter was to 
investigate the role of the Mto2-Mto2 interaction in Mto2 function and whether it 
contributes to the assembly of the Mto1/2 complex. Mto2 is required for 
multimerisation of the Mto1/2 complex containing full length Mto1, which is 
believed to consist of several copies of the Mto1/2 heterotetramer. I predicted that 
Mto2 multimerisation may drive this association.  
 Using purified recombinant protein and endogenous Mto2, I have shown that 
in the absence of Mto1, Mto2 forms a complex that is most likely to contain 4 
molecules of Mto2.  
 I observed that the oligomerisation state of Mto2 changes during the cell 
cycle, with Mto2 forming a dimer during mitosis. This was interesting as it supported 
the prediction that the Mto1/2 heterotetramers may be multimerising through the 
association of Mto2 dimers, and this interaction is then disrupted during mitosis. 
However, this idea was contradicted by the phenotypic analysis of HFG-Mto2, which 
forms a dimer in the absence of Mto1 but does not affect MT nucleation from non-
SPB iMTOCs. Additionally, as the Mto1-YFP foci present at iMTOCs in the 
presence of either CFP-Mto2 or untagged Mto2 were ess ntially the same, this 
suggests that tetramerisation of Mto2 does not contribute to the assembly of Mto1/2 
complexes at iMTOCs (Samejima et al. 2005). Based on these results I believe that 
tetrameric Mto2 is most likely to be the default form of Mto2 dimers when not 
present in complex with Mto1. For example, if the Mto1 interaction domains of the 
Mto2 dimers are strongly hydrophobic, then dimeric Mto2 may be unstable. This 
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interpretation also suggests that the Mto2 dimer-dimer interface overlaps with the 
Mto1 interaction interface [fig 4.14, Panel A]. 
  In summary, these results suggest that higher-order multimerisation of the 
Mto2 dimer is unlikely to facilitate the association f Mto1/2 heterotetramers. 
Alternatively, it is possible that Mto2 may promote Mto1/2 multimerisation through 
other mechanisms, e.g. inducing a conformational chnge in Mto1 that promotes 
Mto1 self-association. It is possible that recruitment of monomeric Mto2 may be 
sufficient to induce a conformation change in Mto1, but through Mto2 dimerisation 
the cell is able make this process more efficient. 
 To test whether Mto2 dimerisation is required for Mto2 activity, I attempted 
to make a monomeric version of Mto2, which required dentification and disruption 
of both the Mto2 dimeric interaction domain, and the Mto2 dimer association 
interface. Thus, I identified a coiled-coil domain in the N-terminal region of Mto2 
[114 – 147 aa]. Removal of a large section of Mto2 that contained the coiled-coil 
domain disrupted the interaction with full length Mto2 in vitro. Regions at the C-
terminus of Mto2 were also shown to be required for the Mto2-Mto2 interaction. It is 
likely that these two domains represent the Mto2 dimer c and Mto2 dimer association 
interaction domains. However, removal of either of these proposed interaction 
domains did not preserve the Mto2-mto2 interaction, possibly due to a decrease in 
stability from exposure of hydrophobic domains that would usually be internalised 
within the Mto2 tetramer.  
 In addition, this interpretation assumes that MBP-Mto2 is tetrameric. The 
oligomeric state of MBP-Mto2 was not determined in this analysis, as hydrodynamic 
analysis of purified MBP-Mto2 was found to assemble into large aggregates [data 
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not shown]. Given that a tag of a similar size [HFG] has been shown to disrupt the 
Mto2 tetramer, it is possible that MBP-Mto2 is also dimeric. Unfortunately, further 
analysis of the truncation mutants in vivo was hindered by a decrease in protein 
stability. 
 Targeted mutagenesis of the coiled-coil domain result d in a disruption of the 
Mto2-Mto2 interaction in vitro but not in vivo. I subsequently demonstrated by 
hydrodynamic analysis of yeast extract that the Mto2-L133DL137D coiled-coil 
mutant was dimeric in the absence of Mto1. The lost of Mto2 dimerisation in vitro 
may be a consequence of sub-optimal buffer conditions, particulary if the resulting 
dimer contains sensitive hydrophobic regions that would not normally be exposed 
through Mto2 tetramerisation/interaction with Mto1. However, it is unclear why this 
would not also be observed in yeast extract. 
 Previous analysis has demonstrated that dimeric protein does not affect MT 
nucleation, however, phenotypic analysis of the coiled-coil mutant revealed an 
mto2∆-like phenotype; a reduction in the number of cytoplasmic MTs, and MT 
nucleation was restricted to the SPB. As HFG-Mto2-L133DL137D did not efficiently 
localise to non-SPB iMTOCs, the mto2∆-like phenotype was predicted to result from 
a disruption of the Mto1-Mto2 interaction. This was confirmed biochemically, where 
it was also shown that mutation of the coiled-coil aused a reduction in the efficiency 
of the Mto1 / γ-TuSC interaction. 
 The hydrodynamic analysis of HFG-tagged Mto2 has indicated that it is 
dimeric. However, it is not clear whether the Mto2 dimeric interaction or the Mto2 
dimer association interaction domain has been disrupted. Depending on which 
interaction has been disrupted, the resultant Mto1 / HFG-Mto2 complex would be 
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very different.  Figure 4.14, Panel B and C, describe possible conformations of the 
Mto1 / HFG-Mto2 complex. The conformation described in Panel B is supported by 
the 50% reduction in HFG-Mto2 co-precipitated by Mto1-TAPS compared with 
untagged Mto2. This may have resulted from the disruption of dimeric interaction. 
This would result in an active complex that contained monomeric Mto2 and thus 
supports the theory that Mto2 induces a structural ch nge in Mto1 that in turn, 
promotes Mto1 multimerisation.  
 Alternatively, the 50% reduction in HFG-Mto2 pulled down by Mto1 may 
represent a reduction in the affinity of Mto1-Mto2 interaction as a consequence of 
the HFG tag. This would support the model described n Panel C. The conformation 
described in Panel C is also supported by the hydrodynamic analysis of the Mto2 
coiled-coil mutant. Both HFG-Mto2 and Mto2-L133DL137D are dimeric, suggesting 
that the dimer association domain and not the dimerisation domain has been 
disrupted. As HFG-Mto2-L133DL137D is dimeric this ind cates that the same 
interaction interface has been disrupted in both cases. As the coiled-coil mutations 
also disrupt the Mto1-Mto2 interaction, this suggests that the Mto2 dimer association 
domain overlaps with the Mto1 interaction domain. Interestingly, it was shown also 
that Mto2-L133DL137D does not form monomers in mitosis, this indicates that the 
same Mto2 dimer association/Mto1-Mto2 interaction dmain is disrupted by the 
coiled-coil mutation that is targeted in mitosis [fig 4.14, Panel D]. To definitively 
show that the Mto1 / HFG-Mto2 complex contains dimeric Mto2 the stoichiometry 
of the Mto1 / HFG-Mto2 complex would need to be determined. 
 Unfortunately, I was not able to construct monomeric Mto2 in this analysis. 
This form of Mto2 is required to assess the contribu ion of the Mto2-Mto2 
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interaction to the formation of an active Mto1/2 complex, with relation to Mto1/2 
heterotetramer multimerisation and the proposed activation of the γ-TuSC. However, 
I did identify the Mto1 interaction domain, which may be useful to the subsequently 
structural studies of the protein complex that are required to fully understand the 
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Figure 4.14 Schematic representation of Mto2 multimerisation. [A] In the 
absence of Mto1, Mto2 forms a tetramer. The A-B dimer-dimer interface forms 
the same region required to interact with Mto1. This interface is disrupted by 
the L133DL137D coiled-coil mutant. [B and C] HFG tagged Mto2 cannot 
form tetramers due to steric inhibition, however it can still interact with Mto1 
to a level sufficient to promote the Mto1 / γ-TuSC interaction. The HFG tag 
can disrupt either Mto2 dimer interaction [B] or the Mto2 dimer association 
[C]. If B were true, the introduction of the coiled-coil mutation would result in 
monomeric protein, if C were true, the HFG-tagged coiled-coil mutant would 
be dimeric. [D] During mitosis the same Mto2 dimer-dimer interaction is 
disrupted as is perturbed by both the HFG tag and the coiled-coil mutant. This 
is predicted to cause the disruption of the Mto1-Mto2 interaction. 
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CHAPTER FIVE 




 The mto2∆ phenotype demonstrates that the Mto1/2 complex is specifically 
required for MT nucleation from non-SPB iMTOCs. Nucleation does not occur from 
non-SPB sites during mitosis [e.g. on the nucleation envelope], indicating that the 
nucleation complexes containing Mto1/2 are either not assembled or not active 
during mitosis. This suggests that the Mto1/2 complex may be subject to some level 
of cell cycle-dependent regulation. Although phosphorylation of Mto1 has yet to be 
shown, phosphorylation of Mto1 homologs in other species has been documented. 
Dobbelaere and colleagues demonstrated that phosphorylati n of Cnn in D. 
melanogaster during mitosis is dependent on Polo kinase (Dobbelaer  et al. 2008). 
More recently it has been shown that SpPcp1, a paralogous protein required for 
nucleation from the nucleoplasmic face of the SPB, is also phosphorylated by PLK-1 
(Fong, C. S. et al. 2009a). When analysed by SDS-PAGE and western blot, Mt 2 is 
present as several isoforms, which indicates that Mto2 may also be phosphorylated.   
 In chapter four I have demonstrated that the oligomerisation state of Mto2 is 
altered in mitosis. I predict, based on evidence from this study, that this change in 
oligomerisation state may reflect the mitotic disruption of the Mto1-Mto2 interaction. 
It is possible that disruption of the Mto1-Mto2 interaction during mitosis may occur 
to allow a re-modelling of the Mto1/2-γ-TuC complex and subsequently re-
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localisation of the γ-TuC to the SPB. Alternatively, the Mto1/2 complex may be 
disrupted to allow a different Mto1 complex, which does not require Mto2, to 
assemble at the SPBs. 
   
5.1.2 Aims and Objectives 
 
 In this chapter I will attempt to confirm that Mto2 is phosphorylated, and 
investigate whether this correlates with a cell cycle-dependent regulation of Mto2. I 
will also examine the significance of Mto2 phosphorylation on the Mto1-Mto2 
interaction. To do this I will take the following approaches: 
 
• Confirm that Mto2 is phosphorylated using phosphatase treatment. 
• Follow Mto2 phosphorylation over the cell cycle. 
• Analyse the effect of Mto2 phosphorylation on the Mto1-Mto2 interaction. 
• Use bioinformatic and biochemical phosphorylation mapping techniques to 
identify phosphorylated residues.  
• Create phospho-mutants to confirm the significance of Mto2 phosphorylation 
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5.2 RESULTS 
 
5.2.1 Identification and Characterisation of Mto2 phosphorylation 
 
5.2.1.1 Mto2 is phosphorylated 
 
 Previous analysis of Mto2 by western blotting has demonstrated that it 
migrates as several isoforms by SDS-PAGE (Samejima et al. 2005). These isoforms 
could result from a number of post-translational modifications such as 
phosphorylation, ubiquitination, SUMOylation, acetyla ion, and biotinylation. To 
confirm phosphorylation of Mto2, fission yeast extract was treated with purified 
phosphatase, heat-inactivated λ-PPase and/or the phosphatase inhibitors. Figure 4.1 
shows that when extract was treated with λ-PPase, the Mto2 isoforms collapse into a 
single, fast migrating form. This did not occur when heat-inactivated phosphatase 
was added, and the de-phosphorylation was incomplete when phosphatase inhibitors 
were also added. This result indicates that the isoforms of Mto2 are due to 
phosphorylation.  
 
5.2.1.2 Mto2 phosphorylation is cell cycle-dependent 
 
 Mto2-dependent MT nucleation from non-SPB iMTOCs is pecific to 
interphase and MT nucleation during mitosis is restricted to the SPB, a process that 
does not require Mto2. This suggests that the Mto1/2 complex may be subject to cell 
cycle regulation.  

























Figure 5.1 λ-protein phosphatase treatment of fission yeast confirms that Mto2 is 
phosphorylated. Total extracts from KS516 were treated with λ-PPase/heat-
inactivated λ-PPase [HI] and/or phosphatase inhibitors. The extracts were analysed 
by 10% SDS-PAGE and the western blot was probed with an i-Mto2 antibody. The 
IRDye800 signal was detected using Odyssey V3.0. WCE = whole cell extract. 
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 It is likely that this regulation is instigated through phosphorylation therefore 
Mto2 phosphorylation was examined over the cell cyce. Phosphorylation of Mto2 
was analysed in a strain containing a temperature sensitive allele of the cell cycle 
regulator Cdc25 [cdc25-22ts], which at restrictive temperature blocks the cells in G2 
(Russell et al. 1986; Gould, K. L. et al. 1989). Following incubation at the restrictive 
temperature between 50 – 80 % of the culture was arre ted in G2 [indicated by the 
appearance of highly elongated cells [data not shown]. Upon return to the permissive 
temperature and release into mitosis, cells were harvested at 20 min intervals. Figure 
5.2, Panel A shows the septation assay, which measur s the proportion of cells in the 
culture that have formed septa. The septation index peaked at 60 min, at which point 
the synchrony of the culture was approximately 78% [n = 200]. Following the first 
septation peak, the cells entered a second mitosis at 140 min. Figure 5.2, Panel B 
shows that there was a distinct mobility shift as the cells proceeded though the cell 
cycle, which I interpret to be phosphorylation based on the results in section 5.2.1. 
Notably, there was an increase in hyperphosphorylated Mto2 20 min after G2 release, 
corresponding to the time of entry into mitosis. These slower migrating isoforms are 
replaced by faster migrating de-phosphorylated isoforms of Mto2 as the septation 
index drops and cells enter interphase.  
 The uniformity of the non-specific band [*] suggests that the increase in 
Mto2 signal at 140 min is not due to loading error. Alternatively, it may have 
resulted from an enrichment of two or more phosphorylation states at this point, 
which then disperse into a range of phosphorylated forms as the cells pass through 
mitosis. At t = 160 the hyperphosphorylated isoforms of Mto2 observed at entry into 
the first mitosis returned, however, the signal from the slowest migrating bands was  

























Figure 5.2 Analysis of Mto2 phosphorylation over the cell cycle indicates that 
Mto2 is hyperphosphorylated in mitosis. [A] Septation ndex of cell samples taken 
every 20 min after release from cdc25-22ts G2 arrest based on fluorescent brightener 
staining. [KS1280]. [B] Extracts made from samples taken from synchronous 
culture were analysed by 10% SDS-PAGE and the western blot was probed with 
anti-Mto2 antibody. Signal from GT-34-HRP secondary ntibody was detected by 
ECL. Non-specific band indicates loading [*]. Time is indicated in minutes. Image 
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significantly weaker than the first mitosis. This likely to be caused by a reduction in 
cell synchrony by the time cells pass through the second mitosis.  
This result indicates that Mto2 phosphorylation is regulated in a cell cycle specific 
manner. 
  
5.2.1.3 The Mto1-Mto2 interaction is disrupted in a metaphase arrest 
 
 The most likely mechanism by which Mto2 phosphorylation down-regulates 
the activity of the Mto1/2 complex during mitosis, i  through the disruption of the 
Mto1-Mto2 interaction. To test this idea, Mto2 co-precipitation by Mto1-TAPS was 
compared between asynchronous cell culture and cells arrested in metaphase using 
nda3-KM311. Figure 5.3 shows that the amount of Mto2 pulled down by Mto1-
TAPS in mitotic extract is significantly reduced compared to Mto2 from 
asynchronous extract. The small amount of Mto2 present in the eluate of the mitotic 
pulldown is likely to be comparatively dephosphorylated Mto2 that has escaped the 
arrest. Examination of the supernatants from the pulldown demonstrated that the 
hyperphosphorylated Mto2 observed in the input of the nda3-KM311 extract did not 
bind to Mto1-TAPS [data not shown].  
 Figure 5.3 shows a clear difference in the ability of dephosphorylated and 
phosphorylated Mto2 to interact with Mto1, where hyperphosphorylation of Mto2 
appears to disrupt the Mto1-Mto2 interaction. This re ult confirms the prediction that 
the Mto1-Mto2 interaction is disrupted in mitosis. However, this result does not 
correlate with observations in vivo, as fluorescence microscopy has shown that 
Mto1-YFP and Mto2-CFP co-localise throughout the cell cycle (Samejima et al. 
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2005). It is possible that Mto2 associates with the γ-TuSC independently of Mto1, 
although, this interaction is very weak (Samejima et l. 2008). Further investigation 
is required to determine the mechanism by which Mto2 localises to the SPB during 
mitosis. 
 
5.2.1.4 Analysis of the mitotic disruption of the Mto1-Mto2 interaction using 
cdc25-22ts G2
 block and release 
 
 In addition to an nda3-KM311 arrest, the Mto1-Mto2 interaction was 
examined over a cdc25-22ts G2 block and release, where the interaction could be 
followed over the entire cell cycle. A cdc25-22ts strain containing Mto1-TAPS 
[KS5795] was arrested in G2. On return to permissive temperature, samples were
harvested at 20 min intervals. Figure 5.4, Panel A shows the septation index of cell 
samples taken at 20 min time points, indicating that septation peaked at 60 min [70% 
synchrony].  
 Western blot analysis of the Mto2 inputs showed a similar pattern to that 
observed in Figure 5.2, Panel B, in which Mto2 hyper- hosphorylation occurred as 
cells entered mitosis, in both the first and second mitoses after G2 release. 
Examination of the eluates from the Mto1-TAPS precipitation showed that despite a 
uniform level of Mto1-TAPS, the Mto2 signal was lost at t =20 and t = 140 / t = 160, 
which corresponds to the G2 / M transition of the first and second cell cycles, 
respectively [fig 5.4, Panel B]. Samples have been under-loaded at t = 60, resulting 
in a weaker signal than expected. These results confirm previous observations and 
show that the Mto1-Mto2 interaction is disrupted during mitosis, which correlates  

























Figure 5.3 The Mto1-Mto2 interaction is disrupted during da3-KM311 
metaphase arrest. Extracts from asynchronous and metaphase-arrested cells were 
incubated with IgG-Dynabeads [Strains KS516, KS3524 and KS3575]. The 
eluates were analysed by 10% SDS-PAGE and the western blot was probed with 
anti-Mto1 and anti-Mto2 antibodies. The signal from GT-34-HRP secondary 
antibody was detected by ECL. A / S – asynchronous extract. Image represents a 








































































Figure 5.4 Analysis of the Mto1-Mto2 interaction in synchronised culture shows 
that it is disrupted in mitosis. [A] The septation index of cell samples taken every 
20 min after release from cdc25-22ts G2 arrest based on fluorescent brightener 
staining. [B] Extracts made from sample of synchronous culture were incubated 
with IgG-Dynabeads. The eluates were analysed by 10% SDS-PAGE and the 
western blot was probed with anti-Mto1 and anti-Mto2 antibodies. Signal from 
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with Mto2 hyper-phosphorylation. However, it remains unclear whether Mto2 
phosphorylation directly causes the disruption of the Mto1/2 complex 
or whether phosphorylation is responsible for upstream events that lead to Mto1/2 
disruption, e.g. recruitment of proteins that compete for Mto1 binding. It is also 
possible that Mto2 phosphorylation is purely coincidental and does not affect  
Mto1/2 complex formation. 
 
5.2.1.5 The Mto1/2 complex is disrupted following CDK1-Cyclin B treatment 
 
 In order to test whether phosphorylation of the Mto1/2 complex is directly 
responsible for its mitotic disruption, purified Mto1/2 complex was incubated with 
purified recombinant human CDK1-Cyclin B. Mto1 [1-800]-TAPS was used in this 
experiment as a higher yield of protein can be recov red compared to full length 
Mto1-TAPS (K. Sawin, personal communication). Figure 5.5 shows that when the 
complex is treated with CDK1-Cyclin B, Mto2 becomes phosphorylated, as 
demonstrated by the appearance of slower migrating isoforms similar to those 
observed during an da3-KM311 metaphase arrest. Compared with untreated Mto1/2 
complex, where the bulk of Mto2 remained associated with Mto1, the majority of 
phosphorylated Mto2 was present in the supernatant, h ving dissociated from Mto1 
[1-800]-TAPS.  
 This result confirms that phosphorylation of the Mto1/2 complex directly 
causes the dissociation of Mto2 from Mto1. This analysis does not indicate whether 
phosphorylation of Mto1 or Mto2 [or both] causes the Mto1/2 complex to dissociate. 
In order to determine if phosphorylation of Mto1 contributes to the disruption of the  

























Figure 5.5 Treatment of purified Mto1/2 complex with CDK1-Cyclin B causes 
Mto2 to dissociate. [Strains KS3476 and KS1956]. Mto1/2 complex that had been 
purified on IgG-Dynabeads was incubated 100 U of CDK1-Cyclin B. Eluates and 
supernatants were analysed by 10% SDS-PAGE and the west rn blot was probed 
with anti-Mto1 and anti-Mto2 antibodies. IRDye800 signal was detected using 
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complex, individually purified Mto1 could be treated with CDK1-Cyclin B before 
the interaction with Mto2 is assayed. Due to the nature of this experiment it is also 
possible that incubation with CDK1-Cyclin B may phosphorylate the Mto1/2 
complex in a non-physiological manner. This may artificially disrupt the Mto1-Mto2 
interaction. The co-localisation of Mto1 and Mto2 during mitosis means that it is not 
possible to test whether the disruption of the Mto1-Mto2 complex occurs in vivo 
through methods such as fluorescence resonance energy transfer [FRET]. However, 
if one can isolate specific Mto2-dependent processes that are interrupted in mitosis, 
one can infer that the Mto1-Mto2 interaction may have been disrupted. 
 
5.2.1.6 Mto2-dependent localisation Mto1 [1-549]-GFP at the nuclear 
envelope 
 
 Removal of Mto1 C-terminal targeting domains [1051 – 115 aa] prevents 
Mto1 from localising to the SPB and eMTOC, and therefore Mto1 [1-1051] is only 
found at iMTOCs along the nuclear envelope and along pre-existing MTs (Samejima 
et al., manuscript in preparation). Further truncation generates Mto1 [1-800], which 
only localises to iMTOCs on the nuclear envelope and to a small number of MT 
minus ends that are ejected from the surface of the nucleus and become bundled into 
adjacent MTs (Sawin et al., data unpublished). Ongoing work by E. Lynch in our
laboratory has shown that the nuclear envelope localisation is maintained upon 
further truncation of the C-terminus to Mto1 [1-549], however, this localisation is 
lost in Mto1 [1-500]. This correlates with disruption of the Mto2 interaction domain 
[461 – 549 aa] (Samejima et al. 2005).  
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 To confirm that Mto1 [1-549]-GFP localisation at the nuclear envelope is 
dependent on Mto2, I created strains that contained Mto1 [1-549]-GFP expressed 
from both endogenous promoter and over-expressed from the nmt81 promoter, in 
combination with mto2+ [KS5349/KS5609], nmt81:mto2 [KS5647/KS5801] and 
mto2∆ [KS5802/KS5803]. Figure 5.6 shows that Mto1 [1-549]-GFP failed to localise 
to the nuclear envelope in mto2∆ cells whether over-expressed or expressed from the 
endogenous promoter [fig 5.6 Panel B, I and II]. In the presence of endogenous Mto2 
the level of Mto1 [1-549]-GFP present on the nuclear envelope did not increase when 
Mto1 expression level was up-regulated [fig 5.6 Panel B, III and IV]. Only when 
Mto2 was also up-regulated did over-expressed Mto1 [1-549]-GFP localise to the 
nuclear envelope [fig 5.6 Panel B, V and VI].  
 These results suggest that Mto1 [1-549]-GFP localisation to the nuclear 
envelope is dependent on Mto2, most likely as a consequence of assembly into the 
Mto1/2 complex, and that the quantitative levels of Mto2 protein limit the amount of 
Mto1 [1-549]-GFP that is able to localise. It is not known what the Mto1/2 complex 
binds to at the nuclear envelope. A screen was performed in the laboratory of P. 
Nurse to identify proteins involved in the establishment of the MT cytoskeleton. 
They identified the nucleoporin-like protein Amo1 (Pardo et al. 2005). Due to its 
punctate localisation at the nuclear envelope, Amo1 is a potential Mto1 targeting 











































































Figure 5.6 Mto1 [1-549]-GFP localisation to the NE requires Mto2. [A] 
Schematic map of Mto1 depicting PAIRCOIL2 predicted coiled-coil domains 
[pink] and regions of overlap [purple] with protein interaction domains [blue]. 
Amino acid residue numbers are indicated including the Mto1 [1-549] truncation.  
[B, I-VI] Maximum projection of confocal images of Mto1 [1-549]-GFP 
expressed under nmt81 and nmt41 promoters in the presence and absence of Mto2. 
Scale bar = 10 µm.  
Figure 5.7 Mto1 1-549-GFP localisation at the NE is disrupted in mitosis. 
Maximum projection of confocal images taken of Mto1 [1-549]-GFP expressed 
under an nmt41 promoter. Images were taken from different cells representing cell 
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5.2.1.7 Localisation of Mto1 [1-549]-GFP at the nuclear envelope is disrupted 
in mitosis 
  
 Mto1 [1-549]-GFP localisation at the nuclear envelop  requires Mto2. 
Biochemical analysis has demonstrated that the Mto1- to2 interaction is disrupted 
during mitosis, therefore I predict that the nuclear nvelope localisation of Mto1 [1-
549]-GFP is also cell-cycle dependent. Figure 5.7 shows a montage of confocal 
images, each panel representing different stages of interphase and mitosis. Compared 
to the interphase cell [top], signal of Mto1 [1-549]-GFP is depleted at the NE during 
all stages of mitosis. The weak signal at the start of mitosis disappears until the end 
of anaphase. This result provides in vivo evidence to support the conclusion that the 
Mto1-Mto2 interaction is disrupted in mitosis. 
 
5.2.1.8 Mto2 is not required for the Mto1 / γ-TuC interaction at the SPB or 
during mitosis 
 
 Mto2 is required for Mto1 to efficiently interact with the γ-TuSC (Samejima 
et al. 2008). In addition, my work has demonstrated that t e Mto1-Mto2 interaction 
is disrupted during mitosis. Therefore, I investigated whether the requirement of 
Mto2 for an efficient Mto1 / γ-TuSC interaction is specific for the nucleation 
complex formed in interphase. As Mto2 is not required for nucleation from the SPB 
during mitosis, I predict that Mto1 / γ-TuSC interaction is not affected by the loss of 
Mto2. This was tested using a co-immunoprecipitation of Mto1-TAPS in 
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asynchronous culture and a3-KM311 metaphase-arrested cells in both mto2+ and 
mto2∆ backgrounds.  
 The interaction of the γ-TuSC with a C-terminal truncation of Mto1 [1-1051] 
was also examined. As Mto1 [1-1051] is unable to loca ise to the SPB/eMTOC this 
would indicate whether the predicted requirement of Mto2 for the Mto1 / γ-TuSC 
interaction during interphase is specific to the loca isation of the complex to the SPB.   
Figure 5.8, Panel A-F shows the integrated intensities of eluates from the Mto1-
TAPS co-precipitation normalised against Mto1-TAPS in the pulldown and signal 
from the untagged control. The corresponding western blot is shown in figure 5.8, 
Panel F. Comparison of Mto1-TAPS eluates from both asynchronous culture showed 
that, in mto2∆, the interaction efficiency of γ-TuSC with full length Mto1 was 
reduced by approximately five-fold compared to mt 2+. However, this reduction was 
not reflected in the metaphase arrest, which showed that the level of γ-TuSC is not 
affected by the loss of Mto2. This indicates that Mto2 does not contribute to the 
interaction between Mto1 and the γ-TuC during metaphase. 
 Interestingly, in asynchronous extract both Mto2 and the γ-TuSC interacted 
more efficiently with Mto1 [1-1051] than with full length Mto1. This may be a 
consequence of a redistribution of Mto1 [1-1051] molecules away from the protein 
dense SPB into the smaller iMTOCs where it may be more accessible to Mto2 and 
the γ-TuC. 
 In metaphase arrested extract only dephosphorylated M o2 that has escaped 
the arrest interacted with Mto1-TAPS and Mto1 [1-105 ]-TAPS. The level of 
dephosphorylated Mto2 was particularly high in the Mto1 [1-1051]-TAPS pull down. 
This is likely to have caused the efficiency of theγ-TuSC / Mto1 [1-1051]-TAPS   


































































































































































































































































































































































































































Figure 5.8 The Mto1 / γ-TuSC interaction during mitosis does not require Mto2 and 
is not effected by SPB localisation. [A] Schematic map of Mto1 depicting 
PAIRCOIL2 predicted coiled-coil domains [pink] and regions of overlap [purple] 
with protein interaction domains [blue]. Amino acid residue numbers are indicated 
including the Mto1 [1-1051] truncation. The Mto1-TAPS purifications were 
performed using the following strains: KS516, KS3475, KS3524, KS3575, KS3577, 
KS4323, KS5578, KS5579, KS5580. [G] The eluates were analysed by 10% SDS-
PAGE and the western blot was probed with anti-Mto1, anti-Mto2, anti-Alp6 and 
anti-γ-tubulin [GTU-88] antibodies. [B-F] Integrated intesities of the IRDye800 
signal were measured using Odyssey V3.0. Values were normalised relative to 
levels of protein in the untagged negative control and levels of Mto1-TAPS in the 
eluates. Mto2D = mto2∆. Image represents a typical result from two experimnts. 
G 
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interaction to be artificially high compared to full length Mto1. This result suggests 
that the effect of redistributing Mto1 away from the SPB is not likely to change the 
indispensability of Mto2 for the Mto1/γ-TuSC interaction during mitosis. 
 This result indicates that the Mto1 / γ-TuC complex formed at the SPB in 
metaphase is different to the nucleation complex active at non-SPB iMTOCs during 
interphase. There is no evidence to suggest that the metaphase complex is a 
functional nucleator as MTs are not nucleated from the cytoplasmic face of the SPB 
during metaphase, however, as mto2∆ cells are still able to nucleate astral MTs, this 
would suggest that the Mto2 is also not required for Mto1 to form an active 





5.2.2 Identification of Mto2 phosphorylation sites 
 
 Evidence collected in this chapter indicates that Mto2 phosphorylation [and 
potentially Mto1 phosphorylation] during mitosis causes Mto2 to dissociate from the 
Mto1/2 complex. In order to determine whether Mto2 phosphorylation is the primary 
cause of this disruption, the phosphorylation sites of Mto2 were identified using a 
number of different biochemical and bioinformatics based methods. This analysis 
may also provide insight to the identity of the Mto2 kinase.  
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5.2.2.1 Identification of phosphorylation sites through alignment with 
homologous sequence from Schizosaccharomyces japonicus 
 
 Sequence conservation is a powerful tool to identify areas of a gene that are 
important for function, as these regions are less tolerant to changes in nucleotide and 
amino acid sequence. The S. japonicus genome was used to identify conserved 
regions of Mto2 as it was the closest relative to S. pombe whose genome sequence 
was publically available at the time this analysis was performed. The S. japonicus 
homolog of S. pombe Mto2 was identified as SJAG_03264.2 by performing a PSI-
BLAST search (Altschul et al. 1997) of the S. japonicus genome. The alignment of 
the sequences is shown in Figure 5.9. Five conserved S/T-P putative phosphorylation 
sites were identified [T35, S179, S220, S366 and T394] and are highlighted in red. 
These sites are closely related to the CDK1 kinase consensus sequence of [S/T]–P–
X–[R/K] (Endicott et al. 1999). 
 
5.2.2.2 Phosphorylation site prediction by NetPhos 2.0 
 
 The NetPhos 2.0 server is a phosphorylation prediction software developed at 
the Centre for Biological Sequence Analysis, University of Denmark (Blom et al. 
1999). NetPhos 2.0 gives each S/T/Y residue a score describing the likelihood that it 
is phosphorylated, as well as identifying the presence of that residue within kinase 
consensus sites. 45 out of 106 S/T/Y residues of Mt2 had a NetPhos score greater 
than 0.75. The scores for each S/T/Y residues are listed in Appendix IX.  
 

























CLUSTAL 2.0.10 multiple sequence alignment 
 
 
Spombe          MSEHNYQSDREVAEDPFLNYEASANQLSSNSRES-----------------TPRGSPWRA 43 
Sjaponicus      MSRLSFSPKKQLDADPFLDYEASTGLSERSHRTVGSFLHDSVSENVNEEPRTPFFGPNSS 60 
                **. .:...:::  ****:****:.  . . *                   **  .*  : 
 
Spombe          GMRSASLMTEPLEDSMYSDNNYLDNG-------VSFTKDENPLYSPSWPSLADANVNSMK 96 
Sjaponicus      SFQAQSIFSPNSTFQGKSQQNLRPSSQRRGKFLFQHARSETTNVYGRFASSSPTRPRQLD 120 
                .::: *:::     .  *::*   ..       ...::.*..     :.* : :. ..:. 
 
Spombe          SNNAIQEHKAAKFVSEKSLEKVSTADN-NLVLQELENLRERLNQVELQLSERPSSYLGYH 155 
Sjaponicus      LALTMNDNNSDTALERATQQLSLTSPQPQVRSRELEHTVPNPATNEFIFRELRSLRERLG 180 
                   ::::::: . :.. : :   *: : ::  :***:   .    *: : *  *       
 
Spombe          NNLSPYRSPNSYPSLLPSTHSPHSPAPLSTMQTALMRLRTYHPSPIILKPVEQAVNHAIT 215 
Sjaponicus      QVEAELARTRMEATTTLTRASLSSPVPAQKLQLALQRLASHHPPDDVLKPLERAARNALL 240 
                :  :    ..  .:   :  *  **.* ..:* ** ** ::**.  :***:*:*..:*:  
 
Spombe          LVNTSPSSVVDALCRSLAELCLGLVQEAIDASILSQQESSNSLDLVRHTPPLN-YTSSVD 274 
Sjaponicus      LTQTSPGPTVDALCRSLTETCLGLVQECLNARMLADESQTPRLPGPNGEEEMSGYATITA 300 
                *.:***...********:* *******.::* :*:::..:  *   .    :. *:: .  
 
Spombe          SSPQRMASDSYGRPSLHLNDPFPSVDLQSNELSHHNVRTTLFSDDSRFHSKIHTHSTPPS 334 
Sjaponicus      ASTGESGRNSYSFPVPTTAFTAPTLTNTNNNNNSNNEGLGRFSNAHTIMTTPRSQRIIPP 360 
                :*. . . :**. *      . *::   .*: . :*     **:   : :. :::   *. 
 
Spombe          QMYSAASHFR---YRSDPSTRHVSNSTNKSSLHPSPTSLRVAHPIIPQRASPASQSFP-- 389 
Sjaponicus      TSSPLSDRVKTPVLRDRDGDQMPASSRFQSKISLSPNRELRASPVSPRSPPFHRKRFSKT 420 
                   . :.:.:    *.  . :  :.*  :*.:  **.    * *: *: ..   : *.   
 
Spombe          -------------------SLQDTPSP---------------- 397 
Sjaponicus      ASSNVLVTPANAYAQPPTHSAQSSPTRFSLIDKVLSGHRDSLS 463 
                                   * *.:*:                  
 
Figure 5.9 Sequence alignment of Mto2 homologs from S. pombe and S. 
japonicus. BLAST search against the S. japonicus sequence database identified 
SJAG_03264.2 as a homologue of Mto2. The alignment was generated by Clustal 
W2 (Larkin, 2007 #561) where SJAG_03264.2 and Mto2 have a sequence identity 
score of 16.1%. The five identified conserved S / T - P putative phosphorylation 
sites are labelled in red. 
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5.2.2.3 Identification of Mto2 residues within kinase consensus sites  
 
 An additional method for predicting Mto2 phosphorylation sites was to 
identify residues within consensus sites of mitotic kinases. Three CDK1 kinase 
consensus sites [S/T]–P–X–[R/K] (Endicott et al. 1999) were identified. 17 sites 
were identified that contained degenerate Aurora A consensus sites following [S/T]-
X[1,2]-[R/K] or [R/K]-X[1,2]-[S/T], where the strict consensus would contain the 
basic residues on both side of the phospho-serine/threonine (Dephoure t al. 2008). 
28 sites were identified that contained degenerate POLO consensus sequence 
following [S/T]-X[1,2]-[D/E] or [D/E]-X[1,2]-[S/T], where the strict PLK1 
consensus sequence would contain acidic amino acidson both sides of the phospho-
serine/threonine (Nakajima et al. 2003; Dephoure t al. 2008). These are labelled in 
Appendix IX. Interestingly, upon further examination f the sequence, 3 polo-box 
domain [PDB] interaction sites were identified based upon the following consensus 
S-[S/T]-P-[X/R] (Elia et al. 2003b). These were T35, S267, and T331. These 
domains are the sites of Polo kinase binding, and are primed by phosphorylation 
[often by CDK1] prior to Polo association (Elia et al. 2003b). 
 
5.2.2.4 Identification of fungal homologs of Mto2 
 
 Following the release of the S. japonicus genome, the genome sequences of 
several other fungal species, including Schizosaccharomyces octosporus were also 
released. PSI-BLAST was performed using the Mto2 sequence as bait to identify a 
number of additional Mto2 homologs. The sequences listed in table 5.3 are a 
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selection of fungal genes which gave HSPs with an e-score < 1e-02. As the annotation 
of these sequences has been generated automatically through sequence similarity to 
known proteins, the majority of Mto2 homologs have be n assigned as putative 
LPXTG-cell wall anchor domain proteins. The LPXTG motif is found in bacterial 
cell wall proteins therefore it has no relevance to M 2 function in yeast. The 
sequences from the fungal homologs were used to generate a phylogenetic tree to 
demonstrate the relative sequence divergence between Mto2 homologs [fig 5.10]. 
The S. octosporus sequence SOCG_01774.2, was the closest sequence with f er 
amino acid substitutions. Amino acid sequences were ent red into the MegAlign 
software program [Lasergene 8, DNAstar] and the alignment report is shown in 
Appendix V. This alignment was used to assess whether S/T/Y residues were 
conserved i.e. if present in 8/15 of the homologs. 41 out of 106 S/T/Y residues were 
conserved in the fungal alignment and 11 of these ridues were S/T-P sites. 3 out of 
5 of the S/T–P residues conserved in the alignment with SJAG_03264.2 were also 
conserved in the large scale fungal alignment. 
 
5.2.2.5 Identification of 25 phosphorylation sites using two-step denaturing 
purification of Mto2-HTB and mass spectrometry analysis 
 
 A tandem affinity tag that contained 6 x histidine residues and a biotinylation 
site was developed in the laboratory of Peter Kaiser (Tagwerker et al. 2006). This 
permits consecutive purification on Ni2+-bound and streptavidin-linked resins under 
strong denaturing conditions. These conditions are expected to preserve 
phosphorylation, as a result of inactivation of phosphatases.   










Magnaporthe grisea XP_359559 hypothetical protein MGG_05218 5e
-05 
Neurospora crassa XP_962857 hypothetical protein NCU06253 4e
-05 
Gibberella zeae XP_387151 hypothetical protein FG06975.1 4e
-05 
Penicillium marneffei XP_002144160 
LPXTG-motif cell 
wall anchor domain 
protein, putative 
2e-07 
Coccidioides immitis XP_001248197 hypothetical protein CIMG_01968 8e
-06 
Ajellomyces 





XP_002562312 Pc18g04810 5e-08 
Aspergillus nidulans XP_662149 hypothetical protein AN4545.2 6e
-05 
Aspergillus clavatus XP_001272930 
LPXTG-motif cell 
wall anchor domain 
protein, putative 
2e-05 
Neosartorya fischeri XP_001265845 
LPXTG-motif cell 
wall anchor domain 
protein, putative 
2e-05 
Aspergillus fumigatus XP_749412 
LPXTG-motif cell 
wall anchor domain 
protein 
3e-06 







Mto2   9.2e
-43 
Aspergillus terreus XP_001218235 conserved hypothetical protein 3e
-06 
Aspergillus flavus XP_002379344 conserved hypothetical protein 1e
-04 
Table 5.1 Fugal homologs of Mto2. Genes were identified by BLASTP searches. 
The sequence hits which gave HSP e-scores < 1e-2 are included. Full alignment is 
available in Appendix V. 

























Figure 5.10 Phylogenetic tree generated from ClustalW alignment of Mto2 
homologs. The sequences from homologs listed in table 5.1 were used to generate 
a phylogenetic tree that represents the divergence of the Mto2 sequence.  
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 A two-step purification was performed as described in section 2.4.5.2.1. Two 
bands of a size corresponding to Mto2-HTB were excised from the gel, digested with 
trypsin, and analysed by the LTQ-Orbitrap Mass Spectrometer [fig 5.11, Panel A].  
 88 peptides from Mto2 were identified, and from these peptides 33 amino 
acid residues were shown to be phosphorylated. 25 of the predicted sites had an 
Identity score > 20 and were considered for further analysis. These sites included 19 
serines, 4 threonines, and 2 tyrosines. The peptide assignments and identity scores 
for each residue are listed in table 5.1. If residues were identified in more than one 
peptide the highest identity score is given. Two of the serine residues had been 
previously identified as potential phosphorylation sites based on sequence alignment 
with S. japonicus SJAG_03264.2 [S179 and S366], and 10 residues were id ntified 
in the large-scale fungal alignment.  
 
5.2.2.6 Identification of two mitosis specific phosphorylation sites using 
SILAC 
 
 I have previously shown by western blot that different isoforms of Mto2 exist 
during interphase [fig 5.2], indicating that Mto2 phosphorylation is not specifically a 
mitotic event. In order to identify mitotic phosphorylation sites, Stable Isotope 
Labelling of Amino acids in Cell culture [SILAC] was used to distinguish between 
phospho-peptides from mitotic and asynchronous Mto2. SILAC is a method used for 
quantitative proteomics developed in the laboratory of M. Mann (Ong et al. 2002). 
SILAC has been used for many proteomic applications e.g. mapping of protein-
protein interactions and phosphorylation sites, and quantitation of translation and 
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protein degradation (Gruhler t al. 2005; Guerrero et al. 2006; Neher et al. 2006; 
Schwanhausser et al. 2009). SILAC is an accurate method for quantitative mass 
spectrometry as the isotopes are introduced at an early stage of sample preparation 
and have negligible effects on cell growth. Research performed by C. Bicho in our 
laboratory has developed a methodology that has enabl d SILAC to be applied to 
fission yeast (Bicho et al., manuscript in preparation).  
 A second mapping was performed on Mto2 isolated from both heavy labelled 
[13C615N4-arginine and 13C615N2-lysine] asynchronous culture and ‘light’ non-
labelled culture arrested in metaphase using an nd 3-KM311 arrest. Following the 
arrest, normalised numbers of cells from the two cultures were mixed and the 
resultant extract was used in a single step purificat on using an Mto2-TAPS binding 
to IgG-Dynabeads. Figure 5.12, Panel A shows the Coomassie stained SDS-PAGE 
gel containing a band representing purified Mto2-TAPS. The band was excised from 
the gel, digested with trypsin and analysed by the LTQ-Orbitrap Mass Spectrometer.
 16 unique phosphorylation sites were found in 18 peptides [fig 5.12, Panel B; 
table 5.2]. The ratio of H/L is the quantitative amount of heavy labelled peptide to 
unlabelled peptide and reflects the ratio of interphase phosphorylation to mitotic 
phosphorylation. Therefore, ratios < 1 represent residues phosphorylated during 
mitosis, and ratios > 1 represent sites phosphorylated during interphase. Ratios were 
normalised relative to the ratio of total heavy to light protein present in the sample. 
The significance score was given to each phosphorylated residue based on 
comparison with a target-decoy database (Elias et l. 2007). Three significant 
residues [S2, S199 and S307] were identified [p < 0.05]. S2 was significantly 
enriched in the asynchronous extract, and S199 and S307 were significantly enriched 
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in the mitotic extract. None of these sites had been id ntified in the previous mapping, 
and only S307 was conserved in the large-scale fungal alignment. The identity scores 
of the 13 remaining sites were not significant [p > 0.05], and therefore were not 
assigned to mitotic or asynchronous extracts. 
 This phosphorylation site mapping has identified fwer phosphorylated 
residues compared to the previous analysis in section 5.2.2.5. I predict that this is due 
to a decrease in the amount of Mto2 analysed as a re ult of a two-fold reduction in 
the starting material used in the second mapping [30 g of cells vs. 15 g of cells]. 13 
out of the 16 peptides identified in the second mapping were not statistically 
significant. This is likely to have been exacerbated by a ten-fold enrichment of 
peptides from metaphase arrested culture. It is posible that the over-representation 
of non-labelled protein is due to inefficient incorp ation of the isotopes. To test this, 
random proteins were isolated from boiled extracts of cells grown in labelled 
isotopes. Analysis of the proteins by mass spectrometry demonstrated that isotope 
labels were being efficiently incorporated [data not shown]. Alternatively, it is 
possible that there was inaccurate mixing of the cultures prior to harvesting, therefore 
in future experiments extracts should be normalised after cell harvesting and extract 
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Figure 5.11 Mto2 phosphorylation sites identified by mass spectrometry analysis 
of protein purified under denaturing conditions. [A] Purified Mto2 was analysed 
by 10% SDS-PAGE and the gel was stained with Coomassie [Strain KS3953]. 
Mto2 [right lane] was identified relative to molecular weight standards [left lane]. 
Mto2 bands 1 and 2 were analysed and the majority of Mt 2 peptides were found 
in band 1. [B] The Mto2 amino acid sequence with the 25 identified 


































Table 5.2 25 high-scoring phosphorylation sites identified by mass spectrometry 
analysis. 25/33 of the identified resides had an ide tity score > 20 and were 
considered for further analysis. These included 19 serines, 4 threonines, and 2 
tyrosines. Peptide assignments and identity scores f  the 25 residues are listed, 
where residues were identified in more than one peptid , the highest scores are 
listed above.  
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61   SDNNYLDNGV SFTKDENPLY SPSWPSLADA NVNSMKSNNA IQEHKAAKFV SEKSLEKVST 
121  ADNNLVLQEL ENLRERLNQV ELQLSERPSS YLGYHNNLSP YRSPNSYPSL LPSTHSPHSP 
181  APLSTMQTAL MRLRTYHPSP IILKPVEQAV NHAITLVNTS PSSVVDALCR SLAELCLGLV 
241  QEAIDASILS QQESSNSLDL VRHTPPLNYT SSVDSSPQRM ASDSYGRPSL HLNDPFPSVD 
301  LQSNELSHHN VRTTLFSDDS RFHSKIHTHS TPPSQMYSAA SHFRYRSDPS TRHVSNSTNK 
361  SSLHPSPTSL RVAHPIIPQR ASPASQSFPS LQDTPSP 
 
Figure 5.12 Phosphorylation mapping of mitotic phosphorylation sites using 
SILAC identified two residues that were significantly enriched in metaphase 
arrested sample. [A] Mto2-TAPS was purified using IgG-linked Dynabeads [Strains 
KS5479 and KS5477]. Eluate was analysed by 10% SDS-PAGE and the gel was 
stained with Coomassie. [B] 16 phosphorylation sites w re identified. 3 sites were 
found to be significantly enriched in either interphase or mitosis. Green = mitotic 









































Table 5.3 Phosphorylation sites identified by mass spectrometry analysis of 
purified Mto2 using SILAC. 16 phosphorylation sites were identified. The ratio of 
H [heavy] / L [light] was normalised relative to total protein levels, and represents 
quantitative interphase/mitotic levels. The significance of each score was plotted 
and those residues with p < 0.05 were considered for further analysis. 
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5.2.3 Generation of phosphorylation mutants and analysis of 
phenotypes 
 
 Having identified a number of candidate phosphorylation sites on the Mto2 
protein, a series of mutants were generated based on different criteria. For historical 
reasons, the phenotypic analyses of the preliminary mutants described in this section 
were based on cellular localisation of HFG-Mto2. The results described in the first 
part of this chapter show that phosphorylation by CDK1-Cyclin B disrupts the 
Mto1/2 complex, therefore, I predict that the Mto1-Mto2 interaction would be 
maintained by the introduction of non-phosphorylatable mutations. As wild-type 
Mto2 co-localises with Mto1 throughout the cell cycle, the subsequent maintenance 
of the Mto1-Mto2 interaction would not change Mto2 l calisation. Alternatively, 
phospho-mimetic mutants could cause a constitutive disruption of the Mto1-Mto2 
interaction and subsequently all HFG-Mto2 localisation would be lost, however, it 
would difficult to distinguish between loss of function due to the disruption of the 
Mto1-Mto2 interaction and loss of function due to perturbation of Mto2 protein 
folding.  
 Consequently, the phenotype of phospho-mutants contructed in the latter 
part of this section were assayed based on the nuclar envelope localisation of Mto1 
[1-549]-GFP. In section 5.2.1.6 and 5.2.1.7, I showed that Mto1 [1-549]-GFP 
localisation at the nuclear envelope is dependent on Mt 2 [most likely through the 
formation of the Mto1/2 complex] and that this localis tion is lost during mitosis. 
This suggests that disruption of the Mto1/2 complex during mitosis is sufficient to 
dissociate the complex from the nuclear envelope. Th refore the nuclear envelope 
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localisation was used to indirectly assay the disruption of the Mto1/2 complex 
containing non-phosphorylatable Mto2 mutants. I predict d that as Mto2 is not 
phosphorylated, the Mto1 [1-549]-GFP / Mto2 complex, and subsequently the 
nuclear envelope localisation of Mto1 [1-549]-GFP would be maintained in mitosis. 
 However, this prediction is based on the assumption that maintenance of the 
Mto1/2 complex is sufficient to sustain nuclear envlope localisation during mitosis. 
It is possible that other factors may be involved, .g. disruption of the interaction 
between Mto1 and the unidentified nuclear envelope protein. Consequently, 
biochemical methods are required to directly determine whether the Mto1-Mto2 
interaction has been maintained during mitosis in the Mto2 non-phosphorylatable 
mutant background.  
 
5.2.3.1 Phenotypic analysis of Mto2 phospho-mutants derived from 
conservation with S. japonicus 
 
 Five S/T-P residues conserved within the alignment of S. japonicus 
SJAG_03264.2 were mutated to alanine using site-directed mutagenesis. A sixth 
mutant was constructed that contained S/T → A mutations for all five sites. Each 
mutant was recombined into an nmt81:HFG-tagging vector (Matsuyama et al. 2004) 
and transformed into mto2∆ [KS976]. Control images were taken of both 
endogenous Mto2-GFP and mt81:HFG-Mto2. Figure 5.13 demonstrates that the 
localisation of Mto2 at the eMTOC, iSPB, mSPB and MT-associated satellites in all 
six mutants was comparable to both wild-type controls. Examination of the mitotic 
cells demonstrates that there are no residual iMTOCs, and the level of Mto2 at the  
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Figure 5.13 Phenotypic analysis of alanine mutants identified by conservation of 
Mto2 S/T-P sites with S. japonicus demonstrated that there were no defects in 
cellular localisation compared to WT. [Strains KS1460, KS3915, KS3923, KS3925, 
KS3927, KS3929, KS3931 and KS3933]. Maximum projections of wide-field 
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SPB and eMTOC appears to be normal. Following this analysis, several other fungal 
homologs of Mto2 were identified, including the S. octosporus homolog 
SOCG_01774.2. This sequence was found to be significa tly more closely related to 
Mto2 than S. japonicus SJAG_03264.2. The alignment with all fungal homologs 
showed that only two of the five S/T-P sites that were mutagenised in this analysis 
were conserved in other fungi [Appendix V]. Based on this observation, it is unlikely 
that further analysis would demonstrate that these non-phosphorylatable mutants 
could prevent the Mto1/2 complex dissociating in mitosis.  
 
5.2.3.2 Phenotypic analysis of Mto2 phospho-mutants derived from mass 
spectrometry mapping 
 
 The 25 phosphorylation sites identified by the initial mass spectrometry 
analysis can be roughly divided into three clustered groups as shown in Figure 5.14, 
Panel A. These groups were separately targeted for mutagenesis. For all three groups, 
sequences that contained both non-phosphorylatable S/T→A and phospho-mimetic 
S/T→D substitutions were constructed. HFG-tagged mutants were constructed 
through recombination into an nmt81:HFG N-terminal tagging vector (Matsuyama et 
al. 2004). The sequences were transformed into mto2∆ Atb2-GFP [KS1409], where 
Mto2 was expressed from an nmt81 promoter at the leu1 locus. Figure 5.14, Panel B, 
shows the MT distribution in the HFG-Mto2 block mutan  background. This was 
quantified in Figure 5.14, Panel C [summarised in table 5.4]. Mto2 localisation and 
MT length/number were compared for the six phosphorylation site mutants. The 
most striking difference in MT bundle number and length was observed for the 
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Mto2-1D mutant. HFG-Mto2-1D had fewer MT bundles [2.5 5 ± 0.733] than wild-
type [3.737 ± 0.943], and the distribution of short t  long MT bundles resembled the 
profile observed for mto2∆ strain [in mto2∆, 80% of the MT bundles were longer 
than half the length of the cell]. Mto2-1A and Mto2-2A had the same number of MT 
bundles as wild-type but a higher proportion of short MT bundles. The significance 
of this observation is unclear.  
 These results suggest that the function of Mto2 has been compromised in 
HFG-Mto2 1D, particularly in relation to MT nucleation during interphase. The 
nature of this analysis meant that maintenance of the Mto1/2 complex in HFG-Mto2 
1A could not be detected. However, due to the stronger phenotype, the properties of 
HFG-Mto2 1D were analysed further. This mutant is particularly interesting, as the 
mutated sites are close to the coiled-coil domain which is predicted to facilitate the 
Mto1-Mto2 interaction as described in chapter four. 
 
5.2.3.3 MBP-Mto2 1D is able to interact with wild-type Mto2 and Mto1 
  
 In vivo characterisation of HFG-Mto2 1D suggests that the function of Mto2 
has been compromised. In order to test this further both the Mto2-Mto2 and Mto1-
Mto2 interaction of Mto2 1D were analysed in vitro. Figure 5.15, Panel A and B 
show amylose pulldown assays using MBP-Mto2 1D as bait. In fig 5.15, Panel A 
NusA-Mto2 protein was pulled down by both MBP-Mto2 and MBP-Mto2 1D at 
comparable levels, indicating that the phosphorylation site mutants did not affect the 
ability of Mto2 to self-interact.  Figure 5.15, Panel B shows that Mto1-13myc was 
co-precipitated in the presence of MBP-Mto2 at similar levels for both wild-type and  

























Block 1A  S159A, S169A, T174A, S176A, S179A, T185A 
Block 2A  S275A, S276A, S282A, S284A 
Block 3A  S361A, S362A, S366A, S369A 
Block 1D  S169D, T174D, S176D, S179D 
Block 2D S282D, S284D 









































Table 5.4 Quantitative analysis of MT length and number in large scale phospho-
mutants. Statistical analysis was performed using Students unpaired t test for 
comparison between two data sets. Mean values ± SD [Standard Deviation]. P 
values < 0.05 indicate a significance when compared to WT control. Mto2D = 
mto2∆. 
C 
Figure 5.14 Analysis of MT dimensions in Mto2 large scale phospho-mutant 
demonstrates that Mto2 1D has a weak mto2∆-like phenotype. [Strains KS1409, 
KS3915, KS4466, KS4469, KS4472, KS4475, KS4478 and KS4481] [A] 
Schematic diagram of 25 phosphorylation sites of Mto2 identified by mass 
spectrometry superimposed on predicted secondary structure. α-helix [blue 
cylinders], β-sheet [red arrows]. S/T/Y residues as indicated were divided into 3 
Blocks. [B] Maximum projections of widefield images of HFG-tagged block 
mutants. Scale bar = 10 µm. [C] Quantitation of MT bundle number and length. X = 
length of the cell. Error bars are calculated from standard deviation. 
























Figure 5.15 Biochemical analysis of Mto2-1D demonstrated that it is able to 
interact with recombinant Mto2 and Mto1 from yeast extract. Bacterial extract 
containing either MBP-Mto2 or MBP-Mto2 1D was incubated with either [A] 
bacterial NusA-Mto2 or [B] yeast extract containing Mto1-13Myc [KS1507]. 
Eluates were analysed by 10% SDS-PAGE and the gel was stained with 
Coomassie or the western blot was probed with anti-myc [9E10] antibody. Signal 
from anti-mouse-HRP secondary antibody was detected with ECL. WCE = whole 
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Mto2 1D mutant. This indicates that the phospho-mimet c mutations of the Block 1 
residues do not affect the Mto1-Mto2 interaction. This contradicts the in vivo 
evidence which suggests that the Mto1-Mto2 interaction may have been disrupted in 
these mutants. One possible explanation is that in vi ro, Mto2 1D lacks additional 
phosphorylated residues required to fully disrupt the Mto1-Mto2 interaction. 
Alternatively, as suggested by the analysis of the Mto2 coiled-coil mutant in chapter 
four, it is possible that small changes in the efficiency of the Mto1-Mto2 interaction 
that may not be detectable in vitro, may be sufficient to alter the function of the 
Mto1/2 complex. More direct methods should be used to assay the Mto1-Mto2 
interaction in the Mto1-1D/1A mutant background such as those described in section 
5.2.1.3.  
 
5.2.3.4 Phenotypic analysis of tyrosine phosphorylation mutants 
 
 The mass spectrometry analysis of Mto2 purified uner denaturing conditions 
identified two potential tyrosine phosphorylation site  [Y167, Y269]. To test whether 
phosphorylation of these residues is important for Mto2 function, Y168 and Y269 
were mutated to non-phosphorylatable phenylalanine using site directed mutagenesis. 
Mutated sequences were then recombined into an N-terminal nmt81:HFG tagging 
vector (Matsuyama et al. 2004) and integrated into an mto2∆ strain under the nmt81 
promoter at the leu1 locus. Figure 5.15, Panel A shows that for both mutants there 
were no observable defects in protein localisation at iMTOC, eMTOC, iSPB and 
mSPB, compared to wild-type HFG-Mto2. The large-scale fungal alignment showed 
that neither of the tyrosine residues were conserved [Appendix V]. Based on this  
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observation, it is unlikely that phosphorylation of these residues contributes to the  
disruption of the Mto1/2 complex during mitosis.  
 
5.2.3.5 Biochemical analysis of purified Mto2 demonstrates that there is no 
tyrosine phosphorylation  
 
 To confirm that Mto2 is not phosphorylated on tyrosine residues, Mto2 was 
purified by performing an anti-Mto2 immunoprecipitation from extracts taken during 
a cdc25-22ts cell cycle block and release. These extracts were then probed with an 
antibody raised against phospho-tyrosine. Figure 5.16, Panel B shows that when 
compared with the positive control there was no detectable signal from purified Mto2. 
This indicates that, despite the obvious phosphorylation shift in Mto2 [shown when 
the western blot is probed with anti-Mto2], the tyrosine residues in Mto2 are not 
phosphorylated. This suggests that tyrosine residue identified by the mass 
spectrometry analysis in section 5.2.2.5 [Y168, Y269] may be false-positive 
identifications or the stoichiometry of this phosphorylation is below detectable levels, 
possibly having been lost during the preparation of ative extract. 
 
5.2.3.6 Design of Mto2 combinatorial phosphomutants 
 
 Six phospho-variants containing non-phosphorylatabe S/T→ A mutations 
were designed based on combined evidence from bioinformatic and biochemical 
identification methods. Variant 1 [table 5.5] contai ed 17 mutations which were 
targeted if they had a NetPhos score greater than 0.9, and were either conserved in  
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Figure 5.16 Lack of phospho-tyrosine signal and WT phenotype of Mt 2-Y168F 
and Mto2-Y269F mutants suggests that Mto2 is not phs orylated at tyrosine 
resides. [A] Maximum projections of wide-field images taken of HFG-Mto2- 
Y168F and HFG-Mto2-Y269F. [Strains KS3915, KS4185 and KS4186] WT 
MTOCs indicated [grey arrows].  Scale bar = 10 µm. [B] Mto2 was purified by 
anti-Mto2 immunoprecipitation from extracts made from samples taken every 20 
min following release from a cdc25-22ts G2 arrest [KS1280]. Eluates were analysed 
by SDS-PAGE and the western blot was probed with an anti-phospho-tyrosine 
antibody and anti-Mto2. EGF-stimulated mouse embryo extract was used as a 
positive control. Image represents the result of a single experiment.  
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8/14 species within the fungal alignment or identified in either of the two mass 
spectrometry based mappings. Variant 1 also contained all three residues that were 
identified within a PBD interaction site consensus equence [S-S/T-P-X-R] (Elia et 
al. 2003b). Variant 2 contained 10 S/T-P sites identified by an in vitro CDK1  
 kinase assay performed in the laboratory of K. Gould, Vanderbuilt U.S.A. 
(Rosenburg, J. 2007) [table 5.6]. Variant 3 contained 14 mutations of sites that were 
found within a degenerate Aurora A consensus sequence following [S/T]-X[1,2]-
[R/K] or [R/K]-X[1,2]-[S/T] [table 5.7] (Dephoure et al. 2008). Variant 4 contained 
10 mutations in sites that were found within a degen rate PLK-1 consensus sequence 
following [S/T]-X[1,2]-[D/E] or [D/E]-X[1,2]-[S/T] [table 5.8] (Nakajima et al. 
2003; Dephoure t al. 2008).  
 
5.2.3.7 Mto2 phosphorylation does not affect the Mto1 [1-549]-GFP nuclear 
envelope localisation during mitosis 
 
 Four Mto2 phospho-variants were synthesised by GeneART [Germany]. 
Mutagenised Mto2 sequences containing 2 X STOP codons were recombined into a 
C-terminal nmt81:GFH-tagging vector and integrated into the genome where it was 
expressed from an mt81 promoter at the leu1 locus. Transformed strains contained 
Cut12-tdTomato in order to identify mitotic cells [indicated by duplicated SPBs] and 
Mto1 [1-549]-GFP to detect the persistence of the Mto1-Mto2 interaction in mitosis 
through the localisation of Mto1 [1-549]-GFP at thenuclear envelope.  
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 Figure 5.17 shows that all four of the Mto2 phospho-variants displayed Mto1 
[1-549]-GFP nuclear envelope localisation during interphase, indicating that the 
folding and stabilisation of the Mto2 protein has not been affected by the mutations.  
Examination of the signal from Cut12-tdTomato in all four of the mutants 
demonstrated that Mto1 [1-549]-GFP did not localise to the nuclear envelope in 
mitosis. To examine the phosphorylation state of the Mto2 phospho-variants, extracts 
from each strain were analysed by western blot. Figure 5.18 shows that the level of 
hyperphosphorylation in Variant 3 and 4 is comparable with wild-type nmt81:Mto2, 
indicating that it is unlikely that Polo or Aurora kinases contribute to Mto2 
phosphorylation. However, the hyperphosphorylation of Variant 1, and to a lesser 
extent Variant 2, was significantly reduced compared to wild-type. This suggests that 
the majority of the sites that have been targeted for mutagenesis in Variant 1 are 
genuine phosphorylation sites. Interestingly, this mutant contains three out of six of 
the Block 1 sites identified by both mass spectrometry mappings, which gave an 
mto2∆-like phenotype when mutated to aspartate. This confirms that these sites 
appear to be significant in Mto2 function. The western blot also indicates that the C-
terminal GFH tag is not expressed [expectant molecular weight of Mto2-GFH is 74 
kDa]. 
 As this assay does not examine the Mto1-Mto2 interaction directly, I cannot 
say conclusively whether the Mto1/2 complex remains intact during mitosis in the 
Variant 1 background. However, if the Mto1/2 complex has been maintained, this 
result suggests that although disruption of the Mto1/2 complex may be sufficient to 
dissociate Mto1 [1-549]-GFP from the nuclear envelop , maintenance of the 
complex is not sufficient to keep it at the nuclear nvelope during mitosis. This 
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would indicate that there may be other mechanisms in place to ensure that Mto1 is 
removed from the nuclear envelope. 
 Alternatively, if the Mto1/2 complex has not been disrupted, this indicates 
that Mto2 phosphorylation does not contribute to the dissociation of the Mto1/2 
complex. To confirm the Mto1-Mto2 interaction in the phospho-Variant 1 
background in mitosis, co-precipitation of Mto2 in a Mto1-TAPS pull down assay 
could be compared between asynchronous and metaphase arre ted extract, as 










































Table 5.5 Mutated residues in Mto2 phospho-variant 1. Mutant contained S/T→ 
A substitution at sites that had a NetPhos prediction score greater than 0.9 in 
addition to either being identified in the mass spectrometry mapping or conserved 
in 8/15 species in the fungal alignment. Residues wre also included if present 
within a PBD recognition site consensus [17 sites]. 
Table 5.6 Mutated residues in Mto2 phospho-variant 2. Mutant contained S/T→ 
A substitution of sites identified in CDK-1-Cyclin B in vitro kinase assay [10 
sites] [Rosenburg, J. 2007].  

























Table 5.7 Mutated residues in Mto2 phospho-variant 3. Mutant contained S/T→ 
A substitution of sites found within Aurora kinase consensus sequence [14 sites]. 
Table 5.8 Mutated residues in Mto2 phospho-variant 4. Mutant contained S/T→ 
A substitution of sites found within Polo kinase consensus sequence [10 sites]. 

















































Figure 5.17 NE localisation of Mto1 [1-549]-GFP in Mto2 phospho-mutant 
variants is comparable to WT Mto2. Maximum projections of confocal images 
taken of nmt81:Mto1 [1-549]-GFP and Cut12-tdTomato. Mitotic cell is shown 
in the top frame for each mutant [Strains KS5972, KS5973, KS5974, 
KS5975]. Mto2 was expressed under an nmt81 promoter at the leu1 locus. 
Scale bar = 10 µm. 
Figure 5.18 Western blot analysis of Mto2 phospho-variants. Extracts from 
WT Mto2 and Mto2 phospho-variants 1-4 were analysed by SDS-PAGE and 
the western blot was probed with anti-Mto2 antibody. The signal from 
IRDye800 was detected using Odyssey V3.0. [Strains KS5972, KS5973, 
KS5974, KS5975]. Molecular weight standards are indicated. Image 
represents the result of a single experiment. 
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5.3 SUMMARY OF RESULTS 
 
 In this chapter I demonstrated that Mto2 is phosphrylated. Mto2 
phosphorylation was found to be regulated in a cell cyc e-dependent manner, 
increasing as cells entered mitosis. Co-immunopreciitat on experiments 
demonstrated that when cells were arrested in metaphase, Mto2 was unable to 
interact with Mto1. The mitotic disruption was confirmed when the Mto1-Mto2 
interaction was followed over the whole cell cycle. 
 In the process of analysing the localisation of the Mto1 truncation, Mto1 [1-
549], I discovered that Mto1 [1-549]-GFP localisation at the nuclear envelope was 
dependent on Mto2. Upon further examination, I found that Mto1 [1-549]-GFP 
localisation at the nuclear envelope was disrupted as cells entered mitosis and 
returned during telophase. Based on this result, I conclude that the dissociation of 
Mto1 [1-549]-GFP from the nuclear envelope results from the disruption of the 
Mto1/2 complex most likely as a consequence of Mto2 phosphorylation. 
 Analysis of the Mto1 / γ-TuSC interaction revealed that Mto2 is not required 
for Mto1 to efficiently interact with the γ-TuSC during mitosis. This is not surprising 
given that astral MTs are nucleated in mto2∆ strains. This result suggests that a 
different Mto2-independent Mto1 complex is assembled at mSPBs [and probably 
iSPBs] compared with the Mto2-dependent Mto1 complex assembled at non-SPB 
iMTOCs. It is possible that Mto2 may not be required for nucleation from the SPB 
[and eMTOC to a lesser extent] as the high local concentration of low affinity γ-
TuSC / Mto1 interactions may be sufficient to support MT nucleation. However, this 
result is contradicted by the localisation of Mto2  the mSPB in vivo (Samejima et al. 
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2005). If the Mto1-Mto2 interaction is disrupted, how is Mto2 being targeted to the 
mSPB? It is possible that the weak interaction with the γ-TuSC is sufficient to recruit 
Mto2 to the SPBs (Samejima et al. 2008). An in depth analysis of the timing of 
Mto2-GFP recruitment [in addition to other fluorescnt tags] in the absence of Mto1, 
may help to resolve this issue. 
  
 Multiple bioinformatic and biochemical based methods were used to identify 
potential phosphorylation sites on Mto2. These phosrylation sites are listed in 
Appendix IX. Initial attempts to characterise the phenotype of several phospho-
mutants was based on the cellular localisation of HFG-Mto2. This assay was 
subsequently discovered to be inappropriate, as I showed that the primary effect of 
Mto2 phosphorylation is likely to be through the disruption of the Mto1-Mto2 
complex, therefore maintenance of the interaction va generation of non-
phosphorylatable mutants would result in wild-type Mto2 localisation. Further 
analyses of these mutants should examine the Mto1-Mt 2 interaction by co-
immunoprecipitation.  
 The phospho-mutants that had been designed based on mass spectrometry 
mapping of Mto2 purified under denaturing conditions were also characterised based 
on MT length and number. This analysis demonstrated that the phosphorylation sites 
near to the predicted coiled-coil Mto1 interaction domain [Block 1] may contribute 
to disruption of the Mto1-Mto2 interaction, as phospho-mimetic mutations resulted 
in an mto2∆-like phenotype [expected if the Mto2 was unable to in eract with Mto1]. 
In vitro analysis of the Block 1 phospho-mimetic mutants demonstrated that both the 
Mto2-Mto2 interaction and the Mto1-Mto2 interaction had not been disrupted. It is 
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possible that the in vitro assay used to test the interactions was not sensitive enough 
to detect small changes in the efficiency of the Mto1-Mto2 interaction that may have 
large effects Mto1 function in vivo.  
 Overall this mutagenic analysis suggests that some or all of the 
phosphorylation sites in the Block 1 mutant are likly to be phosphorylated. It is 
possible that phosphorylation of these residues occurs in addition to several other 
sites, and only when all of these residues have been modified will this be sufficient to 
disrupt the Mto1-Mto2 interaction to a level that cn be detected in vitro.      
  
 A method of SILAC labelling has been developed for fission yeast in our 
laboratory by C. Bicho (Bicho et al., manuscript in preparation). The quantitative 
nature of this method made it possible to identify by mass spectrometry those 
residues that were specifically phosphorylated during mitosis. Unfortunately, the 
results from this mass spectrometry analysis only identified 15 unique 
phosphorylation sites, compared with 25 sites that were identified in the first 
mapping attempt. It is possible that this may be du to a reduction in the amount of 
purified material analysed. For future analysis, more Mto2 protein needs to be 
analysed in order to increase the likelihood of identifying more phosphorylation sites, 
particularly sites that are phosphorylated with a low stoichiometry. 
 Four additional non-phosphorylatable mutants were d signed using evidence 
from a combination of biochemical and bioinformatic analyses. The sites in each 
mutant were selected based on the several criteria. Variant 1 sites were targeted if 
they had a high NetPhos score and were either highly conserved or identified in one 
of the two mass spectrometry mappings. Variant 1 also included the three residues 
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that were found within the PDB binding consensus sequence. Variant 2 sites were 
targeted for mutagenesis as they had previously been id ntified as in vitro CDK1-
Cyclin B phosphorylation sites (Rosenberg t al., 2007). Residues were mutated in 
Variants 3 and 4 if they were found within Aurora A and Polo kinase consensus sites, 
respectively. Unlike the first set of mutants, the Mto1-Mto2 interaction was assayed 
in these phospho-variants. This was based on the nucl ar envelope localisation of 
Mto1 [1-549]-GFP during mitosis, where it was assumed that if the complex was 
maintained in a non-phosphorylatable mutant Mto2 background, the nuclear 
envelope localisation will also be maintained. 
 Microscopic analysis demonstrated that the mitotic nu lear envelope 
localisation of Mto1 [1-549]-GFP was disrupted in all four mutants. Interestingly, 
when the Mto2 phospho-variant proteins were examined by western blot, Variant 1 
showed a significant reduction in Mto2 hyperphosphorylation. This result indicates 
that a proportion of the residues targeted in Variant 1, are phosphorylated in vivo.     
 This demonstrates that the inability to phosphorylate Mto2, and potentially 
the presence of an intact Mto1/2 complex, is not sufficient to maintain the Mto1 [1-
549]-GFP at the nuclear envelope during mitosis. Other factors may be involved to 
ensure that nucleation complexes are re-localised in mitosis. For example, the 
nuclear envelope protein that binds Mto1, along with Mto1 itself, may also be 
phosphorylated. Mto1/2 complexes may be re-localised from iMTOCs other than the 
nuclear envelope in a similar manner, however, it is likely that in all cases other 
mechanisms are also in place to ensure that Mto1 is re-localised efficiently e.g. de-
polymerisation of cytoplasmic MTs through the action of plus-end binding proteins 
and other MAPs (Grallert et al. 2006). 
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 In order to conclusively examine the role of Mto2 phosphorylation in the 
formation of the Mto1/2 complex I need to directly demonstrate that the Mto1-Mto2 
interaction has been maintained in the Variant 1 background in mitosis.   
 
 Alternatively, it is possible that Mto2 phosphorylation in mitosis is merely 
correlated with the disruption of the Mto1-Mto2 interaction and not causally linked 
i.e. Mto2 phosphorylation may play a role in a different aspect of Mto1/2 function. 
The phenotype of Mto2 Variant 1 needs to be examined i  the full length Mto1 
background, to determine the consequences of Mto2 ph sphorylation to the MT 


















































 One of the aims of this project was to determine the mechanism that underlies 
Mto1/2-mediated activation of the γ-TuSC in facilitating the nucleation of non-
centrosomal linear MT arrays of S. pombe. Specifically, it was hoped that my 
research may be able to provide evidence to support a template model for γ-TuRC 
assembly by the Mto1/2 complex. Through calculation of the size of Mto1/2 complex 
I aimed to confirm whether multimerisation of several copies of the Mto1/2 complex 
is required to drive γ-TuRC assembly.   
 Determination of the copy number of Mto1 and Mto2 in the Mto1/2 complex 
has been challenging due to the formation of the Mto1/2 60 – 80 S complex. I was 
unable to determine whether the Mto1 60 – 80 S complex resulted from Mto1 
association with large cellular particles, or whether it was caused by protein 
aggregation. Assembly of this large complex was promoted by association with the 
SPB, however, this was only true for a fraction of the 60 – 80 S complex and it 
remains possible that SPB-association may promote pr t in aggregation by 
increasing the local concentration.  
 Inclusion into a 60 - 80 S complex was also observed for members of the γ-
TuSC, independently of Mto1. The hydrodynamic analyses of purified γ-TuSC 
proteins in other organisms has not revealed the presence of large complexes [ > 35 
S], suggesting that the complex formed in S. pombe may not represent the equivalent 
complex in higher eukaryotes (Kellogg et al. 1992; Raff et al. 1993; Stearns et al. 
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1994; Zheng et al. 1995; Oegema et al. 1999). Unlike the extraction buffers using in 
this study, these analyses have included 100 µM GTP, which has been shown to 
reduce γ-TuSC aggregation (Oegema et al. 1999). Therefore all future analysis of the 
γ-TuSC in S. pombe should be performed in the presence of GTP. It is possible that 
this may also help prevent aggregation of the Mto1/2 complex. 
 Hydrodynamic analysis of both Mto1 and Mto2 has been difficult due to the 
unusually large distribution of protein over both the sucrose density gradient and gel 
filtration fractions. The large spread of Mto1 and Mto2 following fractionation 
means that all molecular weight calculations are lik ly to represent an average value.   
 I hypothesised that the spreading may arise from the inclusion of protein 
within detergent micelles, however, use of a different detergent [0.5% v/v CHAPS] 
with a smaller micelle size had very little effect on protein distribution [data not 
shown]. When purified recombinant Mto2 was analysed by gel filtration following 
pre-fractionation by sucrose gradient, there was les  spreading [fig 4.1]. This 
indicates that the spreading is likely to result from the presence of other cellular 
proteins; therefore future hydrodynamic analyses should be performed using purified 
yeast protein, as I predict that this will produce a more homogenous mixture of 
protein that would distribute among fewer fractions.   
 Using protein quantification methods derived from protocols performed in the 
laboratory of T. Pollard (Wu et al. 2005), I was able to determine that there are 
equivalent numbers of Mto1 and Mto2 molecules within t e cell [Appendices VII 
and VIII]. Additionally, in chapter five I have shown that the nuclear envelope 
localisation of over-expressed Mto1 [1-549]-GFP requires simultaneous over-
expression of Mto2. Therefore, although I was not able to demonstrate the copy 
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numbers of Mto1 and Mto2 within an active nucleation c mplex, these additional 
results suggest that the Mto1/2 complex is likely to contain comparable levels of 
Mto1 and Mto2.  
 In chapter three I demonstrated that removal of the C-terminal 315 aa of 
Mto1 prevents it from associating with or assembling into the 60 – 80 S complex. 
This allowed me to determine that the Mto1 [1-800] / Mto2 complex is likely to be a 
heterotetramer composed of two molecules of Mto1 and two molecules of Mto2. In 
vivo evidence suggests that multiple Mto1/2 heterotetrame s are present at non-SPB 
iMTOCs. However, as only single heterotetramers are det cted by hydrodynamic 
analysis, it has not been possible to determine the copy number of Mto1 [1-800] and 
Mto2 within the active complex. It would be interesting to investigate using purified 
proteins in vitro, whether single heterotetramers are able to promote MT nucleation. 
Although this is unlikely to reflect the situation in vivo, the activity of single Mto1/2 
heterotetramers would at least suggest that the γ-TuSC has the potential to nucleate 
MT without further assembly into the γ-TuRC. The nature of this association would 
reinforce the Protofilament model of MT nucleation (Erickson et al. 1996a). 
Arguments against γ-TuSC-mediated nucleation from higher eukaryotes propose that 
the efficiency of nucleation from this complex would not be high enough to support a 
dynamic MT array. However, as S. pombe does not have as many MT bundles it is 
possible that a high concentration of low efficiency complexes may be sufficient.  
Alternatively, single Mto1/2 heterotetramers may not i duce nucleation from single 
γ-TuSCs e.g. possible that each heterotetramer, which contain two γ-TuSC binding 
domains, can induce γ-TuRC formation by an increase in local concentration of γ-
TuSC, sufficient to promote γ-TuRC self-assembly.  
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 In summary, I have shown that it will not be possible to analyse the Mto1/2 
complex containing full length Mto1. The inconsistencies between the in vitro and in 
vivo data highlight the difficulties of studies of this nature. Subsequent purification 
and structural analysis should therefore be performed using the Mto1/2 complex 
containing truncated forms of Mto1, such as Mto1 [1-800] or Mto1 [1-549], in order 
to determine the level of Mto1/2 complex multimerisat on. This line of research is 
currently being pursued in the Sawin lab. This should be accompanied by in vivo 
methods such as Fluorescence Correlation Spectroscopy (FCS) that may be able to 
measure the concentration of molecules at iMTOCs. 
  
 My research has also addressed the role of Mto2 within the Mto1/2 complex. 
I proposed that Mto2 binding has two functions: firstly, Mto2 may facilitate Mto1 
multimerisation either through forming higher-order complexes or through inducing 
structural changes in Mto1 that promotes Mto1 self association, and secondly, Mto2 
binding may activate Mto1 which promotes the Mto1 / γ-TuSC interaction. This 
hypothesis was supported by observations in this study, whereby in vivo, the signal 
from Mto1-tdRFP satellite foci was reduced in the absence of Mto2 and I have 
shown in vitro that there is approximately a 4-fold reduction in the amount of γ-
TuSC that interacted with Mto1-TAPS in mto2∆.  
 The observation that Mto2 is present in dimeric form within an active 
nucleation complex [Mto1 [1-800] / Mto2] suggested hat the Mto2-Mto2 interaction 
may play an important role in one or both of these functions. In chapter four, I 
described attempts to determine the contribution of Mt 2 multimerisation to Mto1/2 
complex function. This analysis was encumbered by the fact that Mto2 was found to 
   221  
be tetrameric, therefore there are a number of interac ion sites that needed to be 
identified and disrupted in order to generate the monomeric form of Mto2 required to 
conclusively test the contribution of the Mto2 multimerisation to the function of the 
Mto1/2 complex.    
 Mapping of the Mto2-Mto2 interaction and subsequent identification and 
mutagenesis of Mto2 coiled-coil, suggested that this region is required for the Mto2-
Mto2 interaction. Hydrodynamic analysis of the coiled-coil mutant demonstrated that 
it was dimeric, consequently there are other regions near the C-terminus that also 
facilitate the Mto2-Mto2 interaction.  Further analysis of the Mto2 coiled-coil mutant 
has shown that this region is required for the efficient interaction with Mto1. Despite 
being sufficient to disrupt the Mto2-Mto2 interaction, mutation of hydrophobic 
residues within the Mto2 coiled-coil domain to aspartic acid was not sufficient to 
completely interrupt the Mto1-Mto2 interaction. However, phenotypic analysis of 
this mutant revealed an mto2∆ phenotype whereby MT nucleation from non-SPB 
iMTOCs was abolished. This result suggests that the system is highly sensitive to 
changes in interaction efficiencies e.g. a 50% drop in the efficiency of the Mto1-
Mto2 interaction [in a HFG-Mto2 background] does not affect the function of the 
nucleation complex, however, further a reduction [coiled-coil mutant] causes loss of 
all non-SPB iMTOC nucleation. 
 In chapter four I demonstrated that dimeric HFG-Mto2 is sufficient to 
promote wild-type MT nucleation, which in addition to previous analysis of Mto1-
YFP satellite foci in the presence of Mto2-CFP and u tagged Mto2 (Samejima et al. 
2005) suggest that Mto2 tetramerisation is not requi d for Mto1/2 complex 
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assembly or function. Rather, tetrameric Mto2 may arise from the association of un-
complexed Mto2 dimers, acting as a storage form of pr tein. 
 This analysis does not support my prediction that large-scale multimerisation 
of Mto2 is able to drive Mto1/2 assembly. Alternatively, it is possible that Mto2 
binding induces a structural change in Mto1 that promotes multimerisation of Mto1.  
 Weak Mto1-tdRFP satellite foci were observed in mto2∆. This suggests that 
Mto1 has a limited capacity to self-assemble, which is likely to be promoted by 
increasing the local concentration of Mto1 through targeting the protein to MTOCs. 
When the localisation signals in the C-terminus of Mto1 are removed, assembly of 
the complex appears to be facilitated solely by the presence of Mto2, as large Mto1 
[1-549]-GFP foci at the nuclear envelope were not present in the absence of Mto2. 
Although no obvious differences can be observed betwe n the Mto1 satellites in the 
full length and Mto1 [1-549] backgrounds, it would be interesting to investigate 
whether they are structurally different, the former having been assembled primarily 
through the Mto1 coiled-coil, and the latter having been assembled though the action 
of Mto2.  
 In addition to inducing Mto1 multimerisation it was proposed that Mto2 may 
also function by promoting the Mto1 / γ-TuC interaction. For example, Mto2 binding 
may cause a structural change in the conformation of Mt 1 that increases the affinity 
for γ-TuC [and also potentially promote Mto1 multimerisat on]. It is also possible 
that Mto2 may provide part of the γ-TuC interaction interface as suggested by the 
observation that Mto2 can interact with the γ-TuSC independently of Mto1 
(Samejima et al. 2008). Further work is required to determine whether is aspect of 
Mto2 function occurs independently of Mto1/2 complex multimerisation, or whether 
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the increase in Mto1-γ TuC interaction efficiency occurs as a result of Mto2-
dependent association of γ-TuC-binding sites. In addition, further mutagenesis i  
required to obtain monomeric Mto2, which would allow ne to assess the 
significance of the Mto2-Mto2 interaction to the function of Mto2.  
  
 The research presented in chapter five examined the role of Mto2 
phosphorylation in the regulation of Mto1/2 complex activity. The regulation of this 
complex is proposed to be a key mechanism to allow the cell to specify when and 
where MT nucleation occurs. Spatial and temporal mis-regulation of MT nucleation 
may have drastic effects on cellular organisation, particularly in mitosis when 
nucleation of an interphase array may restrict the lev l of αβ-tubulin available to 
polymerise the MT spindle.  
 Thus, I demonstrated that hyperphosphorylation of Mt 2 during mitosis 
corresponds to the disruption of the Mto1/2 complex. The Mto1/2 complex may be 
disrupted during mitosis to facilitate re-modelling of the Mto1 / γ-TuC complex i.e. 
allowing Mto1 and the γ-TuC to relocate to the SPB where they are required to 
nucleate the spindle and astral MTs. Simultaneously, by preventing Mto2 from 
interacting with Mto1, this may be part of a number of edundant mechanisms that 
discourage iMTOCs being assembled during mitosis. 
 In this analysis I used several bioinformatic and biochemical based 
techniques to identify Mto2 phosphorylation sites. These include identification of 
conserved S/T residues and analysis of purified Mto2 by mass spectrometry. 
Purification of Mto2-HTB under denaturing conditions successfully identified 25 
phosphorylation sites, however, attempts to enrich for mitotic sites using SILAC did 
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not generate convincing results. It is thought thate reduction in identifications may 
be due to the relative amounts of purified protein; this should be considered when 
performing Mto2 purifications in future analyses.   
 Initial attempts to assess the contribution of the identified potential 
phosphorylation sites to Mto2 function were not successful, with the exception of the 
analysis of the Block 1 mutant, constructed based on the results of the mass 
spectrometry analysis. This mutant included four residues that were within 30 aa of 
the Mto2 coiled-coil domain / Mto1 interaction domain. This result correlates with 
the conclusions drawn from previous data which state that the Mto1-Mto2 interaction 
is disrupted as a result of Mto2 phosphorylation. 
 Phenotypic analysis of the mutants constructed in the latter stages of my 
study involved examination of the Mto2-dependent loca isation of Mto1 [1-549]-
GFP at the nuclear envelope. These mutants were constructed based on several lines 
of evidence gathered over the course of my project. Unfortunately, none of the four  
non-phosphorylatable Mto2 variants displayed the ret ntion of Mto1 [1-549]-GFP on 
the nuclear envelope that was predicted based on a sust ined Mto1-Mto2 interaction. 
However, Mto2 Variant 1 did show a significant reduction in phosphorylation when 
the protein was analysed by SDS-PAGE and western blot. This result is interesting as 
several of the phosphorylation sites uniquely targeted in Variant 1 overlap with sites 
identified by both mass spectrometry based mappings a d a number of these sites 
were mutated in the Mto2 Block 1 mutant. Again, supporting previous evidence that 
phosphorylation of the Mto1 interaction domain of Mto2 may contribute to the 
disruption of the Mto1/2 complex. Unfortunately, the local environment of the 
residues that had been uniquely targeted in Variant 1 was not indicative of a specific 
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kinase consensus. However, as the phosphorylation state of Mto2 was partially 
reduced in the Variant 2 background, this suggests that Cdc2 is the most likely 
candidate. This is supported by my in vitro kinase assay, and the observation that 
Cdc2 interacts with Mto1 during mitosis in vivo [data not shown]. 
 Further investigation of Mto2 Variant 1 should first determine biochemically 
whether the Mto1-Mto2 interaction is maintained during mitosis. Without showing 
that the complex has been disrupted it is not possible to conclude that Mto2 
phosphorylation plays a role in Mto1/2 complex formation. My in vitro CDK kinase 
assay did not distinguish whether Mto1/2 disruption was caused by Mto1 
phosphorylation or Mto2 phosphorylation. This is important as previous evidence 
have indicated that Mto1 homologs are phosphorylated during mitosis in other 
organisms (Dobbelaere et al. 2008).    
 
 One key question regarding the function of Mto2 that was not directly 
addressed in this study is why Mto2 is specifically required for nucleation from 
iMTOCs and not the SPB. The research presented in this report may provide 
information that can help to answer this question. I hypothesise that Mto2 may not be 
required at the SPB because Mto1 dimers [and probably higher order complexes] are 
present at a high enough concentration that their wak affinity for the γ-TuSC is able 
to compensate for the lack of high efficiency Mto1/2 complexes, and is sufficient to 
support MT nucleation. For example, if 1 out of every 10 Mto1 dimers were able to 
initiate MT nucleation, but 9 out of every 10 Mto1/2 complexes were able to nucleate 
MTs, then 9 Mto1 complexes would be required to nucleate that same amount of 
MTs for every single Mto1/2 complex. As relatively few MTs are nucleated from the 
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SPB, particularly during mitosis, it is likely that the cell can tolerate this low 
efficiency of MT nucleation.  
 This theory partially applies to nucleation from the eMTOC. The high 
number of Mto1 binding sites increases the number of low efficiency Mto1 / γ-TuSC 
nucleation events, therefore a low level of MT nucleation can be achieved in the 
absence of Mto1/2 complex. However, based on the weak PAA formed in mto2∆, it 
appears that it is not sufficient to nucleate a wild-type array.   
 The formation of high efficiency Mto1/2 nucleation complexes may also 
explain why the Mto1/2 complex is disrupted in mitos s. For example, in addition to 
highly efficient MT nucleation not being required at this point, it would probably be 
detrimental to have highly efficient nucleation complexes at the SPB as retention or 
depletion of cytoplasmic free-tubulin may prevent sufficient levels from entering the 
nucleus. In summary, the Mto1/2 complex may be disrupted during mitosis as it is 
too efficient at nucleating MTs, and the cell needs to limit the level of nucleation 
from the SPB.  
 This idea can be related to the nature of the γ-TuC formed in the presence of 
different types of Mto1 complex. The Mto1/2-linked nucleation complexes are 
efficient MT nucleators because they may be able to efficiently facilitate γ-TuRC 
assembly as a result of Mto2-induced multimerisation of Mto1 γ-TuSC interaction 
domains and/or the presence of a form of Mto1 that can interact with the γ-TuSC 
more efficiently. This is compared with a slow Mto1-mediated γ-TuRC assembly at 
the SPB, which, due to the concentration of Mto1 is able to undergo some level of 
multimerisation, but due to the absence of Mto2, interacts with the γ-TuRC less 
efficiently. 
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 The presence of both high and low efficiency MT nucleation complexes 
would be advantageous to the cells as in addition to regulating the time and place of 
MT nucleation, it also allows it to regulate the efficiency of the nucleation. This level 
of regulation may be instigated in part by Mto2. This may be why there are no 
known homologs Mto2 in higher eukaryotes, as in these cells the majority of 
cytoplasmic MT nucleation is restricted to the centrosome, where there may be less 



































































Sucrose Gradient calibration for recombinant protein 
 
  A 2 ml 5-20% sucrose gradient was calibrated using gel filtration molecular 
weight markers [Sigma]. Lyophilised protein was made up to 50 X stock solution [10 
mgml-1] in 1 X TBS. This contained carbonic anhydrase [2.8 S, MW = 29 kDa], 
bovine serum albumin [4.3 S, MW = 66 kDa], alcohol dehydrogenase [7.4 S, MW = 37 
kDa], β-amylase [9 S, MW = 50 kDa] and thyroglobulin [19 S, MW = 110 kDa].  Prior 
to use markers were diluted in 1 X TBS and 100 µl was loaded onto the gradient. 
After centrifugation, 50 µl fractions were collected diluted in 2 X SB. 50µl of each 
sample was analysed by SDS-PAGE and gel was stained with Coomassie. Signal was 
quantified using Odyssey V3.0 software.  
 Intensities were plotted and graph was used to visually estimate the peak 
fraction for each marker [Figure AI, Panel A and B]. The peak was then plotted 
against the known S-values for each protein [Figure AI, Panel C]. This curve was 



























































Figure I.a Calibration of the 5-20 % sucrose gradient for purified protein. [A] 
Graph plotting the integrated intensities for four molecular weight standards listed 
in table AI. Intensities were measured using Odyssey V3.0 [Licor Biosciences, 
U.S.A.]. Peak fractions listed in [B] were used to construct a calibration curve 
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APPENDIX II 
 
Sucrose Gradient calibration for yeast extract analyses. 
 
 A 2 ml 5-20% sucrose gradient was calibrated using gel filtration molecular 
weight markers. Lyophilised protein was made up to 50 X stock solution [10 mgml-1] 
in 1 X TBS. This contained carbonic anhydrase [2.8 S, MW = 29 kDa], bovine serum 
albumin [4.3 S, MW = 66 kDa], alcohol dehydrogenase [7.4 S, MW = 37 kDa], β-
amylase [9 S, MW = 50 kDa] and thyroglobulin [19 S, MW = 110 kDa]. Prior to use 
markers were diluted in 1 X TBS and 100 µl was loaded onto the gradient. After 
centrifugation, 100 µl fractions were collected diluted in 2 X SB. 50 µl of each 
sample was analysed by SDS-PAGE and gel was stained with Coomassie. Signal was 
quantified using Odyssey V3.0 software.  
 Intensities were plotted on a graph which was used to visually estimate the 
peak fraction for each marker. The peak was then plotted against the known S-values 

























































































Figure II.a Calibration of the 5-20% sucrose gradient for purified protein. [A] 
Graph plotting the integrated intensities for four molecular weight standards. 
Intensities were measured using Odyssey V3.0 [Licor Bi sciences, U.S.A.]. Peak 
fractions listed in [B] were used to construct a calibr tion curve against known S-
values [C]. 
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APPENDIX III 
 
Superose-6 calibration for KS1 
 
 KS1 Superose 6 10/300GL high performance column [GE healthcare, U.S.A] 
was used for analysis of yeast lysate. Calibration was performed using markers from 
a Gel Filtration Calibration Kit [GE healthcare, U.S.A] [thyroglobulin, β-amylase 
and ferretin], in combination with molecular weight markers from Sigma, U.S.A. 
[BSA and carbonic anhydrase]. A 10 X stock solution of molecular weight markers 
were made in 1 X TBS as follows: thyroglobulin = 5 mgml-1, β-amylase = 4 mgml-1, 
ferritin = 0.3 mgml-1, BSA = 4 mgml-1, carbonic anhydrase = 3 mgml-1 [stock made 
up in dH2O]. Prior to use stock solution was diluted with 1 X TBS, and 100µl was 
loaded onto the column. AU 600 nm was measured for 30 ml at a flow rate of 0.4 











Kav = Ve – V0 
           Vt – V0 
 
Ve = elution volume 
V0 = void volume of the column 
Vt = total volume of the gel bed 
 
Table III.a Molecular weight markers used for calibration of KS1. Rm = Stokes 
Radius, Ve = elution volume. 

























Figure III.a Calibration plot for KS1. Stokes radii of known molecular weight 
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APPENDIX IV 
 
Superose-6 calibration for KS2 
 
 KS2 Superose 6 10/300GL high performance column [GE healthcare, U.S.A] 
was used for analysis of purified protein. Calibration was performed using molecular 
weight standards from a Gel Filtration Calibration Kit [GE healthcare, U.S.A] 
[thyroglobulin, ferretin, aldolase, ovalbumin, ribonuclease A], in combination with 
molecular weight markers from Sigma, U.S.A [carbonic anhydrase]. A 10 X stock 
solution of molecular weight markers were made in 1X TBS as follows: 
thyroglobulin = 5 mgml-1, ferritin = 0.3 mgml-1, aldolase = 4 mgml-1, ovalbumin 4 
mgml-1, ribonuclease A = 3mgml-1, carbonic anhydrase = 3 mgml-1 [stock made up in 
dH2O]. Prior to use stock solution was diluted with 1 X TBS, and 100µl was loaded 
onto the column. AU 600 nm was measured for 30 ml at a flow rate of 0.3 mlmin-1.  
 









Kav = Ve – V0 
           Vt – V0 
 
Ve = elution volume 
V0 = void volume of the column 
Vt = total volume of the gel bed 
 






























Table 1V.a Molecular weight markers used for calibration of KS2. Rm = 
Stokes Radius, Ve = elution volume. 
Figure 1V.a Calibration plot for KS2. Stokes radii of known molecular weight 
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APPENDIX V 
 























































































































































































































































































































































 Alignment was performed using the MegAlign software p ogram [Lasergene 
8, DNAstar]. Residues highlighted in green indicate conservation of amino acid 
similarity with the Mto2 sequence in 8 or more homologs. H. cryophobus sequence 

















































VAHPIIPQRAS----PASQSFPSLQD--------TPSP                       397mto2aaseq
TSYNHSTPTK------SSLNVSPEPE--------SPL                        396Schizo_Octosporus
NSFHQSTPTKG-----SSLNFSPEPE--------SPL                        410h cryophobus
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APPENDIX VI 
 









































Table VI.a PAIRCOIL2 probability scores for amino acids surronding predicted 
coiled-coil. PAIRCOIL2 scores for amino acid sequence 104 - 152 are listed, 
where those residues found to have a significant score are highlighted in grey [114 
– 147 aa]. The cut-off score used for prediction was 6.0 where significance was 
indicated by p-values < 0.05. 
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APPENDIX VII 
 
Quantification of Cellular levels of Mto2 
 
Quantification of MBP-Mto2 
 
 The concentration of purified MBP-Mto2 was calculated through comparison 
with a calibration curve created from purified BSA of known concentration [NEB, 
U.S.A.]. A dilution series of extract made from E. coli expressing MBP-Mto2 was 
analysed by SDS-PAGE. The integrated intensity of the Coomassie stain gel, 
scanned using the 600 channel, was quantified by Odyssey V3.0 [fig 5.10, Panel A]. 
This was compared to a standard curve from a Coomassie stained gel of known 
amounts of BSA [fig 5.10, Panel B].  On comparison with the calibration curve, the 
concentration of MBP-Mto2 was calculated as 0.15 µgµl-1.  
 
 For example, 6 µl of MBP-Mto2 has an intensity of 1.82 which corresponds 

































































In vivo Quantification of Mto2 
 
 Known amounts of MBP-Mto2 were then added to yeast xtract made from 3 
x106 cells [KS516], as determined using a haemocytometer. Extracts were then 
analysed by western blot and probed with anti-Mto2. IRDye800 signal from both 
endogenous Mto2 and MBP-Mto2 was quantified using Odyssey V3.0 [Licor 
Biosciences, U.S.A.]. Average intensity of endogenous Mto2 from 3 x 106 cells was 
calculated as 19.1, which when compared with the MBP-Mto2 calibration curve [fig 
5.11] equates to 0.61 ng of MBP-Mto2.  
Figure VII.a Quantification of MBP-Mto2. [A] Integrated intensities of a range 
of volumes of the MBP-Mto2 sample were measured using Odyssey V3.0 
software. Average intensity was compared with a BSA standard curve [B] and the 
concentration was calculated as 0.153 µgµl-1 
B 
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 The molecular weight of endogenous Mto2 is 44 kDa, therefore there are 
44,017.5 g in 1 mole. Avogadro’s constant states that there are 6.022x1023 molecules 
of Mto2 in 1 mole, therefore:  
 6.022 x 1023 / 44017.5 x 1012 pg = 1.368 x 107 molecules of Mto2 in 1 pg. 
  
0.61 ng of Mto2 in 3 x 106 cells 
2.03 x 10-10pg of Mto2 in 1 cell 
2.03 x 10-10pg X 1.368 x 107 molecules per pg = 2777 ± 277 molecules of Mto2 per 
cell.  
 The quantification of MBP-Mto2 used Coomassie stain o identify the protein. 
The stain binds to both MBP and Mto2 portions of the protein. The molecular weight 
of MBP is equal to Mto2 therefore the contribution of Mto2 to the concentration of 
the MBP-Mto2 is exactly half. Therefore, the in vivo quantification of Mto2 is an 
underestimate by a factor of two. Consequently, the molecules per cell can be 





















































Figure VII.b Calibration curve for MBP-Mto2. Known amount of MBP-Mto2 
were used to spike cell extracts. Extracts were then analysed by SDS-PAGE and 
the western blot was probed with α-Mto2. The integrated intensity of the signal 
from both endogenous and MBP-Mto2 was quantified by Od ssey V3.0. The 
average intensity for endogenous Mto2 was 19.1, which when compared to the 
MBP-Mto2 calibration curve was estimated to represent 0.61 ng of protein. 
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APPENDIX VIII 
 




 A dilution series of extract made for E. coli expressing Mto1-His6 was 
analysed by SDS-PAGE. The integrated intensity of the Coomassie stain gel scanned 
using the 600 channel, was quantified by Odyssey V3.0 [fig 5.12, Panel A]. This was 
compared to a standard curve from a Coomassie stained gel of known amounts of 
BSA [fig 5.12, Panel B].  On comparison with the calibr tion curve, the 
concentration of Mto1-6His was calculated as 0.18 µgµl-1. 
 
 For example, 5 µl of Mto1-6His has an intensity of 3.99 which corresponds to 















































In vivo Quantification of Mto1  
 
 Yeast extract was made from 6 x105 and 1.2 x 106 cells from strains 
expressing endogenous mto1+ and mto1∆ [KS516 and KS1017]. The mto1∆ extract 
was  spiked with serial dilutions of bacterial lysate containing known amounts of 
Mto1-6His.  Extracts were then analysed by SDS-PAGE and the western blot was 
probed α-Mto1 [fig 5.13, Panel A]. The integrated intensity of the IRDye800 signal 




















Figure VIII.a Quantification of Mto1-His6. (A) Integrated intensities of a range 
of volumes of the Mto1-6His sample was measured using Odyssey V3.0 software. 
Average intensity was compared with a BSA standard cu ve (B) and the 
concentration was calculated as 0.18 µgµl-1 
 
B 
   248  
endogenous Mto1 from 1.2 x 106 cells was calculated as 24.22, when compared with 
the Mto1-6His calibration curve equates to 0.34 ng of Mto1.  
 The molecular weight of endogenous Mto1 is 128,469.08 Da, therefore there 
are 128,469.08 g in 1 mole. Avogadro’s constant state  that there are 6.022x1023 
molecules of Mto1 in 1 mole, therefore: 
 6.022x1023 / 128,469.08 x 1012 pg = 4.69 x106 molecules of Mto1 in 1 pg. 
 
0.34 ng of Mto1 in 1.2 x 106 cells 
2.83 x 10-4 pg of Mto1 in 1 cell 
2.83 x 10-4 pg X 4.69 x 107 molecules per pg = 1327 ± 133 molecules of Mto1 per 
cell 
 Quantification has shown that the number of protein molecules of both Mto2 
and Mto1 present within the cell are approximately equal. This does not give any 
indication as to the relative levels of Mto1 and Mto2 present within a functional 
nucleation complex, as at any one time as not all of the expressed protein is 
incorporated at the MTOC.  
 When compared with quantification performed following a similar methods 
on other molecules, ~1,300 molecules per cell of both Mto1 and Mto2 fall within a 
similar range to proteins involved in the fission yeast cytoskeleton and cytokinesis 
(Wu et al. 2005). For example Sad1, a SPB protein, has 3,300 ± 1,100 molecules per 




   249  














































Figure VIII.b Quantification of cellular levels of Mto1. [A] Western blot analysis 
of endogenous Mto1, where Mto1-6His was added to extract from mto1∆ strain. 
Average signal intensity for endogenous Mto1 was compared with a calibration 
curve created from known amounts of Mto1-6His [B]. The amount of Mto1 
expressed from 1.2 x 106 cells was estimated as 0.34 ng of protein.  
B 
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2 MSEHNY S 0.004      yes [I] 
6 SEHNYQSDR Y 0.913       
8 HNYQSDREV S 0.792       
20 PFLNYEASA Y 0.311       
23 NYEASANQL S 0.003       
28 ANQLSSNSR S 0.046       
29 NQLSSNSRE S 0.997   yes    
31 LSSNSREST S 0.988   yes    
34 NSRESTPRG S 0.997       
35 SRESTPRGS T 0.996 yes 
AURORA/ 
PDB yes yes   
39 TPRGSPWRA S 0.994 yes 
AURORA/ 
CDK yes yes   
47 AGMRSASLM S 0.038   yes    
49 MRSASLMTE S 0.888  AURORA     
52 ASLMTEPLE T 0.04   yes    
58 PLEDSMYSD S 0.151       
60  EDSMYSDNN Y 0.98       
61 DSMYSDNNY S 0.074       
65 SDNNYLDNG Y 0.985       
71 DNGVSFTKD S 0.063       
73 GVSFTKDEN T 0.294       
80 ENPLYSPSW Y 0.798       
81 NPLYSPSWP S 0.926 yes  yes  yes yes 
83 LYSPSWPSL S 0.017       
86 PSWPSLADA S 0.394   yes    
94 ANVNSMKSN S 0.461       
97 NSMKSNNAI S 0.019   yes    
111 AKFVSEKSL S 0.965  AURORA   yes  
114 VSEKSLEKV S 0.902  POLO yes    
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119 LEKVSTADN S 0.955  POLO     
120 EKVSTADNN T 0.109  AURORA yes    
145 ELQLSERPS S 0.871       
149 SERPSSYLG S 0.938   yes    
150 ERPSSYLGY S 0.982  AURORA yes  yes  
151 RPSSYLGYH Y 0.094       
154 SYLGYHNNL Y 0.767       
159 HNNLSPYRS S 0.979 yes CDK  yes yes yes 
161 NLSPYRSPN  Y 0.242       
163 SPYRSPNSY S 0.732 yes     yes 
166 RSPNSYPSL S 0.597       
167 SPNSYPSLL Y 0.523 yes  yes  yes  
169 NSYPSLLPS S 0.313     yes yes 
173 SLLPSTHSP S 0.331   yes    
174 LLPSTHSPH T 0.029   yes  yes yes 
176 PSTHSPHSP S 0.93 yes  yes  yes yes 
179 HSPHSPAPL S 0.994 yes  yes  yes yes 
184 PAPLSTMQT S 0.797       
185 APLSTMQTA T 0.014     yes yes 
188 STMQTALMR T 0.12   yes    
195 MRLRTYHPS T 0.279  AURORA yes    
196 RLRTYHPSP Y 0.037       
199 TYHPSPIIL S 0.091 yes     yes [M] 
215 NHAITLVNT T 0.363   yes    
219 TLVNTSPSS T 0.058   yes    
220 LVNTSPSSV S 0.964 yes  yes    
222 NTSPSSVVD S 0.087   yes    
223 TSPSSVVDA S 0.995   yes    
231 ALCRSLAEL S 0.11   yes    
247 AIDASILSQ S 0.014       
250 ASILSQQES S 0.877       
254 SQQESSNSL S 0.164   yes    
255 QQESSNSLD S 0.098   yes    
257 ESSNSLDLV  S 0.027       
264 LVRHTPPLN T 0.169 yes AURORA yes yes yes  
   252  
269  PPLNYTSSV Y 0.171     yes  
270 PLNYTSSVD T 0.064   yes    
271 LNYTSSVDS S 0.955     yes  
272 NYTSSVDSS S 0.051     yes  
275 SSVDSSPQR S 0.643   yes  yes  
276 SVDSSPQRM S 0.985 yes CDK/PDB yes yes yes  
282 QRMASDSYG S 0.982  AURORA yes  yes yes 
284 MASDSYGRP S 0.988     yes  
285 ASDSYGRPS Y 0.9       
289 YGRPSLHLN S 0.981  AURORA    yes 
298 DPFPSVDLQ S 0.013   yes    
303 VDLQSNELS S 0.221  POLO    yes 
307 SNELSHHNV S 0.158   yes   yes [M] 
313 HNVRTTLFS T 0.015   yes    
314 NVRTTLFSD T 0.89  AURORA yes    
317 TTLFSDDSR S 0.337       
320 FSDDSRFHS S 0.268       
324 SRFHSKIHT S 0.988  AURORA     
328 SKIHTHSTP T 0.029  AURORA     
330  IHTHSTPPS S 0.381     yes  
331  HTHSTPPSQ T 0.578 yes PDB  yes yes yes 
334 STPPSQMYS S 0.104     yes  
337 PSQMYSAAS Y 0.081       
338 SQMYSAASH S 0.034       
341 YSAASHFRY S 0.978       
345 SHFRYRSDP Y 0.263       
347 FRYRSDPST S 0.846  AURORA     
350 RSDPSTRHV S 0.785       
351 SDPSTRHVS T 0.112       
355 TRHVSNSTN S 0.916  AURORA yes    
357 HVSNSTNKS S 0.8       
358 VSNSTNKSS T 0.167       
361 STNKSSLHP S 0.048     yes  
362 TNKSSLHPS S 0.782  AURORA   yes  
366 SLHPSPTSL S 0.964 yes   yes yes yes 
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368  HPSPTSLRV T 0.26       
369 PSPTSLRVA S 0.479     yes  
382 PQRASPASQ S 0.992 yes AURORA  yes   
385 ASPASQSFP S 0.974       
387 PASQSFPSL S 0.013   yes    
390 QSFPSLQDT S 0.992       
394 SLQDTPSP-  T 0.772 yes  yes yes   
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